Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

 



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

Date: October 26, 2021

 

UBS Group AG

Commission File Number: 1-36764

 

UBS AG

Commission File Number: 1-15060

 

 

(Registrants' Name)

 

Bahnhofstrasse 45, Zurich, Switzerland

Aeschenvorstadt 1, Basel, Switzerland

(Address of principal executive offices)

 

Indicate by check mark whether the registrants file or will file annual reports under cover of Form 20‑F or Form 40-F.

 

Form 20-F                         Form 40-F 

 

 


 

This Form 6-K consists of the Third Quarter 2021 Report of UBS Group AG, which appears immediately following this page.

 


 

 

 

Our financial results

 

Third quarter 2021 report 

 

 


 

 

   
 

 


 

 

Corporate calendar UBS Group AG

Publication of the fourth quarter 2021 report:                     Tuesday, 1 February 2022

Publication of the Annual Report 2021:                              Monday, 7 March 2022

Publication of the Sustainability Report 2021:                      Friday, 11 March 2022

Annual General Meeting 2022:                                         Wednesday, 6 April 2022

Publication of the first quarter 2022 report:                         Tuesday, 26 April 2022

 

Corporate calendar UBS AG

Publication of the third quarter 2021 report:                       Friday, 29 October 2021

Publication dates of future quarterly and annual reports and results are made available as part of the corporate calendar of UBS AG at ubs.com/investors

 

Contacts

Switchboards

For all general inquiries
ubs.com/contact 

Zurich +41-44-234 1111
London +44-207-567 8000
New York +1-212-821 3000
Hong Kong +852-2971 8888

Singapore +65-6495 8000

Investor Relations

UBS’s Investor Relations team manages relationships with institutional investors, research analysts and credit rating agencies.

ubs.com/investors

Zurich +41-44-234 4100
New York +1-212-882 5734

Media Relations

UBS’s Media Relations team manages relationships with global media and journalists.

ubs.com/media

Zurich +41-44-234 8500
mediarelations@ubs.com

London +44-20-7567 4714
ubs-media-relations@ubs.com

New York +1-212-882 5858
mediarelations@ubs.com

Hong Kong +852-2971 8200
sh-mediarelations-ap@ubs.com


Office of the Group Company Secretary

The Group Company Secretary handles
inquiries directed to the Chairman or to other members of the Board of Directors.

UBS Group AG, Office of the Group Company Secretary
P.O. Box, CH-8098 Zurich, Switzerland

sh-company-secretary@ubs.com

Zurich +41-44-235 6652

Shareholder Services

UBS’s Shareholder Services team, a unit
of the Group Company Secretary’s office,
manages relationships with shareholders and the registration of UBS Group AG registered shares.

UBS Group AG, Shareholder Services
P.O. Box, CH-8098 Zurich, Switzerland

sh-shareholder-services@ubs.com

Zurich +41-44-235 6652

US Transfer Agent

For global registered share-related
inquiries in the US.

Computershare Trust Company NA
P.O. Box 505000
Louisville, KY 40233-5000, USA

Shareholder online inquiries:
www-us.computershare.com/
investor/contact

Shareholder website:
computershare.com/investor 

Calls from the US
+1-866-305-9566
Calls from outside the US
+1-781-575-2623
TDD for hearing impaired
+1-800-231-5469
TDD for foreign shareholders
+1-201-680-6610

Imprint

Publisher: UBS Group AG, Zurich, Switzerland | ubs.com 
Language: English

© UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

 

 

  

 


Third quarter 2021 report 

Our key figures

 

 

As of or for the quarter ended

 

As of or year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

31.12.20

30.9.20

 

30.9.21

30.9.20

Group results

 

 

 

 

 

 

 

 

Operating income

 

 9,128 

 8,976 

 8,117 

 8,935 

 

 26,810 

 24,273 

Operating expenses

 

 6,264 

 6,384 

 6,132 

 6,357 

 

 19,054 

 18,103 

Operating profit / (loss) before tax

 

 2,865 

 2,593 

 1,985 

 2,578 

 

 7,755 

 6,169 

Net profit / (loss) attributable to shareholders

 

 2,279 

 2,006 

 1,636 

 2,093 

 

 6,109 

 4,921 

Diluted earnings per share (USD)1

 

 0.63 

 0.55 

 0.44 

 0.56 

 

 1.68 

 1.33 

Profitability and growth2

 

 

 

 

 

 

 

 

Return on equity (%)

 

 15.3 

 13.7 

 11.0 

 14.4 

 

 13.8 

 11.5 

Return on tangible equity (%)

 

 17.2 

 15.4 

 12.4 

 16.2 

 

 15.5 

 12.9 

Return on common equity tier 1 capital (%)

 

 20.8 

 19.3 

 16.8 

 21.9 

 

 19.5 

 17.6 

Return on risk-weighted assets, gross (%)

 

 12.2 

 12.2 

 11.4 

 12.7 

 

 12.2 

 11.8 

Return on leverage ratio denominator, gross (%)3

 

 3.5 

 3.4 

 3.2 

 3.7 

 

 3.4 

 3.5 

Cost / income ratio (%)

 

 68.7 

 71.8 

 74.9 

 70.4 

 

 71.4 

 72.7 

Effective tax rate (%)

 

 20.1 

 22.4 

 17.2 

 18.8 

 

 21.0 

 20.1 

Net profit growth (%)

 

 8.9 

 62.8 

 126.7 

 99.5 

 

 24.2 

 37.4 

Resources2

 

 

 

 

 

 

 

 

Total assets

 

 1,088,773 

 1,086,519 

 1,125,765 

 1,065,153 

 

 1,088,773 

 1,065,153 

Equity attributable to shareholders

 

 60,219 

 58,765 

 59,445 

 59,451 

 

 60,219 

 59,451 

Common equity tier 1 capital4

 

 45,022 

 42,583 

 39,890 

 38,197 

 

 45,022 

 38,197 

Risk-weighted assets4

 

 302,426 

 293,277 

 289,101 

 283,133 

 

 302,426 

 283,133 

Common equity tier 1 capital ratio (%)4

 

 14.9 

 14.5 

 13.8 

 13.5 

 

 14.9 

 13.5 

Going concern capital ratio (%)4

 

 20.0 

 20.2 

 19.4 

 19.2 

 

 20.0 

 19.2 

Total loss-absorbing capacity ratio (%)4

 

 34.0 

 35.6 

 35.2 

 34.5 

 

 34.0 

 34.5 

Leverage ratio denominator3,4

 

 1,044,916 

 1,039,939 

 1,037,150 

 994,366 

 

 1,044,916 

 994,366 

Common equity tier 1 leverage ratio (%)3,4

 

 4.31 

 4.09 

 3.85 

 3.84 

 

 4.31 

 3.84 

Going concern leverage ratio (%)3,4

 

 5.8 

 5.7 

 5.4 

 5.5 

 

 5.8 

 5.5 

Total loss-absorbing capacity leverage ratio (%)4

 

 9.8 

 10.0 

 9.8 

 9.8 

 

 9.8 

 9.8 

Liquidity coverage ratio (%)5

 

 157 

 156 

 152 

 154 

 

 157 

 154 

Net stable funding ratio (%)5

 

 118 

 115 

 119 

 117 

 

 118 

 117 

Other

 

 

 

 

 

 

 

 

Invested assets (USD billion)6

 

 4,432 

 4,485 

 4,187 

 3,807 

 

 4,432 

 3,807 

Personnel (full-time equivalents)

 

 71,427 

 71,304 

 71,551 

 71,230 

 

 71,427 

 71,230 

Market capitalization1

 

 55,423 

 53,218 

 50,013 

 40,113 

 

 55,423 

 40,113 

Total book value per share (USD)1

 

 17.48 

 16.90 

 16.74 

 16.57 

 

 17.48 

 16.57 

Total book value per share (CHF)1

 

 16.30 

 15.64 

 14.82 

 15.27 

 

 16.30 

 15.27 

Tangible book value per share (USD)1

 

 15.62 

 15.05 

 14.91 

 14.78 

 

 15.62 

 14.78 

Tangible book value per share (CHF)1

 

 14.57 

 13.92 

 13.21 

 13.61 

 

 14.57 

 13.61 

1 Refer to the “Share information and earnings per share” section of this report for more information.    2 Refer to the “Performance targets and capital guidance” section of our Annual Report 2020 for more information about our performance targets.    3 Leverage ratio denominators and leverage ratios for the respective periods in 2020 do not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    4 Based on the Swiss systemically relevant bank framework as of 1 January 2020. Refer to the “Capital management” section of this report for more information.    5 Prior-period “Net stable funding ratio” is based on estimated pro forma reporting. Refer to the “Liquidity and funding management” section of this report for more information.    6 Consists of invested assets for Global Wealth Management, Asset Management and Personal & Corporate Banking. Refer to “Note 32 Invested assets and net new money” in the “Consolidated financial statements” section of our Annual Report 2020 for more information.

 

 

Alternative performance measures

An alternative performance measure (an APM) is a financial measure of historical or future financial performance, financial position or cash flows other than a financial measure defined or specified in the applicable recognized accounting standards or in other applicable regulations. We report a number of APMs in the discussion of the financial and operating performance of the Group, our business divisions and our Group Functions. We use APMs to provide a more complete picture of our operating performance and to reflect management’s view of the fundamental drivers of our business results. A definition of each APM, the method used to calculate it and the information content are presented under “Alternative performance measures” in the appendix to this report. Our APMs may qualify as non-GAAP measures as defined by US Securities and Exchange Commission (SEC) regulations.

 

 

2 


 

UBS Group

Management report

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Terms used in this report, unless the context requires otherwise

“UBS,” “UBS Group,” “UBS Group AG consolidated,” “Group,” “the Group,” “we,” “us” and “our”

UBS Group AG and its consolidated subsidiaries

“UBS AG consolidated”

UBS AG and its consolidated subsidiaries

“UBS Group AG” and “UBS Group AG standalone”

UBS Group AG on a standalone basis

“UBS AG” and “UBS AG standalone”

UBS AG on a standalone basis

“UBS Switzerland AG” and “UBS Switzerland AG standalone”

UBS Switzerland AG on a standalone basis

“UBS Europe SE consolidated”

UBS Europe SE and its consolidated subsidiaries

“UBS Americas Holding LLC” and

“UBS Americas Holding LLC consolidated”

UBS Americas Holding LLC and its consolidated subsidiaries

 

 

 


Recent developments 

Recent developments

Regulatory and legal developments

Revision of the Swiss Liquidity Ordinance

In September 2021, the Swiss Federal Department of Finance launched a consultation on proposed revisions to the Swiss Liquidity Ordinance, with the aim of strengthening the resilience of systemically important banks in Switzerland. As proposed, the revisions would increase the regulatory minimum liquidity requirements for systemically important banks, including UBS. The consultation period is scheduled to end on 13 January 2022. UBS is assessing the implications of the proposed revisions.

Climate-related disclosure requirements

In August 2021, the Swiss Federal Council decided to introduce mandatory reporting requirements for large Swiss companies based on the recommendations of the Financial Stability Board (the FSB) Task Force on Climate-related Financial Disclosures (the TCFD). A consultation on the draft proposal is planned in mid-2022, with mandatory requirements expected to apply to the 2023 annual reporting. Our disclosures are already largely aligned with the 2017 TCFD recommendations and we expect to fully implement those by the end of 2022. Recently, the TCFD published a 2021 annex to its original 2017 recommendations, and we are currently analyzing the impact of these updates, including the implementation timelines.

Starting with our 2021 annual reporting, we will also comply with the revised Swiss Financial Market Supervisory Authority (FINMA) Circular 2016/1 “Disclosure – banks,” which includes climate risk-related disclosure requirements. We will further provide information required by Art. 8 of the EU Taxonomy Regulation, starting with the disclosure of taxonomy-eligible assets of UBS AG and UBS Europe SE on a standalone basis for the year-end 2021.

Registration under the US security-based swaps regulations

Under US Securities and Exchange Commission (SEC) regulations, UBS AG is required to register as a security-based swap dealer by 1 November 2021. On 8 October 2021, FINMA and the SEC finalized a memorandum of understanding relating to cooperation in oversight of Swiss entities registered under the SEC’s security-based swaps regulations. The SEC also published a substituted compliance order modifying the application of certain of its regulations for Swiss security-based swap dealers.

Stress capital buffer in the US

Following the completion of the annual Dodd–Frank Act Stress Testing (DFAST) and the Comprehensive Capital Analysis and Review (CCAR), UBS Americas Holding LLC was assigned a stress capital buffer (SCB) of 7.1% (previously 6.7%) under the SCB rule as of 1 October 2021, resulting in a total common equity tier 1 (CET1) capital requirement of 11.6%. As of 30 September 2021, the CET1 ratio of UBS Americas Holding LLC was 20.7%.


Removal of ECB restrictions on capital distributions by banks

In July 2021, the European Central Bank (the ECB) announced its decision to remove the COVID-19-related restrictions on capital distributions and share buybacks by banks with effect from 1 October 2021.

Other developments

Sale of domestic wealth management business in Austria

As announced in December 2020, we completed the sale of our domestic wealth management business in Austria to LGT in the third quarter of 2021. This sale is consistent with our ongoing effort in Europe to focus on our core markets and resulted in a pre-tax gain of USD 100 million in Global Wealth Management. The post-tax increase of UBS’s CET1 capital amounted to USD 78 million.

Strategic partnership with Sumitomo Mitsui Trust Holdings

In 2019, UBS entered into a strategic wealth management partnership in Japan with Sumitomo Mitsui Trust Holdings, Inc. (SuMi Trust Holdings). In January 2020, the first phase was launched, with operations commencing in the joint venture that was established to promote our respective services. At the time, UBS and SuMi Trust Holdings also started offering each other’s products and services to their respective clients.

In the third quarter of 2021, the second phase of the partnership was completed, with the launch of a new operational partnership entity, UBS SuMi TRUST Wealth Management Co., Ltd., which is 51% owned and controlled by UBS, requiring us to consolidate this entity. The new entity offers global securities and wealth management capabilities, together with the custody, real estate, inheritance and wealth transfer expertise of a Japanese trust banking group.

Upon completion of this transaction in the third quarter of 2021, UBS’s CET1 capital increased by USD 189 million, with no effect on profit or loss.

Sale of our domestic wealth management business in Spain

In October 2021, consistent with our ongoing efforts to focus on our core European markets, we signed an agreement to sell our domestic wealth management business in Spain to Singular Bank. The agreement includes the transition of employees, client relationships, products and services of the wealth management business of UBS in Spain. The transaction is subject to customary closing conditions and is planned to close in the third quarter of 2022. We expect to record a pre-tax gain of approximately USD 0.2 billion upon closing of the transaction.

  


 

Group performance

Income statement

 

 

 

 

 

 

 

 

 

 

 

 

For the quarter ended

 

% change from

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

Net interest income

 

 1,693 

 1,628 

 1,517 

 

 4 

 12 

 

 4,934 

 4,240 

Other net income from financial instruments measured at fair value through profit or loss

 

 1,697 

 1,479 

 1,769 

 

 15 

 (4) 

 

 4,485 

 5,507 

Credit loss (expense) / release

 

 14 

 80 

 (89) 

 

 (83) 

 

 

 121 

 (628) 

Fee and commission income

 

 6,119 

 6,041 

 5,211 

 

 1 

 17 

 

 18,330 

 15,418 

Fee and commission expense

 

 (510) 

 (484) 

 (440) 

 

 5 

 16 

 

 (1,472) 

 (1,316) 

Net fee and commission income

 

 5,610 

 5,557 

 4,771 

 

 1 

 18 

 

 16,858 

 14,103 

Other income

 

 115 

 233 

 967 

 

 (51) 

 (88) 

 

 412 

 1,052 

Total operating income

 

 9,128 

 8,976 

 8,935 

 

 2 

 2 

 

 26,810 

 24,273 

Personnel expenses

 

 4,598 

 4,772 

 4,631 

 

 (4) 

 (1) 

 

 14,170 

 13,235 

General and administrative expenses

 

 1,148 

 1,103 

 1,173 

 

 4 

 (2) 

 

 3,340 

 3,369 

Depreciation and impairment of property, equipment and software

 

 511 

 500 

 538 

 

 2 

 (5) 

 

 1,520 

 1,452 

Amortization and impairment of goodwill and intangible assets

 

 7 

 9 

 15 

 

 (22) 

 (54) 

 

 24 

 47 

Total operating expenses

 

 6,264 

 6,384 

 6,357 

 

 (2) 

 (1) 

 

 19,054 

 18,103 

Operating profit / (loss) before tax

 

 2,865 

 2,593 

 2,578 

 

 10 

 11 

 

 7,755 

 6,169 

Tax expense / (benefit)

 

 576 

 581 

 485 

 

 (1) 

 19 

 

 1,629 

 1,242 

Net profit / (loss)

 

 2,289 

 2,012 

 2,094 

 

 14 

 9 

 

 6,127 

 4,927 

Net profit / (loss) attributable to non-controlling interests

 

 9 

 6 

 0 

 

 67 

 

 

 18 

 6 

Net profit / (loss) attributable to shareholders

 

 2,279 

 2,006 

 2,093 

 

 14 

 9 

 

 6,109 

 4,921 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income

 

 

 

 

 

 

 

 

 

 

Total comprehensive income

 

 1,678 

 2,602 

 2,180 

 

 (35) 

 (23) 

 

 3,941 

 6,584 

Total comprehensive income attributable to non-controlling interests

 

 (5) 

 20 

 7 

 

 

 

 

 6 

 9 

Total comprehensive income attributable to shareholders

 

 1,683 

 2,582 

 2,173 

 

 (35) 

 (23) 

 

 3,935 

 6,575 

 

5 


Group performance  

Results: 3Q21 vs 3Q20

Profit before tax increased by USD 287 million, or 11%, to USD 2,865 million, reflecting higher operating income and lower operating expenses. Operating income increased by USD 193 million, or 2%, to USD 9,128 million, mainly reflecting USD 839 million higher net fee and commission income and a USD 105 million increase in net interest income and other net income from financial instruments measured at fair value through profit or loss. In addition, net credit loss releases were USD 14 million, compared with net credit loss expenses of USD 89 million in the prior-year quarter. These effects were partly offset by an USD 852 million decrease in other income, largely driven by significant non-recurring gains in the prior-year quarter, including gains from the sale of a majority stake in Fondcenter AG (now Clearstream Fund Centre AG) and from the sale of intellectual property rights associated with the Bloomberg Commodity Index family. Operating expenses decreased by USD 93 million, or 1%, to USD 6,264 million, mainly reflecting a USD 33 million decrease in personnel expenses, USD 27 million lower expenses related to depreciation and impairment of property, equipment and software, and a USD 25 million decrease in general and administrative expenses.

Operating income: 3Q21 vs 3Q20

Total operating income increased by USD 193 million, or 2%, to USD 9,128 million.


Net interest income and other net income from financial instruments measured at fair value through profit or loss

Total combined net interest income and other net income from financial instruments measured at fair value through profit or loss increased by USD 105 million to USD 3,391 million, mainly driven by Global Wealth Management and the Investment Bank, and partly offset by Group Functions.

Global Wealth Management increased by USD 171 million to USD 1,362 million, mainly driven by higher net interest income, reflecting an increase in loan and deposit volumes and higher loan margins, partly offset by lower deposit margins.

The Investment Bank increased by USD 63 million to USD 1,433 million, mainly reflecting USD 71 million higher net income in Financing, driven by capital market financing and prime brokerage products, and USD 27 million higher net income in Derivatives & Solutions as a result of higher revenues in the Equity Derivatives business, partly offset by lower revenues in Foreign Exchange, Rates and Credit. These effects were partly offset by USD 49 million lower revenues in Global Banking, due to net mark-to-market losses across loan and hedging portfolios and lower net interest income compared with the prior-year quarter.

Group Functions changed by USD 142 million, from positive income of USD 93 million to negative income of USD 49 million. This was largely due to the Group Treasury result of negative USD 30 million, compared with positive USD 75 million in the prior-year quarter, mainly due to the net effects related to accounting asymmetries, including hedge accounting ineffectiveness.

     Refer to “Note 3 Net interest income” in the “Consolidated financial statements” section of this report for more information about net interest income

 

 

Net interest income and other net income from financial instruments measured at fair value through profit or loss

 

 

For the quarter ended

 

% change from

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

Net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income

 

 1,356 

 1,270 

 1,199 

 

 7 

 13 

 

 3,890 

 3,309 

Net interest income from financial instruments measured at fair value through profit or loss

 

 338 

 357 

 318 

 

 (5) 

 6 

 

 1,044 

 930 

Other net income from financial instruments measured at fair value through profit or loss

 

 1,697 

 1,479 

 1,769 

 

 15 

 (4) 

 

 4,485 

 5,507 

Total

 

 3,391 

 3,106 

 3,286 

 

 9 

 3 

 

 9,419 

 9,747 

Global Wealth Management

 

 1,362 

 1,321 

 1,191 

 

 3 

 14 

 

 3,984 

 3,813 

of which: net interest income

 

 1,107 

 1,026 

 962 

 

 8 

 15 

 

 3,130 

 3,016 

of which: transaction-based income from foreign exchange and other intermediary activity1

 

 255 

 295 

 228 

 

 (14) 

 12 

 

 854 

 797 

Personal & Corporate Banking

 

 653 

 643 

 642 

 

 2 

 2 

 

 1,900 

 1,859 

of which: net interest income

 

 538 

 526 

 517 

 

 2 

 4 

 

 1,577 

 1,546 

of which: transaction-based income from foreign exchange and other intermediary activity1

 

 115 

 117 

 125 

 

 (1) 

 (8) 

 

 323 

 313 

Asset Management

 

 (9) 

 4 

 (9) 

 

 

 4 

 

 (13) 

 (15) 

Investment Bank2

 

 1,433 

 1,297 

 1,370 

 

 11 

 5 

 

 3,814 

 4,476 

Global Banking

 

 142 

 157 

 191 

 

 (9) 

 (26) 

 

 442 

 462 

Global Markets

 

 1,291 

 1,140 

 1,178 

 

 13 

 10 

 

 3,372 

 4,014 

Group Functions

 

 (49) 

 (158) 

 93 

 

 (69) 

 

 

 (268) 

 (386) 

1 Mainly includes spread-related income in connection with client-driven transactions, foreign currency translation effects and income and expenses from precious metals, which are included in the income statement line Other net income from financial instruments measured at fair value through profit or loss. The amounts reported on this line are one component of Transaction-based income in the management discussion and analysis in the “Global Wealth Management” and “Personal & Corporate Banking” sections of this report.    2 Investment Bank information is provided at the business-line level, rather than by financial statement reporting line, in order to reflect the underlying business activities, which is consistent with the structure of the management discussion and analysis in the “Investment Bank” section of this report.

 

6 


 

Net fee and commission income

Net fee and commission income increased by USD 839 million to USD 5,610 million.

Fees for portfolio management and related services increased by USD 524 million to USD 2,517 million, largely driven by Global Wealth Management, reflecting higher average fee-generating assets, due to positive market performance and net new fee-generating assets.

M&A and corporate finance fees increased by USD 130 million to USD 315 million, primarily reflecting higher revenues from merger and acquisition transactions in our Global Banking business in the Investment Bank, due to the higher number of transactions that closed.

Investment fund fees increased by USD 105 million to USD 1,428 million, driven by Global Wealth Management, mainly reflecting higher average fee-generating assets, and Asset Management, due to an increase in management fees, resulting from a higher average invested asset base, partly offset by lower performance-based fees.

Underwriting fees increased by USD 52 million to USD 348 million, driven by higher equity underwriting revenues from public offerings in the Investment Bank.

     Refer to “Note 4 Net fee and commission income” in the “Consolidated financial statements” section of this report for more information


Other income

Other income was USD 115 million, mainly reflecting a gain of USD 100 million from the sale of our domestic wealth management business in Austria to LGT. In comparison, other income in the third quarter of 2020 was USD 967 million and included a gain of USD 631 million from the sale of a majority stake in Fondcenter AG (now Clearstream Fund Centre AG) and a USD 215 million gain from the sale of intellectual property rights associated with the Bloomberg Commodity Index family.

     Refer to the “Recent developments” section of this report for more information about the sale of our domestic wealth management business in Austria

Credit loss expense / release

Total net credit loss releases were USD 14 million, compared with net credit loss expenses of USD 89 million in the prior-year quarter, reflecting net releases of USD 11 million related to stage 1 and 2 positions and net releases of USD 3 million related to credit-impaired (stage 3) positions.

     Refer to “Note 7 Expected credit loss measurement” in the “Consolidated financial statements” section of this report for more information

 

Credit loss (expense) / release

 

 

 

 

 

 

USD million

Global

Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total

For the quarter ended 30.9.21

 

 

 

 

 

 

Stages 1 and 2

 9 

 (1) 

 0 

 2 

 0 

 11 

Stage 3

 2 

 8 

 0 

 (7) 

 0 

 3 

Total credit loss (expense) / release

 11 

 7 

 0 

 (5) 

 0 

 14 

 

 

 

 

 

 

 

For the quarter ended 30.6.21

 

 

 

 

 

 

Stages 1 and 2

 13 

 51 

 0 

 24 

 (1) 

 88 

Stage 3

 0 

 (5) 

 0 

 (3) 

 0 

 (8) 

Total credit loss (expense) / release

 14 

 46 

 0 

 21 

 (1) 

 80 

 

 

 

 

 

 

 

For the quarter ended 30.9.20

 

 

 

 

 

 

Stages 1 and 2

 0 

 (21) 

 0 

 12 

 0 

 (8) 

Stage 3

 21 

 (71) 

 (2) 

 (27) 

 (2) 

 (81) 

Total credit loss (expense) / release

 22 

 (92) 

 (2) 

 (15) 

 (2) 

 (89) 

 

 

USD million

Global

Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total

Year-to-date 30.9.21

 

 

 

 

 

 

Stages 1 and 2

 27 

 66 

 0 

 32 

 0 

 124 

Stage 3

 0 

 10 

 0 

 (13) 

 0 

 (3) 

Total credit loss (expense) / release

 27 

 76 

 0 

 19 

 0 

 121 

 

 

 

 

 

 

 

Year-to-date 30.9.20

 

 

 

 

 

 

Stages 1 and 2

 (57) 

 (137) 

 0 

 (106) 

 0 

 (299) 

Stage 3

 (39) 

 (143) 

 (2) 

 (109) 

 (37) 

 (329) 

Total credit loss (expense) / release

 (96) 

 (279) 

 (2) 

 (215) 

 (37) 

 (628) 

 

 

7 


Group performance  

Operating expenses: 3Q21 vs 3Q20

Operating expenses decreased by USD 93 million, or 1%, to USD 6,264 million.

Personnel expenses

Personnel expenses decreased by USD 33 million to USD 4,598 million. The decrease mainly reflected lower expenses for variable compensation, as the third quarter of 2020 included a USD 359 million expense related to the modification of conditions for continued vesting of certain outstanding deferred compensation awards for qualifying employees. This decrease was largely offset by an increase in financial advisor compensation resulting from higher compensable revenues. In addition, restructuring expenses were USD 53 million, compared with zero in the prior-year quarter.

     Refer to “Note 5 Personnel expenses” in the “Consolidated financial statements” section of this report for more information

General and administrative expenses

General and administrative expenses decreased by USD 25 million, or 2%, to USD 1,148 million, driven by lower net expenses for litigation, regulatory and similar matters, and lower consulting fees, partly offset by higher IT expenses.  


We believe that the industry continues to operate in an environment in which expenses associated with litigation, regulatory and similar matters will remain elevated for the foreseeable future and we continue to be exposed to a number of significant claims and regulatory matters. The outcome of many of these matters, the timing of a resolution, and the potential effects of resolutions on our future business, financial results or financial condition are extremely difficult to predict.

     Refer to “Note 6 General and administrative expenses” in the “Consolidated financial statements” section of this report for more information

     Refer to “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report and to the “Regulatory and legal developments” and “Risk factors” sections of our Annual Report 2020 for more information about litigation, regulatory and similar matters

Depreciation, amortization and impairment

Depreciation and impairment of property, equipment and software decreased by USD 27 million, or 5%, to USD 511 million, resulting from lower accelerated depreciation expenses related to terminated real estate leases, partly offset by higher expenses for internally generated capitalized software.

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

For the quarter ended

 

% change from

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

Personnel expenses

 

 4,598 

 4,772 

 4,631 

 

 (4) 

 (1) 

 

 14,170 

 13,235 

of which: salaries and variable compensation

 

 2,659 

 2,945 

 2,948 

 

 (10) 

 (10) 

 

 8,475 

 8,206 

of which: financial advisor compensation1

 

 1,239 

 1,183 

 980 

 

 5 

 26 

 

 3,592 

 3,015 

of which: other personnel expenses2

 

 700 

 644 

 704 

 

 9 

 (1) 

 

 2,103 

 2,015 

General and administrative expenses

 

 1,148 

 1,103 

 1,173 

 

 4 

 (2) 

 

 3,340 

 3,369 

of which: net expenses for litigation, regulatory and similar matters

 

 12 

 63 

 41 

 

 (81) 

 (71) 

 

 84 

 49 

of which: other general and administrative expenses

 

 1,136 

 1,039 

 1,132 

 

 9 

 0 

 

 3,256 

 3,321 

Depreciation and impairment of property, equipment and software

 

 511 

 500 

 538 

 

 2 

 (5) 

 

 1,520 

 1,452 

Amortization and impairment of goodwill and intangible assets

 

 7 

 9 

 15 

 

 (22) 

 (54) 

 

 24 

 47 

Total operating expenses

 

 6,264 

 6,384 

 6,357 

 

 (2) 

 (1) 

 

 19,054 

 18,103 

1 Financial advisor compensation consists of grid-based compensation based directly on compensable revenues generated by financial advisors and supplemental compensation calculated on the basis of financial advisor productivity, firm tenure, assets and other variables. It also includes expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.    2 Consists of expenses related to contractors, social security, and post-employment benefit plans, as well as other personnel expenses.

 

Tax: 3Q21 vs 3Q20

We recognized income tax expenses of USD 576 million for the third quarter of 2021, representing an effective tax rate of 20.1%, compared with USD 485 million for the third quarter of 2020 and an effective tax rate of 18.8%. Current tax expenses were USD 432 million, compared with USD 349 million, and related to taxable profits of UBS Switzerland AG and other entities. Net deferred tax expenses were USD 144 million, compared with USD 136 million. These included net expenses of USD 229 million that primarily related to the amortization of deferred tax assets (DTAs) previously recognized in relation to tax losses carried forward and deductible temporary differences of UBS Americas Inc. Deferred tax expenses were decreased by a benefit of USD 85 million in respect of additional DTA recognition that primarily related to the contribution of real estate assets by UBS AG to UBS Americas Inc. and UBS Financial Services Inc. in the third quarter of 2021. This benefit represents three-quarters of the expected full-year benefit and, therefore, a further amount of USD 28 million will be recognized in the
fourth quarter of 2021 in accordance with the requirements of IAS 34,
Interim Financial Reporting

Excluding any potential effects from the reassessment of DTAs in connection with our business planning process and any potential US corporate tax rate changes or other jurisdictional statutory tax rate changes that could be enacted during the year, we expect a tax rate of slightly less than 25% for the fourth quarter of 2021, reflecting the benefit of the aforementioned increase in DTAs from the contribution of real estate assets. Any increase in the US federal tax rate could significantly impact the Group effective tax rate in the period in which it is enacted. Such a rate increase would increase the expected value of future tax savings from tax loss carry-forwards and deductible temporary differences in the US and would, therefore, result in a write-up of the associated DTAs. Based upon our current approach for DTA measurement, and assuming no other changes which impact the value of the US DTAs, we expect that the value of the US DTAs would increase by around USD 0.3 billion for each percentage point increase in the US federal corporate income tax rate.

 

8 


 

Total comprehensive income attributable to shareholders

In the third quarter of 2021, total comprehensive income attributable to shareholders was positive USD 1,683 million, reflecting net profit of USD 2,279 million and other comprehensive income (OCI), net of tax, of negative USD 596 million.

OCI related to cash flow hedges was negative USD 316 million, mainly reflecting net gains on hedging instruments that were reclassified from OCI to the income statement as the hedged forecast cash flows affected profit or loss in the third quarter of 2021.

Foreign currency translation OCI was negative USD 156 million, mainly resulting from the weakening of the euro (2%) and the Swiss franc (1%) against the US dollar.

OCI related to own credit on financial liabilities designated at fair value was negative USD 98 million, primarily due to a tightening of our own credit spreads.

OCI associated with financial assets measured at fair value through OCI was negative USD 33 million, mainly reflecting net unrealized losses of USD 44 million following increases in the relevant US dollar long-term interest rates in the third quarter of 2021.

     Refer to “Statement of comprehensive income” in the “Consolidated financial statements” section of this report for more information

     Refer to “Note 8 Fair value measurement” in the “Consolidated financial statements” section of this report for more information about own credit on financial liabilities designated at fair value

Sensitivity to interest rate movements

As of 30 September 2021, we estimate that a parallel shift in yield curves by +100 basis points could lead to a combined increase in annual net interest income of approximately USD 1.6 billion in Global Wealth Management and Personal & Corporate Banking. A parallel shift in yield curves by –100 basis points could lead to a combined reduction in annual net interest income of approximately USD 0.3 billion.

These estimates are based on a hypothetical scenario of an immediate change in interest rates, equal across all currencies and relative to implied forward rates as of 30 September 2021 applied to our banking book. These estimates further assume no change to balance sheet size and structure, constant foreign exchange rates and no specific management action.

     Refer to the “Risk management and control” section of this report for information about interest rate risk in the banking book


Key figures and personnel

Below we provide an overview of selected key figures of the Group. For further information about key figures related to capital management, refer to the “Capital management” section of this report.

Cost / income ratio: 3Q21 vs 3Q20

The cost / income ratio was 68.7%, compared with 70.4%, reflecting a decrease in expenses and an increase in income. The cost / income ratio is measured based on income before credit loss expenses or releases.

Common equity tier 1 capital: 3Q21 vs 2Q21

During the third quarter of 2021, our common equity tier 1 (CET1) capital increased by USD 2.4 billion to USD 45.0 billion, mainly reflecting operating profit before tax of USD 2.9 billion, an increase of USD 0.2 billion related to the launch of our new operational partnership entity with Sumitomo Mitsui Trust Holdings, Inc. and USD 0.2 billion higher eligible deferred tax assets on temporary differences. These effects were partly offset by current tax expenses of USD 0.4 billion, accruals for capital returns to shareholders of USD 0.3 billion and negative foreign currency translation effects of USD 0.2 billion.

Our share repurchases in the third quarter of 2021 did not materially affect our CET1 capital position, as there was a nearly equivalent reduction in the remaining capital reserve for potential share repurchases. The remaining capital reserve for potential share repurchases was fully utilized during the third quarter of 2021.

Return on CET1 capital: 3Q21 vs 3Q20

The annualized return on CET1 capital (RoCET1) was 20.8%, compared with 21.9%, driven by higher average CET1 capital, partly offset by an increase in net profit attributable to shareholders.

Risk-weighted assets: 3Q21 vs 2Q21

Risk-weighted assets (RWA) increased by USD 9.1 billion to USD 302.4 billion, driven by increases from regulatory add-ons of USD 7.0 billion, asset size and other movements of USD 3.2 billion, and model updates of USD 0.6 billion, partly offset by a decrease from currency effects of USD 1.6 billion, as well as methodology and policy changes of USD 0.1 billion.

 

 


Group performance  

Common equity tier 1 capital ratio: 3Q21 vs 2Q21

Our CET1 capital ratio increased 0.4 percentage points to 14.9%, reflecting an increase in CET1 capital of USD 2.4 billion, partly offset by a USD 9.1 billion increase in RWA.

Leverage ratio denominator: 3Q21 vs 2Q21

The leverage ratio denominator (LRD) increased by USD 5 billion to USD 1,045 billion, reflecting an increase in asset size and other movements of USD 12 billion, partly offset by a decrease due to currency effects of USD 7 billion.

Common equity tier 1 leverage ratio: 3Q21 vs 2Q21

Our CET1 leverage ratio increased from 4.09% to 4.31%, due to the aforementioned USD 2.4 billion increase in CET1 capital, partly offset by a USD 5 billion increase in LRD.


Going concern leverage ratio: 3Q21 vs 2Q21

Our going concern leverage ratio increased from 5.7% to 5.8% in the third quarter of 2021, reflecting an increase in going concern capital of USD 1.2 billion, partly offset by a USD 5 billion increase in LRD.

Personnel: 3Q21 vs 2Q21

The number of personnel employed as of 30 September 2021 was broadly stable at 71,427 (full-time equivalents), a net increase of 123 compared with 30 June 2021.

 

 

Return on equity and CET1 capital

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

Year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

Net profit

 

 

 

 

 

 

 

Net profit / (loss) attributable to shareholders

 

 2,279 

 2,006 

 2,093 

 

 6,109 

 4,921 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

Equity attributable to shareholders

 

 60,219 

 58,765 

 59,451 

 

 60,219 

 59,451 

Less: goodwill and intangible assets

 

 6,401 

 6,452 

 6,428 

 

 6,401 

 6,428 

Tangible equity attributable to shareholders

 

 53,819 

 52,313 

 53,023 

 

 53,819 

 53,023 

Less: other CET1 deductions

 

 8,797 

 9,730 

 14,826 

 

 8,797 

 14,826 

CET1 capital

 

 45,022 

 42,583 

 38,197 

 

 45,022 

 38,197 

 

 

 

 

 

 

 

 

Returns

 

 

 

 

 

 

 

Return on equity (%)

 

 15.3 

 13.7 

 14.4 

 

 13.8 

 11.5 

Return on tangible equity (%)

 

 17.2 

 15.4 

 16.2 

 

 15.5 

 12.9 

Return on CET1 capital (%)

 

 20.8 

 19.3 

 21.9 

 

 19.5 

 17.6 

 

 

Results: 9M21 vs 9M20

Profit before tax increased by USD 1,586 million, or 26%, to USD 7,755 million. Operating income increased by USD 2,537 million, or 10%, to USD 26,810 million.

Net fee and commission income increased by USD 2,755 million to USD 16,858 million, mainly reflecting higher fees for portfolio management and related services and investment fund fees, largely driven by the effect of higher average fee-generating assets in Global Wealth Management. Underwriting fees and M&A and corporate finance fees increased, driven by the Investment Bank, reflecting elevated levels of IPO activity and the higher number of merger and acquisition transactions that closed in the period, respectively. In addition, net brokerage fees increased, reflecting higher levels of client activity in the Cash Equities business of the Investment Bank, as well as in Global Wealth Management.

Net credit loss releases were USD 121 million, compared with net credit loss expenses of USD 628 million.

Total combined net interest income and other net income from financial instruments measured at fair value through profit or loss decreased by USD 328 million to USD 9,419 million. Income was USD 662 million lower in the Investment Bank, reflecting a loss of USD 861 million on the default by a client of our prime brokerage business. Excluding this loss, the Investment Bank increased, mainly driven by USD 191 million higher income in Derivatives & Solutions, mainly due to an increase in revenues from equity derivatives, partly offset by lower income from foreign exchange, rates and credit products. Global Wealth Management increased by USD 171 million, mainly driven by higher net interest income, and Group Functions recognized valuation gains of USD 46 million on auction rate securities in Non-core and Legacy Portfolio, compared with valuation losses of USD 143 million in the prior-year period.

Other income was USD 412 million, reflecting gains from the sale of our domestic wealth management business in Austria and on properties held for sale, as well as income related to a legacy bankruptcy claim, a valuation gain in relation to our equity ownership of SIX Group and a gain from the sale of our remaining minority investment in Clearstream Fund Centre AG (previously Fondcenter AG). In the prior-year period, other income was a USD 1,052 million, mainly reflecting the USD 631 million gain from the partial sale of Fondcenter AG (now Clearstream Fund Centre AG) and a USD 215 million gain from the sale of intellectual property rights associated with the Bloomberg Commodity Index family.

 

10 


 

Operating expenses increased by USD 951 million, or 5%, to USD 19,054 million, and included net restructuring expenses of USD 156 million compared with USD 107 million. Personnel expenses increased by USD 935 million, mainly driven by USD 577 million higher financial advisor compensation as a result of higher compensable revenues. Expenses for salaries and variable compensation increased by USD 269 million, mainly driven by higher salary costs, reflecting foreign currency translation effects, higher restructuring expenses and the insourcing of certain activities from third-party vendors, partly offset by lower expenses for variable compensation, as the prior-year period included expenses related to the modification of conditions for continued vesting of certain outstanding deferred compensation awards.

Outlook

Investor sentiment remained positive in the third quarter of 2021, helped by the continued rebound in economic activity and greater optimism regarding further recovery, which was supported by mass COVID-19 vaccination campaigns around the globe and the ongoing lifting of lockdowns and similar measures imposed to control the pandemic. Fiscal stimulus, along with continued accommodative monetary policy and strong economic data, contributed to generally more positive views on the timing and extent of a sustainable economic recovery.

However, economic, social, and geopolitical tensions remain, raising questions around the sustainability and shape of the recovery. Continued localized outbreaks of COVID-19 infections and the spread of new variants, along with uneven vaccination rates, add to these existing concerns. The severity and duration of the effects of the pandemic on certain economic sectors, supply chains and labor markets also remain uncertain. Indications of rising inflation that could lead to more restrictive monetary policy have become an additional concern for the market.

Our clients value strength and expert guidance, particularly in these uncertain times, and we remain focused on supporting them with advice and solutions. We expect our revenues in the fourth quarter of 2021 to be influenced by seasonal factors, such as lower client activity levels compared with the third quarter of 2021, which saw unusually high levels for a third quarter. Asset prices remain high, supporting recurring fee income in our asset-gathering businesses. However, the continued uncertainty about the environment, including recent policy changes in China, and economic recovery could affect both asset prices and client activity levels.

  

11 


 

 


 

UBS business
divisions
and Group Functions

 Management report

  

 


Global Wealth Management 

Global Wealth Management

Global Wealth Management1

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

% change from

 

Year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

 

 

 

Results

 

 

 

 

 

 

 

 

 

 

Net interest income

 

 1,107 

 1,026 

 962 

 

 8 

 15 

 

 3,130 

 3,016 

Recurring net fee income2

 

 2,872 

 2,774 

 2,341 

 

 4 

 23 

 

 8,274 

 6,904 

Transaction-based income3

 

 894 

 953 

 863 

 

 (6) 

 4 

 

 3,029 

 2,800 

Other income

 

 119 

 8 

 92 

 

 

 30 

 

 163 

 145 

Income

 

 4,992 

 4,760 

 4,258 

 

 5 

 17 

 

 14,598 

 12,865 

Credit loss (expense) / release

 

 11 

 14 

 22 

 

 (21) 

 (51) 

 

 27 

 (96) 

Total operating income

 

 5,002 

 4,774 

 4,280 

 

 5 

 17 

 

 14,625 

 12,769 

Total operating expenses

 

 3,486 

 3,479 

 3,223 

 

 0 

 8 

 

 10,405 

 9,614 

Business division operating profit / (loss) before tax

 

 1,516 

 1,294 

 1,057 

 

 17 

 43 

 

 4,220 

 3,155 

 

 

 

 

 

 

 

 

 

 

 

Performance measures and other information

 

 

 

 

 

 

 

 

 

 

Financial advisor variable compensation4,5

 

 1,119 

 1,065 

 858 

 

 5 

 30 

 

 3,231 

 2,635 

Compensation commitments with recruited financial advisors4,6

 

 120 

 118 

 122 

 

 2 

 (2) 

 

 361 

 380 

Pre-tax profit growth (%)

 

 43.5 

 47.1 

 18.2 

 

 

 

 

 33.8 

 19.9 

Cost / income ratio (%)

 

 69.8 

 73.1 

 75.7 

 

 

 

 

 71.3 

 74.7 

Average attributed equity (USD billion)7

 

 19.0 

 18.5 

 17.4 

 

 3 

 9 

 

 18.6 

 16.8 

Return on attributed equity (%)7

 

 31.9 

 27.9 

 24.3 

 

 

 

 

 30.2 

 25.0 

Risk-weighted assets (USD billion)7

 

 95.7 

 92.0 

 85.0 

 

 4 

 13 

 

 95.7 

 85.0 

Leverage ratio denominator (USD billion)7,8

 

 391.3 

 379.2 

 346.1 

 

 3 

 13 

 

 391.3 

 346.1 

Goodwill and intangible assets (USD billion)

 

 5.0 

 5.1 

 5.1 

 

 0 

 (1) 

 

 5.0 

 5.1 

Net new fee-generating assets (USD billion)

 

 18.8 

 25.0 

 5.1 

 

 

 

 

 80.0 

 22.8 

Fee-generating assets (USD billion)

 

 1,412 

 1,416 

 1,163 

 

 0 

 21 

 

 1,412 

 1,163 

Fee-generating asset margin (bps)9

 

 81.9 

 82.3 

 85.4 

 

 

 

 

 83.4 

 87.5 

Invested assets (USD billion)

 

 3,198 

 3,230 

 2,754 

 

 (1) 

 16 

 

 3,198 

 2,754 

Client assets (USD billion)10

 

 3,602 

 3,658 

 3,062 

 

 (2) 

 18 

 

 3,602 

 3,062 

Loans, gross (USD billion)11

 

 230.7 

 228.1 

 201.5 

 

 1 

 15 

 

 230.7 

 201.5 

Customer deposits (USD billion)11

 

 351.8 

 344.2 

 320.8 

 

 2 

 10 

 

 351.8 

 320.8 

Recruitment loans to financial advisors4

 

 1,876 

 1,821 

 1,863 

 

 3 

 1 

 

 1,876 

 1,863 

Other loans to financial advisors4

 

 623 

 594 

 718 

 

 5 

 (13) 

 

 623 

 718 

Impaired loan portfolio as a percentage of total loan portfolio, gross (%)12,13

 

 0.2 

 0.3 

 0.4 

 

 

 

 

 0.2 

 0.4 

Advisors (full-time equivalents)

 

 9,399 

 9,480 

 9,688 

 

 (1) 

 (3) 

 

 9,399 

 9,688 

1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.    2 Recurring net fee income consists of fees for services provided on an ongoing basis, such as portfolio management fees, asset-based investment fund fees and custody fees, which are generated on client assets, as well as administrative fees for accounts.    3 Transaction-based income consists of the non-recurring portion of net fee and commission income, mainly composed of brokerage and transaction-based investment fund fees, and credit card fees, as well as fees for payment and foreign exchange transactions, together with other net income from financial instruments measured at fair value through profit or loss.    4 Relates to licensed professionals with the ability to provide investment advice to clients in the Americas.    5 Financial advisor variable compensation consists of formulaic compensation based directly on compensable revenues generated by financial advisors and supplemental compensation calculated on the basis of financial advisor productivity, firm tenure, new assets and other variables.    6 Compensation commitments with recruited financial advisors represent expenses related to compensation commitments granted to financial advisors at the time of recruitment that are subject to vesting requirements.    7 Refer to the “Capital management” section of this report for more information.    8 The leverage ratio denominator calculated as of the respective date in 2020 does not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    9 Calculated as revenues from fee-generating assets (a portion of which is included in recurring fee income and a portion of which is included in transaction-based income, annualized as applicable) divided by average fee-generating assets for the relevant mandate fee billing period. For the US, fees have been billed on daily balances since the fourth quarter of 2020 and average fee-generating assets are calculated as the average of the monthly average balances. Prior to the fourth quarter of 2020, billing was based on prior quarter-end balances, and the average fee-generating assets were thus the prior quarter-end balance. For balances outside of the US, billing is based on prior month-end balances and average fee-generating assets were thus the average of the prior month-end balances.    10 Client assets are composed of invested assets and other assets held purely for transactional purposes or custody only.    11 Loans and Customer deposits in this table include customer brokerage receivables and payables, respectively, which are presented in a separate reporting line on the balance sheet.    12 Refer to the “Risk management and control” section of this report for more information about (credit-)impaired exposures.    13 Excludes loans to financial advisors.

 

14 


 

Results: 3Q21 vs 3Q20

Profit before tax increased by USD 459 million, or 43%, to USD 1,516 million, reflecting higher operating income, partly offset by higher operating expenses.

Operating income

Total operating income increased by USD 722 million, or 17%, to USD 5,002 million, with increases across all income lines.

Net interest income increased by USD 145 million to USD 1,107 million, mainly driven by higher loan revenues, reflecting an increase in loan volumes and margins, as well as higher deposit revenues, resulting from an increase in deposit volumes and despite lower margins.

Recurring net fee income increased by USD 531 million, or 23%, to USD 2,872 million, primarily driven by higher average fee-generating assets, reflecting positive market performance and net new fee-generating assets.

Transaction-based income increased by USD 31 million, or 4%, to USD 894 million, mainly driven by high levels of client activity in the Americas, EMEA and Switzerland.

Other income increased by USD 27 million to USD 119 million, including a USD 100 million gain from the sale of our domestic wealth management business in Austria to LGT. The third quarter of 2020 included a gain of USD 60 million from the sale of a majority stake in Fondcenter AG (now Clearstream Fund Centre AG) and a valuation gain of USD 6 million on our equity ownership of SIX Group.

Net credit loss releases were USD 11 million, primarily related to stage 1 and 2 positions, compared with net releases of USD 22 million.

Operating expenses

Total operating expenses increased by USD 263 million, or 8%, to USD 3,486 million. The increase was driven by higher financial advisor variable compensation, reflecting an increase in compensable revenues, and higher restructuring expenses.

Fee-generating assets: 3Q21 vs 2Q21

Fee-generating assets decreased by USD 4.7 billion, to USD 1,412 billion, mainly driven by net negative market performance and foreign currency effects of USD 23.5 billion. These were largely offset by net new fee-generating asset inflows of USD 18.8 billion.

 


Loans: 3Q21 vs 2Q21

Loans increased by USD 2.6 billion, or 1%, to USD 230.7 billion, mainly driven by net new loans of USD 3.3 billion, partly offset by USD 0.9 billion from negative foreign exchange effects. Net new loans were largely driven by an increase in mortgages and Lombard loans. Loan penetration increased from 7.1% to 7.2% in the third quarter of 2021.

Results: 9M21 vs 9M20

Profit before tax increased by USD 1,065 million, or 34%, to USD 4,220 million, reflecting higher operating income, partly offset by higher operating expenses.

Total operating income increased by USD 1,856 million, or 15%, to USD 14,625 million, with increases across all income lines.

Net interest income increased by USD 114 million to USD 3,130 million, as higher loan revenues from higher loan volumes and margins more than offset lower deposit revenues, mainly as a result of lower US dollar interest rates.

Recurring net fee income increased by USD 1,370 million, or 20%, to USD 8,274 million, primarily driven by higher average fee-generating assets, reflecting positive market performance and net new fee-generating assets.

Transaction-based income increased by USD 229 million to USD 3,029 million, reflecting higher levels of client activity across all regions.

Other income increased by USD 18 million to USD 163 million, mainly related to the aforementioned sale of our domestic wealth management business in Austria to LGT in the third quarter of 2021. The first nine months of 2020 included the aforementioned gain of USD 60 million from the sale of a majority stake in Fondcenter AG (now Clearstream Fund Centre AG).

Net credit loss releases were USD 27 million, primarily related to stage 1 and 2 positions, compared with net expenses of USD 96 million.

Total operating expenses increased by USD 791 million, or 8%, to USD 10,405 million, mostly driven by higher financial advisor variable compensation and higher technology expenses, partly offset by lower expenses for provisions for litigation, regulatory and similar matters, as well as lower expenses for professional fees and travel.

 

15 


Global Wealth Management 

Regional breakdown of performance measures

 

 

 

As of or for the quarter ended 30.9.21

USD billion, except where indicated

Americas1

Switzerland

EMEA2

Asia Pacific

Global Wealth Management3

Total operating income (USD million)

 2,741 

 489 

 1,067 

 703 

 5,002 

Total operating expenses (USD million)

 2,182 

 267 

 620 

 410 

 3,486 

Operating profit / (loss) before tax (USD million)

 559 

 222 

 447 

 293 

 1,516 

Cost / income ratio (%)

 79.8 

 54.6 

 58.1 

 58.5 

 69.8 

Loans, gross

 87.54

 42.3 

 49.1 

 50.7 

 230.7 

Net new loans

 4.4 

 0.4 

 0.7 

 (2.2) 

 3.3 

Loan penetration (%)5

 5.0 

 14.9 

 7.8 

 9.3 

 7.2 

Fee-generating assets

 848 

 123 

 326 

 113 

 1,412 

Net new fee-generating assets

 11.8 

 2.9 

 6.0 

 (1.8) 

 18.8 

Invested assets

 1,736 

 284 

 629 

 546 

 3,198 

Advisors (full-time equivalents)

 6,266 

 682 

 1,503 

 865 

 9,399 

1 Including the following business units: United States and Canada; and Latin America.    2 Including the following business units: Europe; Central & Eastern Europe, Greece and Israel; and Middle East and Africa.    3 Including minor functions, which are not included in the four regions individually presented in this table, with USD 3 million of total operating income, USD 8 million of total operating expenses, USD 6 million of operating loss before tax, USD 1.1 billion of loans, USD 0.0 billion of net new loan inflows, USD 1 billion of fee-generating assets, USD 0.1 billion of net new fee-generating asset outflows, USD 3 billion of invested assets and 84 advisors in the third quarter of 2021.    4 Loans include customer brokerage receivables, which are presented in a separate reporting line on the balance sheet.    5 Loans, gross as a percentage of invested assets.

 

 

Regional comments 3Q21 vs 3Q20, except where indicated

Americas

Profit before tax increased by USD 188 million to USD 559 million. Operating income increased by USD 506 million, or 23%, to USD 2,741 million, mainly driven by higher recurring net fee and net interest income. The cost / income ratio decreased from 84.1% to 79.8%. Loans increased 5% compared with the second quarter of 2021, to USD 88 billion, reflecting USD 4.4 billion of net new loans, which were mostly Lombard loans and mortgages. Fee-generating assets increased sequentially to USD 848 billion, mainly driven by net new fee-generating assets of USD 11.8 billion, partly offset by negative market performance.

Switzerland

Profit before tax increased by USD 55 million to USD 222 million. Operating income increased by USD 51 million, or 12%, to USD 489 million, mainly driven by higher recurring net fee and net interest income. The cost / income ratio decreased from 62.0% to 54.6%. Loans increased 1% sequentially to USD 42 billion, largely reflecting USD 0.4 billion of net new loans. Fee-generating assets were unchanged compared with the second quarter of 2021 at USD 123 billion, as net new fee-generating assets of USD 2.9 billion were offset by net negative market performance and foreign currency effects.


EMEA

Profit before tax increased by USD 190 million to USD 447 million. Operating income increased by USD 174 million, or 20%, to USD 1,067 million, mainly driven by recurring net fee income and other income, reflecting the aforementioned gain from the sale of our domestic wealth management business in Austria. The cost / income ratio decreased from 71.3% to 58.1%. Loans were broadly unchanged compared with the second quarter of 2021 at USD 49 billion, as net new loans of USD 0.7 billion were entirely offset by negative foreign currency effects. Fee-generating assets decreased 1% sequentially to USD 326 billion, mainly driven by net negative market performance and foreign currency effects of USD 9.2 billion. This was partly offset by net new fee-generating assets of USD 6.0 billion.

Asia Pacific

Profit before tax increased by USD 32 million to USD 293 million. Operating income was stable at USD 703 million, as higher recurring net fee and net interest income was offset by lower transaction-based income. The cost / income ratio decreased from 63.1% to 58.5%. Loans decreased 4% sequentially to USD 51 billion, driven by net new loan outflows of USD 2.2 billion, mostly in Lombard loans. Fee-generating assets decreased 5% sequentially to USD 113 billion, mainly driven by net negative market performance and foreign currency effects of USD 3.9 billion, and net new fee-generating asset outflows of USD 1.8 billion.

 

  


 

Personal & Corporate Banking

Personal & Corporate Banking – in Swiss francs1

 

 

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

% change from

 

Year-to-date

CHF million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

 

 

 

Results

 

 

 

 

 

 

 

 

 

 

Net interest income

 

 494 

 480 

 472 

 

 3 

 5 

 

 1,444 

 1,461 

Recurring net fee income2

 

 201 

 187 

 170 

 

 8 

 18 

 

 569 

 499 

Transaction-based income3

 

 281 

 288 

 264 

 

 (2) 

 7 

 

 808 

 755 

Other income

 

 19 

 40 

 29 

 

 (52) 

 (33) 

 

 98 

 59 

Income

 

 995 

 995 

 935 

 

 0 

 6 

 

 2,919 

 2,774 

Credit loss (expense) / release

 

 6 

 42 

 (84) 

 

 (85) 

 

 

 70 

 (263) 

Total operating income

 

 1,002 

 1,037 

 850 

 

 (3) 

 18 

 

 2,989 

 2,511 

Total operating expenses

 

 563 

 581 

 545 

 

 (3) 

 3 

 

 1,736 

 1,655 

Business division operating profit / (loss) before tax

 

 439 

 456 

 305 

 

 (4) 

 44 

 

 1,253 

 856 

 

 

 

 

 

 

 

 

 

 

 

Performance measures and other information

 

 

 

 

 

 

 

 

 

 

Average attributed equity (CHF billion)4

 

 8.4 

 8.4 

 8.2 

 

 1 

 2 

 

 8.3 

 8.3 

Return on attributed equity (%)4

 

 20.9 

 21.8 

 14.9 

 

 

 

 

 20.0 

 13.7 

Pre-tax profit growth (%)

 

 43.7 

 99.5 

 (13.4) 

 

 

 

 

 46.3 

 (24.0) 

Cost / income ratio (%)

 

 56.6 

 58.4 

 58.3 

 

 

 

 

 59.5 

 59.6 

Net interest margin (bps)

 

 142 

 139 

 139 

 

 

 

 

 139 

 145 

Risk-weighted assets (CHF billion)4

 

 66.5 

 66.3 

 64.8 

 

 0 

 3 

 

 66.5 

 64.8 

Leverage ratio denominator (CHF billion)4,5

 

 219.7 

 220.8 

 216.6 

 

 0 

 1 

 

 219.7 

 216.6 

Business volume for Personal Banking (CHF billion)

 

 184 

 183 

 175 

 

 0 

 5 

 

 184 

 175 

Net new business volume for Personal Banking (CHF billion)

 

 1.2 

 0.6 

 2.4 

 

 

 

 

 5.1 

 9.5 

Net new business volume growth for Personal Banking (%)6

 

 2.5 

 1.2 

 5.6 

 

 

 

 

 3.8 

 7.5 

Active Digital Banking clients in Personal Banking (%)7

 

 70.2 

 69.8 

 66.3 

 

 

 

 

 69.8 

 65.5 

Active Digital Banking clients in Corporate & Institutional Clients (%)8

 

 78.9 

 79.1 

 77.8 

 

 

 

 

 79.1 

 77.6 

Mobile Banking log-in share in Personal Banking (%)9

 

 75.1 

 72.6 

 69.8 

 

 

 

 

 72.6 

 67.1 

Client assets (CHF billion)10

 

 738 

 742 

 678 

 

 0 

 9 

 

 738 

 678 

Loans, gross (CHF billion)

 

 138.9 

 138.6 

 136.6 

 

 0 

 2 

 

 138.9 

 136.6 

Customer deposits (CHF billion)

 

 159.8 

 159.7 

 157.0 

 

 0 

 2 

 

 159.8 

 157.0 

Secured loan portfolio as a percentage of total loan portfolio, gross (%)

 

 93.0 

 92.6 

 92.2 

 

 

 

 

 93.0 

 92.2 

Impaired loan portfolio as a percentage of total loan portfolio, gross (%)11

 

 1.0 

 1.0 

 1.1 

 

 

 

 

 1.0 

 1.1 

1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.    2 Recurring net fee income consists of fees for services provided on an ongoing basis, such as portfolio management fees, asset-based investment fund fees and custody fees, which are generated on client assets, as well as administrative fees for accounts.    3 Transaction-based income consists of the non-recurring portion of net fee and commission income, mainly composed of brokerage and transaction-based investment fund fees, and credit card fees, as well as fees for payment and foreign exchange transactions, together with other net income from financial instruments measured at fair value through profit or loss.    4 Refer to the “Capital management” section of this report for more information.    5 The leverage ratio denominator calculated as of the respective date in 2020 does not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    6 Calculated as net new business volume for the period (annualized as applicable) divided by business volume at the beginning of the period.    7 “Clients” refers to the number of unique business relationships operated by Personal Banking. At the end of each month, any client that has logged on at least once in that month is determined to be “active” (a log-in time stamp is allocated to all business relationship numbers in a digital banking contract). Excluded are persons under the age of 15, clients who do not have a private account, clients domiciled outside Switzerland, and clients who have defaulted on loans or credit facilities. In the third quarter of 2021, 87.1% of clients of Personal Banking were “activated users” of Digital Banking (i.e., clients who had logged into Digital Banking at least once in the course of their relationship with UBS).    8 “Clients” refers to the number of unique business relationships or legal entities operated by Corporate & Institutional Clients. Excluded are clients that do not have an account, mono-product clients and clients that have defaulted on loans or credit facilities. Refer to footnote 7 for the definition of “active” clients (a log-in time stamp is allocated to all business relationship numbers or per legal entity in a digital banking contract).    9 Mobile Banking app log-ins as a percentage of total log-ins via E-Banking and Mobile Banking app in Personal Banking (if a digital banking contract is linked to multiple business relationships, the log-in is attributed to the business relationship with the most banking products in use).    10 Client assets are composed of invested assets and other assets held purely for transactional purposes or custody only. Net new money is not measured for Personal & Corporate Banking.    11 Refer to the “Risk management and control” section of this report for more information about (credit-)impaired exposures.

 

 

17 


Personal & Corporate Banking 

Results: 3Q21 vs 3Q20

Profit before tax increased by CHF 134 million, or 44%, to CHF 439 million, reflecting higher operating income, partly offset by higher operating expenses.

Operating income

Total operating income increased by CHF 152 million, or 18%, to CHF 1,002 million, reflecting increases in recurring net fee, net interest and transaction-based income, as well as net credit loss releases compared with net credit loss expenses in the third quarter of 2020.

Net interest income increased by CHF 22 million to CHF 494 million, mainly driven by proactive deposit management that led to a decrease in liquidity and funding costs.

Recurring net fee income increased by CHF 31 million to CHF 201 million, primarily driven by higher custody, mandate and investment fund fees, mainly due to an increase in average custody assets, reflecting positive market performance and net new investment product inflows.

Transaction-based income increased by CHF 17 million to CHF 281 million, mainly driven by higher revenues from credit card and foreign exchange transactions, reflecting a continued increase in spending on travel and leisure by clients following the easing of COVID-19-related restrictions in certain countries. The third quarter of 2020 included a CHF 17 million gain in relation to the sale of an equity investment.

Other income decreased by CHF 10 million to CHF 19 million, mostly driven by a lower valuation gain on our equity ownership of SIX Group.

Net credit loss releases were CHF 6 million, compared with net expenses of CHF 84 million for the third quarter of 2020.

Operating expenses

Total operating expenses increased by CHF 18 million, or 3%, to CHF 563 million.


Results: 9M21 vs 9M20

Profit before tax increased by CHF 397 million, or 46%, to CHF 1,253 million, reflecting higher operating income, partly offset by higher operating expenses.

Total operating income increased by CHF 478 million, or 19%, to CHF 2,989 million.

Net interest income decreased by CHF 17 million to CHF 1,444 million, mainly driven by lower deposit revenues, reflecting a decrease in margins. This decrease was partly offset by income resulting from the aforementioned proactive deposit management.

Recurring net fee income increased by CHF 70 million to CHF 569 million, primarily reflecting higher custody, mandate and investment fund fees.

Transaction-based income increased by CHF 53 million to CHF 808 million, mainly driven by higher revenues from credit card and foreign exchange transactions.

Other income increased by CHF 39 million to CHF 98 million, mostly driven by a gain of CHF 26 million from the sale of several small properties in the second quarter of 2021, as well as by higher valuation gains on our equity ownership of SIX Group.

Net credit loss releases were CHF 70 million, primarily related to stage 1 and 2 positions, compared with net expenses of CHF 263 million.

Total operating expenses increased by CHF 81 million, or 5%, to CHF 1,736 million, mainly reflecting increased investments in technology and real estate expenses due to accelerated depreciation as a result of branch closures in the first quarter of 2021, as well as higher other general and administrative expenses and restructuring expenses.

 

 

18 


Personal & Corporate Banking – in US dollars1

 

 

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

% change from

 

Year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

 

 

 

Results

 

 

 

 

 

 

 

 

 

 

Net interest income

 

 538 

 526 

 517 

 

 2 

 4 

 

 1,577 

 1,546 

Recurring net fee income2

 

 219 

 205 

 186 

 

 7 

 18 

 

 622 

 529 

Transaction-based income3

 

 306 

 315 

 288 

 

 (3) 

 6 

 

 882 

 800 

Other income

 

 21 

 44 

 32 

 

 (52) 

 (34) 

 

 106 

 64 

Income

 

 1,084 

 1,089 

 1,023 

 

 0 

 6 

 

 3,187 

 2,938 

Credit loss (expense) / release

 

 7 

 46 

 (92) 

 

 (85) 

 

 

 76 

 (279) 

Total operating income

 

 1,091 

 1,135 

 931 

 

 (4) 

 17 

 

 3,263 

 2,658 

Total operating expenses

 

 613 

 636 

 596 

 

 (4) 

 3 

 

 1,897 

 1,752 

Business division operating profit / (loss) before tax

 

 478 

 498 

 335 

 

 (4) 

 43 

 

 1,366 

 907 

 

 

 

 

 

 

 

 

 

 

 

Performance measures and other information

 

 

 

 

 

 

 

 

 

 

Average attributed equity (USD billion)4

 

 9.2 

 9.1 

 9.0 

 

 1 

 2 

 

 9.1 

 8.8 

Return on attributed equity (%)4

 

 20.8 

 21.8 

 14.9 

 

 

 

 

 19.9 

 13.7 

Pre-tax profit growth (%)

 

 42.8 

 109.8 

 (5.6) 

 

 

 

 

 50.7 

 (19.9) 

Cost / income ratio (%)

 

 56.6 

 58.4 

 58.3 

 

 

 

 

 59.5 

 59.6 

Net interest margin (bps)

 

 144 

 142 

 142 

 

 

 

 

 141 

 146 

Risk-weighted assets (USD billion)4

 

 71.4 

 71.7 

 70.3 

 

 0 

 2 

 

 71.4 

 70.3 

Leverage ratio denominator (USD billion)4,5

 

 235.6 

 238.7 

 235.1 

 

 (1) 

 0 

 

 235.6 

 235.1 

Business volume for Personal Banking (USD billion)

 

 197 

 198 

 190 

 

 (1) 

 3 

 

 197 

 190 

Net new business volume for Personal Banking (USD billion)

 

 1.2 

 0.6 

 2.7 

 

 

 

 

 5.6 

 10.0 

Net new business volume growth for Personal Banking (%)6

 

 2.5 

 1.3 

 5.8 

 

 

 

 

 3.7 

 7.7 

Active Digital Banking clients in Personal Banking (%)7

 

 70.2 

 69.8 

 66.3 

 

 

 

 

 69.8 

 65.5 

Active Digital Banking clients in Corporate & Institutional Clients (%)8

 

 78.9 

 79.1 

 77.8 

 

 

 

 

 79.1 

 77.6 

Mobile Banking log-in share in Personal Banking (%)9

 

 75.1 

 72.6 

 69.8 

 

 

 

 

 72.6 

 67.1 

Client assets (USD billion)10

 

 792 

 802 

 736 

 

 (1) 

 8 

 

 792 

 736 

Loans, gross (USD billion)

 

 148.9 

 149.8 

 148.3 

 

 (1) 

 0 

 

 148.9 

 148.3 

Customer deposits (USD billion)

 

 171.4 

 172.6 

 170.5 

 

 (1) 

 1 

 

 171.4 

 170.5 

Secured loan portfolio as a percentage of total loan portfolio, gross (%)

 

 93.0 

 92.6 

 92.2 

 

 

 

 

 93.0 

 92.2 

Impaired loan portfolio as a percentage of total loan portfolio, gross (%)11

 

 1.0 

 1.0 

 1.1 

 

 

 

 

 1.0 

 1.1 

1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.    2 Recurring net fee income consists of fees for services provided on an ongoing basis, such as portfolio management fees, asset-based investment fund fees and custody fees, which are generated on client assets, as well as administrative fees for accounts.    3 Transaction-based income consists of the non-recurring portion of net fee and commission income, mainly composed of brokerage and transaction-based investment fund fees, and credit card fees, as well as fees for payment and foreign exchange transactions, together with other net income from financial instruments measured at fair value through profit or loss.    4 Refer to the “Capital management” section of this report for more information.    5 The leverage ratio denominator calculated as of the respective date in 2020 does not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    6 Calculated as net new business volume for the period (annualized as applicable) divided by business volume at the beginning of the period.    7 “Clients” refers to the number of unique business relationships operated by Personal Banking. At the end of each month, any client that has logged on at least once in that month is determined to be “active” (a log-in time stamp is allocated to all business relationship numbers in a digital banking contract). Excluded are persons under the age of 15, clients who do not have a private account, clients domiciled outside Switzerland, and clients who have defaulted on loans or credit facilities. In the third quarter of 2021, 87.1% of clients of Personal Banking were “activated users” of Digital Banking (i.e., clients who had logged into Digital Banking at least once in the course of their relationship with UBS).    8 “Clients” refers to the number of unique business relationships or legal entities operated by Corporate & Institutional Clients. Excluded are clients that do not have an account, mono-product clients and clients that have defaulted on loans or credit facilities. Refer to footnote 7 for the definition of “active” clients (a log-in time stamp is allocated to all business relationship numbers or per legal entity in a digital banking contract).    9 Mobile Banking app log-ins as a percentage of total log-ins via E-Banking and Mobile Banking app in Personal Banking (if a digital banking contract is linked to multiple business relationships, the log-in is attributed to the business relationship with the most banking products in use).    10 Client assets are composed of invested assets and other assets held purely for transactional purposes or custody only. Net new money is not measured for Personal & Corporate Banking.    11 Refer to the “Risk management and control” section of this report for more information about (credit-)impaired exposures.

19 


Asset Management 

Asset Management

Asset Management1

 

 

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

% change from

 

Year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

 

 

 

Results

 

 

 

 

 

 

 

 

 

 

Net management fees2

 

 560 

 588 

 505 

 

 (5) 

 11 

 

 1,692 

 1,431 

Performance fees

 

 33 

 40 

 88 

 

 (17) 

 (62) 

 

 166 

 200 

Net gain from disposal of an associate / a subsidiary

 

 

 37 

 571 

 

 

 

 

 37 

 571 

Credit loss (expense) / release

 

 0 

 0 

 (2) 

 

 

 

 

 0 

 (2) 

Total operating income

 

 593 

 666 

 1,162 

 

 (11) 

 (49) 

 

 1,895 

 2,200 

Total operating expenses

 

 379 

 410 

 423 

 

 (8) 

 (10) 

 

 1,199 

 1,146 

Business division operating profit / (loss) before tax

 

 214 

 255 

 739 

 

 (16) 

 (71) 

 

 696 

 1,054 

 

 

 

 

 

 

 

 

 

 

 

Performance measures and other information

 

 

 

 

 

 

 

 

 

 

Average attributed equity (USD billion)3

 

 1.9 

 2.1 

 2.0 

 

 (11) 

 (8) 

 

 2.1 

 1.9 

Return on attributed equity (%)3

 

 46.3 

 49.0 

 147.5 

 

 

 

 

 45.2 

 74.0 

Pre-tax profit growth (%)

 

 (71.0) 

 62.0 

 494.9 

 

 

 

 

 (33.9) 

 199.4 

Cost / income ratio (%)

 

 63.9 

 61.7 

 36.3 

 

 

 

 

 63.3 

 52.1 

Risk-weighted assets (USD billion)3

 

 7.6 

 7.9 

 5.9 

 

 (4) 

 27 

 

 7.6 

 5.9 

Leverage ratio denominator (USD billion)3,4

 

 2.8 

 6.0 

 6.5 

 

 (52) 

 (56) 

 

 2.8 

 6.5 

Goodwill and intangible assets (USD billion)

 

 1.2 

 1.2 

 1.2 

 

 (1) 

 1 

 

 1.2 

 1.2 

Net margin on invested assets (bps)5

 

 7 

 9 

 31 

 

 (17) 

 (76) 

 

 8 

 16 

Gross margin on invested assets (bps)

 

 20 

 23 

 49 

 

 (12) 

 (58) 

 

 22 

 33 

 

 

 

 

 

 

 

 

 

 

 

Information by business line / asset class

 

 

 

 

 

 

 

 

 

 

Net new money (USD billion)

 

 

 

 

 

 

 

 

 

 

Equities

 

 0.5 

 (2.4) 

 19.9 

 

 

 

 

 4.4 

 40.0 

Fixed Income

 

 3.0 

 (1.3) 

 (13.4) 

 

 

 

 

 15.2 

 19.2 

of which: money market

 

 0.4 

 (6.7) 

 (11.9) 

 

 

 

 

 (2.0) 

 8.4 

Multi-asset & Solutions

 

 (1.8) 

 3.7 

 (1.5) 

 

 

 

 

 5.7 

 (1.1) 

Hedge Fund Businesses

 

 0.8 

 1.5 

 1.0 

 

 

 

 

 4.3 

 (1.9) 

Real Estate & Private Markets

 

 (1.0) 

 0.6 

 (0.1) 

 

 

 

 

 0.2 

 1.7 

Total net new money

 

 1.5 

 2.1 

 6.0 

 

 

 

 

 29.9 

 57.9 

of which: net new money excluding money market

 

 1.1 

 8.8 

 17.9 

 

 

 

 

 31.8 

 49.5 

 

 

 

 

 

 

 

 

 

 

 

Invested assets (USD billion)

 

 

 

 

 

 

 

 

 

 

Equities

 

 543 

 559 

 420 

 

 (3) 

 29 

 

 543 

 420 

Fixed Income

 

 279 

 280 

 279 

 

 0 

 0 

 

 279 

 279 

of which: money market

 

 94 

 94 

 112 

 

 0 

 (16) 

 

 94 

 112 

Multi-asset & Solutions

 

 183 

 187 

 148 

 

 (2) 

 23 

 

 183 

 148 

Hedge Fund Businesses

 

 53 

 53 

 43 

 

 1 

 25 

 

 53 

 43 

Real Estate & Private Markets

 

 95 

 95 

 90 

 

 0 

 6 

 

 95 

 90 

Total invested assets

 

 1,154 

 1,174 

 980 

 

 (2) 

 18 

 

 1,154 

 980 

of which: passive strategies

 

 497 

 501 

 390 

 

 (1) 

 27 

 

 497 

 390 

 

 

 

 

 

 

 

 

 

 

 

Information by region

 

 

 

 

 

 

 

 

 

 

Invested assets (USD billion)

 

 

 

 

 

 

 

 

 

 

Americas

 

 273 

 277 

 241 

 

 (1) 

 13 

 

 273 

 241 

Asia Pacific

 

 181 

 189 

 166 

 

 (4) 

 9 

 

 181 

 166 

Europe, Middle East and Africa (excluding Switzerland)

 

 316 

 320 

 244 

 

 (1) 

 30 

 

 316 

 244 

Switzerland

 

 383 

 388 

 329 

 

 (1) 

 16 

 

 383 

 329 

Total invested assets

 

 1,154 

 1,174 

 980 

 

 (2) 

 18 

 

 1,154 

 980 

 

 

 

 

 

 

 

 

 

 

 

Information by channel

 

 

 

 

 

 

 

 

 

 

Invested assets (USD billion)

 

 

 

 

 

 

 

 

 

 

Third-party institutional

 

 671 

 686 

 586 

 

 (2) 

 15 

 

 671 

 586 

Third-party wholesale

 

 139 

 141 

 111 

 

 (2) 

 25 

 

 139 

 111 

UBS’s wealth management businesses

 

 344 

 346 

 282 

 

 (1) 

 22 

 

 344 

 282 

Total invested assets

 

 1,154 

 1,174 

 980 

 

 (2) 

 18 

 

 1,154 

 980 

1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.    2 Net management fees include transaction fees, fund administration revenues (including net interest and trading income from lending activities and foreign exchange hedging as part of the fund services offering), distribution fees, incremental fund-related expenses, gains or losses from seed money and co-investments, funding costs, the negative pass-through impact of third-party performance fees, and other items that are not Asset Management’s performance fees.    3 Refer to the “Capital management” section of this report for more information.    4 The leverage ratio denominator calculated as of the respective date in 2020 does not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    5 Calculated as operating profit before tax (annualized as applicable) divided by average invested assets.

20 


 

Results: 3Q21 vs 3Q20

Profit before tax decreased by USD 525 million, or 71%, to USD 214 million, driven by a gain of USD 571 million from the sale of a majority stake in Fondcenter AG (now Clearstream Fund Centre AG) in the third quarter of 2020. Excluding this gain, profit before tax increased by USD 45 million, or 27%, reflecting continued growth in invested assets and positive operating leverage.

     Refer to the “Recent developments” section of our third quarter 2020 report for more information about the sale of a majority stake in Fondcenter AG

Operating income

Total operating income decreased by USD 569 million, or 49%, to USD 593 million. Excluding the aforementioned gain of USD 571 million in the third quarter of 2020, operating income was broadly stable. Total operating income included a loss of USD 28 million related to an associate in the third quarter of 2021, reflected in net management fees.

Net management fees increased by USD 55 million, or 11%, to USD 560 million, on a higher average invested asset base, reflecting a combination of strong net new money generation over the last twelve months and a constructive market backdrop.

Performance fees decreased by USD 55 million to USD 33 million, mainly in our Hedge Fund Businesses, compared with the particularly high levels of performance fees in the third quarter of 2020.

Operating expenses

Total operating expenses decreased by USD 44 million, or 10%, to USD 379 million, primarily driven by personnel expenses, reflecting lower compensable revenues.

Invested assets: 3Q21  vs 2Q21   

Invested assets decreased by USD 20 billion to USD 1,154 billion, reflecting negative foreign currency effects of USD 11 billion and market performance of USD 10 billion, partly offset by net new money inflows of USD 2 billion.

Excluding money market flows, net new money inflows were USD 1 billion.


Results: 9M21 vs 9M20

Profit before tax decreased by USD 358 million, or 34%, to USD 696 million, driven by the aforementioned gain of USD 571 million from the partial sale of Fondcenter AG (now Clearstream Fund Centre AG), which was followed by the sale of our remaining investment in the second quarter of 2021, resulting in a gain of USD 37 million. Excluding these gains, profit before tax increased by USD 176 million, or 36%, reflecting higher invested assets and positive operating leverage.

     Refer to the “Recent developments” section of our third quarter 2020 report and the “Recent developments” section of our second quarter 2021 report for more information about the sales of the original majority stake and our remaining investment, respectively

 

Total operating income decreased by USD 305 million, or 14%, to USD 1,895 million. Excluding the aforementioned gains from sales, operating income increased by USD 229 million.

Net management fees increased by USD 261 million, or 18%, to USD 1,692 million, on a higher average invested asset base, reflecting a combination of a constructive market backdrop and strong net new money generation.

Performance fees decreased by USD 34 million to USD 166 million, mainly in our Hedge Fund Businesses and in our Equities business, compared with the particularly high levels of performance fees in the first nine months of 2020.

Total operating expenses increased by USD 53 million, or 5%, to USD 1,199 million, primarily driven by foreign currency effects and personnel expenses, reflecting higher compensable revenues.

 

 

  

21 


Investment Bank 

Investment Bank

Investment Bank1

 

 

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

% change from

 

Year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

 

 

 

Results

 

 

 

 

 

 

 

 

 

 

Advisory

 

 270 

 300 

 152 

 

 (10) 

 78 

 

 793 

 444 

Capital Markets

 

 522 

 581 

 500 

 

 (10) 

 4 

 

 1,669 

 1,266 

Global Banking

 

 792 

 881 

 651 

 

 (10) 

 22 

 

 2,462 

 1,710 

Execution Services2

 

 444 

 443 

 418 

 

 0 

 6 

 

 1,442 

 1,430 

Derivatives & Solutions

 

 780 

 773 

 1,017 

 

 1 

 (23) 

 

 2,800 

 2,949 

Financing

 

 498 

 352 

 413 

 

 42 

 21 

 

 531 

 1,329 

Global Markets

 

 1,723 

 1,567 

 1,849 

 

 10 

 (7) 

 

 4,773 

 5,708 

of which: Equities

 

 1,360 

 1,194 

 1,315 

 

 14 

 3 

 

 3,474 

 3,438 

of which: Foreign Exchange, Rates and Credit

 

 363 

 373 

 533 

 

 (3) 

 (32) 

 

 1,299 

 2,270 

Income

 

 2,514 

 2,449 

 2,500 

 

 3 

 1 

 

 7,235 

 7,417 

Credit loss (expense) / release

 

 (5) 

 21 

 (15) 

 

 

 (70) 

 

 19 

 (215) 

Total operating income

 

 2,510 

 2,470 

 2,485 

 

 2 

 1 

 

 7,253 

 7,202 

Total operating expenses

 

 1,673 

 1,802 

 1,853 

 

 (7) 

 (10) 

 

 5,337 

 5,249 

Business division operating profit / (loss) before tax

 

 837 

 668 

 632 

 

 25 

 32 

 

 1,917 

 1,953 

 

 

 

 

 

 

 

 

 

 

 

Performance measures and other information

 

 

 

 

 

 

 

 

 

 

Pre-tax profit growth (%)

 

 32.4 

 9.1 

 267.5 

 

 

 

 

 (1.9) 

 142.2 

Average attributed equity (USD billion)3

 

 12.7 

 13.0 

 12.7 

 

 (2) 

 0 

 

 12.9 

 12.6 

Return on attributed equity (%)3

 

 26.4 

 20.6 

 19.9 

 

 

 

 

 19.9 

 20.7 

Cost / income ratio (%)

 

 66.5 

 73.6 

 74.1 

 

 

 

 

 73.8 

 70.8 

Risk-weighted assets (USD billion)3

 

 98.5 

 92.3 

 92.3 

 

 7 

 7 

 

 98.5 

 92.3 

Return on risk-weighted assets, gross (%)

 

 10.5 

 10.5 

 10.5 

 

 

 

 

 10.2 

 10.3 

Leverage ratio denominator (USD billion)3,4

 

 324.6 

 324.9 

 312.6 

 

 0 

 4 

 

 324.6 

 312.6 

Return on leverage ratio denominator, gross (%)4

 

 3.1 

 3.0 

 3.2 

 

 

 

 

 3.0 

 3.3 

Goodwill and intangible assets (USD billion)

 

 0.1 

 0.2 

 0.2 

 

 (10) 

 (4) 

 

 0.1 

 0.2 

Average VaR (1-day, 95% confidence, 5 years of historical data)

 

 11 

 11 

 12 

 

 (3) 

 (9) 

 

 11 

 13 

1 Comparative figures in this table may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.    2 Execution & Platform, which was disclosed in previous periods, has been renamed Execution Services.    3 Refer to the “Capital management” section of this report for more information.    4 The leverage ratio denominators calculated as of the respective dates in 2020 do not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.

 

22 


 

Results: 3Q21 vs 3Q20

Profit before tax increased by USD 205 million, or 32%, to USD 837 million, driven by lower operating expenses and higher operating income.

Operating income

Total operating income increased by USD 25 million, or 1%, to USD 2,510 million, reflecting higher revenues in Global Banking and lower net credit loss expenses, offset by lower revenues in Global Markets.

Global Banking

Global Banking revenues increased by USD 141 million, or 22%, to USD 792 million, driven by Advisory and Capital Markets revenues, outperforming the overall global fee pool.

Advisory revenues increased by USD 118 million, or 78%, to USD 270 million, primarily reflecting higher revenues from merger and acquisition transactions, due to the higher number of transactions that closed during the quarter.

Capital Markets revenues increased by USD 22 million, or 4%, to USD 522 million, primarily reflecting a USD 57 million, or 32%, increase in Equity Capital Markets revenues, compared with a decline in the global fee pool of 10%. This was partly offset by net mark-to-market losses across loan and hedging portfolios and lower net interest income compared with the prior-year quarter.

Global Markets

Global Markets revenues decreased by USD 126 million, or 7%, to USD 1,723 million, mainly as the third quarter of 2020 included a USD 215 million gain from the sale of intellectual property rights associated with the Bloomberg Commodity Index family. Excluding that gain, revenues increased by USD 89 million, or 5%, primarily driven by higher revenues in equity derivatives, cash equities, prime brokerage and capital market financing.

Execution Services revenues increased by USD 26 million, or 6%, to USD 444 million, driven by higher cash equities revenues.

Derivatives & Solutions revenues decreased by USD 237 million, or 23%, to USD 780 million, primarily due to the third quarter of 2020 including the aforementioned USD 215 million gain from sale. Excluding that gain, revenues decreased by USD 22 million, or 3%, mainly driven by lower revenues in Foreign Exchange, Rates and Credit, partly offset by higher revenues in Equity Derivatives.

Financing revenues increased by USD 85 million, or 21%, to USD 498 million, driven by capital market financing and prime brokerage products.


Equities

Global Markets Equities revenues increased by USD 45 million, or 3%, to USD 1,360 million. Excluding the aforementioned USD 215 million gain from sale, Equities revenues increased by USD 260 million, or 24%, mainly driven by Equity Derivatives and Financing revenues.

Foreign Exchange, Rates and Credit

Global Markets Foreign Exchange, Rates and Credit revenues decreased by USD 170 million, or 32%, to USD 363 million, compared with strong revenues in the third quarter of 2020. Spread compression and lower client flows impacted revenues in the third quarter of 2021.

Credit loss expense / release

Net credit loss expenses were USD 5 million, compared with net credit loss expenses of USD 15 million. Stage 1 and 2 net releases of USD 2 million were more than offset by stage 3 net expenses of USD 7 million across various positions.

Operating expenses

Total operating expenses decreased by USD 180 million, or 10%, to USD 1,673 million, mainly as the third quarter of 2020 included USD 229 million of expenses relating to the modification of certain outstanding deferred compensation awards; excluding this, operating expenses increased by USD 49 million, or 3%, mainly due to foreign exchange effects.

Risk-weighted assets and leverage ratio denominator: 3Q21 vs 2Q21

Risk-weighted assets

Total risk-weighted assets (RWA) increased by USD 6.2 billion, or 7%, to USD 98.5 billion. Market risk RWA increased by USD 5.2 billion, primarily due to the introduction of a regulatory add-on that reflects the outcome of discussions with FINMA regarding our regulatory value-at-risk (VaR) model, which started in late 2019. The third quarter of 2021 also included a USD 1.0 billion increase in credit risk RWA, primarily related to regulatory add-ons for counterparty credit risk of USD 1.2 billion for prime brokerage clients.

     Refer to the “Capital management” section of this report for more information

Leverage ratio denominator

The leverage ratio denominator was USD 325 billion, broadly unchanged from the second quarter of 2021.

     Refer to the “Capital management” section of this report for more information

 

 

23 


Investment Bank 

Results: 9M21 vs 9M20

Profit before tax decreased by USD 36 million, or 2%, to USD 1,917 million, primarily driven by a loss related to the default of a client, reported within Financing in Global Markets, and higher operating expenses. This was partly offset by increased operating income in Global Banking.

     Refer to the “Group performance” section of our first quarter 2021 report for more information about the aforementioned loss

 

Total operating income increased by USD 51 million, or 1%, to USD 7,253 million.

Global Banking revenues increased by USD 752 million, or 44%, to USD 2,462 million, reflecting higher revenues in Capital Markets and Advisory, which outperformed the global fee pool, most notably in Mergers & Acquisitions and Equity Capital Markets.

Advisory revenues increased by USD 349 million, or 79%, to USD 793 million, largely due to higher revenues from merger and acquisition transactions, compared with a 68% increase in the global fee pool.

Capital Markets revenues increased by USD 403 million, or 32%, to USD 1,669 million, mainly reflecting a USD 372 million, or 85%, increase in Equity Capital Markets revenues, compared with an increase in the global fee pool of 45%.

Global Markets revenues decreased by USD 935 million, or 16%, to USD 4,773 million, driven by lower revenues in our Financing and Derivatives & Solutions businesses, partly offset by higher revenues in cash equities products.

Execution Services revenues increased by USD 12 million, or 1%, to USD 1,442 million.


Derivatives & Solutions revenues decreased by USD 149 million, or 5%, to USD 2,800 million, mainly due to the aforementioned USD 215 million gain from the sale of intellectual property rights associated with the Bloomberg Commodity Index family in the third quarter of 2020. Excluding that gain, revenues increased by USD 66 million, or 2%.

Financing revenues decreased by USD 798 million, or 60%, to USD 531 million, predominantly due to an USD 861 million loss on the default of a client of our prime brokerage business. Excluding that loss, revenues increased by USD 63 million, or 5%.

     Refer to the “Group performance” section of our first quarter 2021 report for more information about the loss in the prime brokerage business

 

Global Markets Equities revenues increased by USD 36 million, or 1%, to USD 3,474 million. Equity derivatives and cash equities products revenues increased, while Financing revenues included the aforementioned loss in our prime brokerage business.

Global Markets Foreign Exchange, Rates and Credit revenues decreased by USD 971 million, or 43%, to USD 1,299 million, compared with strong revenues in the first nine months of 2020.

Net credit loss releases were USD 19 million, primarily related to stage 1 and 2 positions, compared with net expenses of USD 215 million.

Total operating expenses increased by USD 88 million, or 2%, to USD 5,337 million, largely driven by foreign currency effects and restructuring expenses.

  

24 


 

Group Functions

Group Functions1

 

 

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

% change from

 

Year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

30.9.20

 

2Q21

3Q20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

 

 

 

Results

 

 

 

 

 

 

 

 

 

 

Total operating income

 

 (68) 

 (68) 

 78 

 

 0 

 

 

 (226) 

 (557) 

Total operating expenses

 

 112 

 56 

 262 

 

 102 

 (57) 

 

 217 

 342 

Operating profit / (loss) before tax

 

 (180) 

 (124) 

 (184) 

 

 46 

 (2) 

 

 (443) 

 (899) 

of which: Group Treasury

 

 (74) 

 (125) 

 23 

 

 (41) 

 

 

 (303) 

 (300) 

of which: Non-core and Legacy Portfolio

 

 (24) 

 (24) 

 (50) 

 

 2 

 (51) 

 

 (43) 

 (339) 

of which: Group Services

 

 (82) 

 25 

 (157) 

 

 

 (48) 

 

 (96) 

 (261) 

 

 

 

 

 

 

 

 

 

 

 

Additional information

 

 

 

 

 

 

 

 

 

 

Risk-weighted assets (USD billion)2

 

 29.3 

 29.4 

 29.6 

 

 0 

 (1) 

 

 29.3 

 29.6 

Leverage ratio denominator (USD billion)2,3

 

 90.5 

 91.2 

 94.0 

 

 (1) 

 (4) 

 

 90.5 

 94.0 

1 Comparatives may differ as a result of adjustments following organizational changes, restatements due to the retrospective adoption of new accounting standards or changes in accounting policies, and events after the reporting period.    2 Refer to the “Capital management” section of this report for more information.    3 The leverage ratio denominator calculated as of the respective date in 2020 does not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.

 

Results: 3Q21 vs 3Q20

Group Functions recorded a loss before tax of USD 180 million, compared with a loss of USD 184 million.

Group Treasury

The Group Treasury result was negative USD 74 million, compared with positive USD 23 million.

Income from accounting asymmetries, including hedge accounting ineffectiveness, was net negative USD 56 million, compared with net positive income of USD 83 million. Accounting asymmetries are generally expected to mean revert to zero over time.

Income related to centralized Group Treasury risk management was negative USD 6 million, compared with negative USD 31 million.

Operating expenses decreased by USD 15 million to USD 12 million.

Non-core and Legacy Portfolio

The Non-core and Legacy Portfolio result was negative USD 24 million, compared with negative USD 50 million.

Group Services

The Group Services result was negative USD 82 million, compared with negative USD 157 million. The third quarter of 2020 included real estate costs of USD 72 million in relation to early lease terminations and associated provisions, and expenses of USD 54 million related to the modification of certain outstanding deferred compensation awards, partly offset by a net gain in that quarter of USD 64 million from properties held for sale.


Results: 9M21 vs 9M20

Group Functions recorded a loss before tax of USD 443 million, compared with a loss of USD 899 million.

The Group Treasury result was negative USD 303 million, compared with negative USD 300 million. This included income related to centralized Group Treasury risk management of negative USD 32 million, compared with negative USD 227 million. Income from accounting asymmetries, including hedge accounting ineffectiveness, was net negative USD 239 million, compared with net negative income of USD 33 million. Operating expenses decreased by USD 18 million to USD 32 million.

The Non-core and Legacy Portfolio result was negative USD 43 million, compared with negative USD 339 million. This result was mainly due to valuation gains of USD 46 million on our USD 1.6 billion portfolio of auction rate securities (ARS), compared with valuation losses of USD 143 million in the same period last year. Our remaining exposures to ARS were all rated investment grade as of 30 September 2021.

The Group Services result was negative USD 96 million, compared with negative USD 261 million. The first nine months of 2020 included real estate costs of USD 72 million in relation to early lease terminations and associated provisions, and expenses of USD 54 million related to the modification of certain outstanding deferred compensation awards.

 

  

25 


Selected financial information of our business divisions and Group Functions 

Selected financial information of our business divisions and Group Functions

Selected financial information of our business divisions and Group Functions1

 

 

For the quarter ended 30.9.21

USD million

 

Global Wealth Management

Personal &

Corporate

Banking

Asset

Manage-

ment

Investment Bank

Group Functions

Total

Operating income

 

 5,002 

 1,091 

 593 

 2,510 

 (68) 

 9,128 

of which: gain from the sale of domestic wealth management business in Austria

 

 100 

 

 

 

 

 100 

 

 

 

 

 

 

 

 

Operating expenses

 

 3,486 

 613 

 379 

 1,673 

 112 

 6,264 

of which: net restructuring expenses2

 

 21 

 7 

 6 

 14 

 17 

 66 

 

 

 

 

 

 

 

 

Operating profit / (loss) before tax

 

 1,516 

 478 

 214 

 837 

 (180) 

 2,865 

 

 

 

 

 

 

 

 

 

 

For the quarter ended 30.6.21

USD million

 

Global Wealth Management

Personal &

Corporate

Banking

Asset

Manage-

ment

Investment Bank

Group Functions

Total

Operating income

 

 4,774 

 1,135 

 666 

 2,470 

 (68) 

 8,976 

 

 

 

 

 

 

 

 

Operating expenses

 

 3,479 

 636 

 410 

 1,802 

 56 

 6,384 

of which: net restructuring expenses2

 

 43 

 5 

 6 

 33 

 2 

 90 

 

 

 

 

 

 

 

 

Operating profit / (loss) before tax

 

 1,294 

 498 

 255 

 668 

 (124) 

 2,593 

 

 

 

 

 

 

 

 

 

 

For the quarter ended 30.9.20

USD million

 

Global Wealth Management

Personal &

Corporate

Banking

Asset

Manage-

ment

Investment Bank

Group Functions

Total

Operating income

 

 4,280 

 931 

 1,162 

 2,485 

 78 

 8,935 

of which: net gain from the sale of a majority stake in Fondcenter AG

 

 60 

 

 571 

 

 

 631 

of which: gain from the sale of intellectual property rights

 

 

 

 

 215 

 

 215 

of which: net gains from properties sold or held for sale

 

 

 

 

 

 64 

 64 

of which: gain related to investment in associates

 

 6 

 19 

 

 

 

 26 

of which: gain from the sale of equity investment measured at fair value through profit or loss

 

 4 

 18 

 

 

 

 22 

 

 

 

 

 

 

 

 

Operating expenses

 

 3,223 

 596 

 423 

 1,853 

 262 

 6,357 

of which: acceleration of expenses in relation to outstanding deferred compensation awards

 

 46 

 3 

 22 

 229 

 58 

 359 

of which: expenses associated with terminated real estate leases

 

 

 

 

 

 72 

 72 

 

 

 

 

 

 

 

 

Operating profit / (loss) before tax

 

 1,057 

 335 

 739 

 632 

 (184) 

 2,578 

1 The “of which” components of operating income and operating expenses disclosed in this table are items that are not recurring or necessarily representative of the underlying business performance for the reporting period specified.    2 Includes curtailment gains of USD 8 million (second quarter of 2021: USD 59 million), which represent a reduction in the defined benefit obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities.

  

26 


Risk, capital, liquidity and funding, and balance sheet

Management report

 

 

 


 

Table of contents

29

Risk management and control

29

Credit risk

32

Market risk

33

Country risk

33

Operational risk

 

 

35

Capital management

36

Swiss SRB requirements and information

38

Total loss-absorbing capacity

42

Risk-weighted assets

44

Leverage ratio denominator

46

Equity attribution and return on attributed equity

 

 

47

Liquidity and funding management

47

Strategy, objectives and governance

47

Liquidity coverage ratio

47

Net stable funding ratio

 

 

48

Balance sheet and off-balance sheet

48

Strategy, objectives and governance

48

Balance sheet assets

48

Balance sheet liabilities

49

Equity

50

Off-balance sheet

 

 

51

Share information and earnings per share

28 


 

Risk management and control

This section provides information about key developments during the reporting period and should be read in conjunction with the “Risk management and control” section of our Annual Report 2020.

Credit risk

Credit loss (expense) / release

 

 

 

 

 

 

USD million

Global

Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total

For the quarter ended 30.9.21

 

 

 

 

 

 

Stages 1 and 2

 9 

 (1) 

 0 

 2 

 0 

 11 

Stage 3

 2 

 8 

 0 

 (7) 

 0 

 3 

Total credit loss (expense) / release

 11 

 7 

 0 

 (5) 

 0 

 14 

 

 

 

 

 

 

 

For the quarter ended 30.6.21

 

 

 

 

 

 

Stages 1 and 2

 13 

 51 

 0 

 24 

 (1) 

 88 

Stage 3

 0 

 (5) 

 0 

 (3) 

 0 

 (8) 

Total credit loss (expense) / release

 14 

 46 

 0 

 21 

 (1) 

 80 

 

 

 

 

 

 

 

 

Credit loss expense / release

Total net credit loss releases were USD 14 million, reflecting net releases of USD 11 million related to stage 1 and 2 positions and net releases of USD 3 million related to credit-impaired (stage 3) positions.

     Refer to “Note 7 Expected credit loss measurement” in the “Consolidated financial statements” section of this report for more information about credit loss expense / release

     Refer to “Note 1 Summary of significant accounting policies,” “Note 9 Financial assets at amortized cost and other positions in scope of expected credit loss measurement” and “Note 20 Expected credit loss measurement” in the “Consolidated financial statements” section of our Annual Report 2020 for information about scenario updates


Overall banking products exposures

Overall banking products exposure increased by USD 16 billion, to USD 666 billion as of 30 September 2021. The increase was driven by a USD 14 billion increase in balances at central banks and a USD 2 billion increase in loan commitments and guarantees.

Credit-impaired gross exposure decreased by USD 190 million to USD 3,128 million, with decreases across Global Wealth Management and Personal & Corporate Banking.

There were no significant changes in total loans and advances to customers across our business divisions.

In aggregate, exposure related to traded products decreased by USD 1.6 billion to USD 52.4 billion during the third quarter of 2021, mainly driven by exposure to clearing houses.

 

 

 

 

29 


Risk, capital, liquidity and funding, and balance sheet | Risk management and control 

Committed credit facilities

We did not observe an increase in drawing of committed credit facilities by clients in the third quarter of 2021. We manage our credit risk on the aggregate of drawn and committed undrawn credit facilities, and model full drawing of committed facilities in our stress testing framework.

Loan underwriting

In the Investment Bank, new loan underwriting activity and distributions continued to be robust during the third quarter of 2021. As of 30 September 2021, mandated loan underwriting commitments totaled USD 4.4 billion on a notional basis (compared with USD 3.6 billion as of 30 June 2021). As of 30 September 2021, USD 0.4 billion of commitments had not yet been distributed as originally planned.

Loan underwriting exposures are classified as held for trading, with fair values reflecting the market conditions at the end of the quarter. Credit hedges are in place to help protect against fair value movements in the portfolio.

Swiss mortgage portfolio

Of our USD 163 billion total Swiss real estate portfolio as of 30 September 2021, USD 148 billion related to residential real estate, USD 6 billion to commercial retail and office real estate, and USD 9 billion to industrial and other real estate.


The residential portfolio consists of USD 123 billion for single-family houses and apartments (average loan-to-value (LTV) ratio of 53%) and USD 25 billion in residential income-producing real estate (average LTV of 52%). We are also carefully monitoring the level of risk in our Swiss commercial retail and office real estate portfolio (average LTV of 46%) and its resilience to the economic impact of COVID-19.

     Refer to the “Risk management and control” section of our Annual Report 2020 for more information about our Swiss mortgage portfolio

Exposure to the Swiss economy and Swiss corporates

Within Personal & Corporate Banking, certain industry sectors continue to exhibit higher risk due to COVID-19 and the associated containment measures. Industry sectors with a negative outlook include tourism and media, as well as, to a lesser degree, culture, sports and education. Our exposure to the tourism sector (including hotels, restaurants and transport) totaled USD 1.9 billion as of 30 September 2021, with hotels accounting for USD 1.0 billion of this exposure. Our other exposures included USD 1.0 billion to the culture, sports and education sector, and USD 0.2 billion to the media sector. Apart from a few large counterparties, our exposures within these sectors are highly diversified across Switzerland.

 

 

30 


 

Banking and traded products exposure in our business divisions and Group Functions

 

 

30.9.21

USD million

 

Global Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total

Banking products1

 

 

 

 

 

 

 

Gross exposure

 

 328,250 

 220,545 

 1,535 

 61,824 

 53,682 

 665,836 

of which: loans and advances to customers (on-balance sheet)

 

 225,393 

 148,937 

 1 

 12,917 

 4,036 

 391,284 

of which: guarantees and loan commitments (off-balance sheet)

 

 10,404 

 28,414 

 0 

 14,750 

 3,623 

 57,191 

Traded products2,3

 

 

 

 

 

 

 

Gross exposure

 

 11,279 

 836 

 0 

 40,300 

 52,415 

of which: over-the-counter derivatives

 

 8,218 

 818 

 0 

 11,760 

 20,796 

of which: securities financing transactions

 

 0 

 0 

 0 

 21,379 

 21,379 

of which: exchange-traded derivatives

 

 3,062 

 18 

 0 

 7,161 

 10,241 

Other credit lines, gross4

 

 12,259 

 23,336 

 0 

 3,462 

 29 

 39,086 

 

 

 

 

 

 

 

 

Total credit-impaired exposure, gross (stage 3)

 

 907 

 1,771 

 0 

 450 

 0 

 3,128 

Total allowances and provisions for expected credit losses (stages 1 to 3)

 

 276 

 712 

 0 

 257 

 4 

 1,248 

of which: stage 1

 

 85 

 118 

 0 

 64 

 4 

 270 

of which: stage 2

 

 46 

 144 

 0 

 36 

 0 

 225 

of which: stage 3 (allowances and provisions for credit-impaired exposures)

 

 145 

 450 

 0 

 157 

 0 

 752 

 

 

 

 

 

 

 

 

 

 

30.6.21

USD million

 

Global Wealth Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total

Banking products1

 

 

 

 

 

 

 

Gross exposure

 

 315,902 

 219,372 

 3,329 

 60,923 

 50,531 

 650,057 

of which: loans and advances to customers (on-balance sheet)

 

 223,082 

 149,806 

 1 

 13,809 

 4,378 

 391,076 

of which: guarantees and loan commitments (off-balance sheet)

 

 10,382 

 26,984 

 0 

 15,053 

 2,789 

 55,208 

Traded products2,3

 

 

 

 

 

 

 

Gross exposure

 

 11,516 

 732 

 0 

 41,762 

 54,009 

of which: over-the-counter derivatives

 

 8,435 

 706 

 0 

 12,506 

 21,647 

of which: securities financing transactions

 

 0 

 0 

 0 

 22,198 

 22,198 

of which: exchange-traded derivatives

 

 3,081 

 25 

 0 

 7,058 

 10,164 

Other credit lines, gross4

 

 11,269 

 24,350 

 0 

 3,147 

 30 

 38,796 

 

 

 

 

 

 

 

 

Total credit-impaired exposure, gross (stage 3)

 

 1,002 

 1,875 

 0 

 441 

 0 

 3,318 

Total allowances and provisions for expected credit losses (stages 1 to 3)

 

 288 

 734 

 1 

 266 

 4 

 1,294 

of which: stage 1

 

 92 

 117 

 0 

 64 

 4 

 277 

of which: stage 2

 

 46 

 149 

 0 

 38 

 0 

 233 

of which: stage 3 (allowances and provisions for credit-impaired exposures)

 

 150 

 469 

 1 

 164 

 0 

 784 

1 IFRS 9 gross exposure including other financial assets at amortized cost, but excluding cash, receivables from securities financing transactions, cash collateral receivables on derivative instruments, financial assets at FVOCI, irrevocable committed prolongation of existing loans and unconditionally revocable committed credit lines, and forward starting reverse repurchase and securities borrowing agreements.    2 Internal management view of credit risk, which differs in certain respects from IFRS.    3 As counterparty risk for traded products is managed at counterparty level, no further split between exposures in the Investment Bank and Group Functions is provided.    4 Unconditionally revocable committed credit lines.  

 

 

Global Wealth Management and Personal & Corporate Banking loans and advances to customers, gross

 

 

Global Wealth Management

 

Personal & Corporate Banking

USD million

 

30.9.21

30.6.21

 

30.9.21

30.6.21

Secured by residential property

 

 62,817 

 61,895 

 

 108,112 

 108,167 

Secured by commercial / industrial property1

 

 3,690 

 3,483 

 

 18,967 

 19,042 

Secured by cash

 

 22,563 

 22,358 

 

 2,449 

 2,625 

Secured by securities

 

 118,520 

 117,802 

 

 1,868 

 1,899 

Secured by guarantees and other collateral

 

 15,495 

 15,266 

 

 7,062 

 7,017 

Unsecured loans and advances to customers

 

 2,307 

 2,277 

 

 10,479 

 11,056 

Total loans and advances to customers, gross

 

 225,393 

 223,082 

 

 148,937 

 149,806 

Allowances

 

 (168) 

 (173) 

 

 (578) 

 (601) 

Total loans and advances to customers, net of allowances

 

 225,225 

 222,908 

 

 148,359 

 149,205 

1 Includes exposures with mixed collateral as security, where the primary purpose of the loan is not to finance a specific property.

 

31 


Risk, capital, liquidity and funding, and balance sheet | Risk management and control 

Market risk

We continued to maintain generally low levels of management value-at-risk (VaR). Average management VaR (1‑day, 95% confidence level) decreased marginally to USD 11 million from USD 12 million at the end of the second quarter of 2021.


There were no new Group VaR negative backtesting exceptions in the third quarter of 2021, and the total number of negative backtesting exceptions within the most recent 250-business-day window remained at 3. The Swiss Financial Market Supervisory Authority (FINMA) VaR multiplier derived from backtesting exceptions for market risk risk-weighted assets was unchanged compared with the prior quarter, at 3.0.

 

Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of our business divisions and

Group Functions by general market risk type1

 

 

 

 

 

 

Average by risk type

USD million

 

Min.

Max.

Period end

Average

Equity

Interest

rates

Credit

spreads

Foreign

exchange

Commodities

Global Wealth Management

 

 1 

 3 

 2 

 2 

 0 

 1 

 2 

 0 

 0 

Personal & Corporate Banking

 

 0 

 0 

 0 

 0 

 0 

 0 

 0 

 0 

 0 

Asset Management

 

 0 

 0 

 0 

 0 

 0 

 0 

 0 

 0 

 0 

Investment Bank

 

 7 

 15 

 11 

 11 

 8 

 9 

 6 

 3 

 2 

Group Functions

 

 5 

 7 

 5 

 5 

 0 

 4 

 3 

 1 

 0 

Diversification effect2,3

 

 

 

 (6) 

 (6) 

 0 

 (5) 

 (5) 

 0 

 0 

Total as of 30.9.21

 

 8 

 16 

 11 

 11 

 8 

 9 

 6 

 3 

 2 

Total as of 30.6.21

 

 4 

 32 

 10 

 12 

 9 

 9 

 7 

 3 

 3 

1 Statistics at individual levels may not be summed to deduce the corresponding aggregate figures. The minima and maxima for each level may occur on different days, and, likewise, the VaR for each business line or risk type, being driven by the extreme loss tail of the corresponding distribution of simulated profits and losses for that business line or risk type, may well be driven by different days in the historical time series, rendering invalid the simple summation of figures to arrive at the aggregate total.    2 The difference between the sum of the standalone VaR for the business divisions and Group Functions and the VaR for the Group as a whole.    3 As the minima and maxima for different business divisions and Group Functions occur on different days, it is not meaningful to calculate a portfolio diversification effect.

 

 

As of 30 September 2021, the interest rate sensitivity of our banking book to a +1-basis-point parallel shift in yield curves was negative USD 31.4 million, compared with negative USD 31.3 million as of 30 June 2021. The reported interest rate sensitivity excludes additional tier 1 (AT1) capital instruments, as per FINMA Pillar 3 disclosure requirements, with a sensitivity of USD 4.9 million per basis point, and our equity, goodwill and real estate, with a modeled sensitivity of USD 22.3 million per basis point, of which USD 5.4 million and USD 16.1 million are attributable to the Swiss franc and the US dollar portfolios, respectively.

The most adverse of the six FINMA interest rate scenarios was the “Parallel up” scenario, which resulted in a change in the economic value of equity of negative USD 6.3 billion, representing a pro forma reduction of 10.5% of tier 1 capital, which is well below the regulatory outlier test of 15% of tier 1 capital. The immediate effect of the “Parallel up” scenario on tier 1 capital as of 30 September 2021 would have been a reduction of 2.0%, or USD 1.2 billion, arising from the part of our banking book that is measured at fair value through profit or loss and from the financial assets measured at fair value through other comprehensive income. This scenario would, however, have a positive effect on net interest income.

     Refer to “Interest rate risk in the banking book” in the “Market risk” section of our Annual Report 2020 for more information about the management of interest rate risk in the banking book

     Refer to “Sensitivity to interest rate movements” in the “Group performance” section of this report for more information about the effects of increases in interest rates on the equity, capital and net interest income of Global Wealth Management and Personal & Corporate Banking

 

 

Interest rate risk – banking book

 

 

 

 

 

 

 

USD million

+1 bp

Parallel up1

Parallel down1

Steepener2

Flattener3

Short-term up4

Short-term down5

CHF

 (5.0) 

 (717.4) 

 800.0 

 (282.1) 

 144.4 

 (133.7) 

 137.8 

EUR

 (1.0) 

 (191.5) 

 219.9 

 (43.6) 

 12.0 

 (46.2) 

 49.3 

GBP

 0.2 

 33.6 

 (33.1) 

 (23.9) 

 29.7 

 41.1 

 (35.5) 

USD

 (25.2) 

 (5,375.9) 

 4,420.2 

 (971.0) 

 (308.1) 

 (2,247.9) 

 2,378.6 

Other

 (0.3) 

 (80.6) 

 (38.2) 

 (9.9) 

 (29.3) 

 (53.5) 

 (35.6) 

Total effect on economic value of equity as per Pillar 3 requirement as of 30.9.21

 (31.4) 

 (6,331.8) 

 5,368.8 

 (1,330.5) 

 (151.2) 

 (2,440.2) 

 2,494.5 

Additional tier 1 (AT1) capital instruments

 4.9 

 931.3 

 (1,015.0) 

 2.0 

 202.2 

 568.2 

 (592.1) 

Total including AT1 capital instruments as of 30.9.21

 (26.5) 

 (5,400.5) 

 4,353.8 

 (1,328.4) 

 51.1 

 (1,872.0) 

 1,902.4 

Total effect on economic value of equity as per Pillar 3 requirement as of 30.6.21

 (31.3) 

 (6,307.9) 

 5,527.2 

 (1,498.3) 

 29.9 

 (2,248.3) 

 2,423.5 

Total including AT1 capital instruments as of 30.6.21

 (26.0) 

 (5,296.8) 

 4,423.0 

 (1,478.3) 

 231.4 

 (1,648.0) 

 1,797.4 

1 Rates across all tenors move by ±150 bps for Swiss franc, ±200 bps for euro and US dollar, and ±250 bps for pound sterling.    2 Short-term rates decrease and long-term rates increase.    3 Short-term rates increase and long-term rates decrease.    4 Short-term rates increase more than long-term rates.    5 Short-term rates decrease more than long-term rates.

 

32 


 

Country risk

The COVID-19 pandemic, and its impact on growth, employment, debt dynamics and supply chains, remains an important driver of country risk, and we expect this to be the case for at least the near future.

Although the availability and effective distribution of vaccines continue to improve and a gradual lifting of lockdowns in many economies is ongoing, the spread of new COVID-19 variants and localized outbreaks are still causing uncertainty around a sustainable recovery.

Concerns have grown about a resurgence in global inflation, but key central banks expect recent price spikes (such as in the US and the Eurozone) to be transitory. There are related concerns about increasing energy prices in a number of countries, and mounting global supply chain stresses are creating negative pressure on growth and employment. China is facing several challenges, including a slowing economy following the post-pandemic boom. We expect measures taken by governments and central banks that are intended to support their economies to give rise to increased sovereign risk.

We remain watchful of developments in Europe and political changes in a number of countries. Our direct exposure to peripheral European countries is limited, although we have significant country risk exposure to the major European economies, including Germany, the UK and France.

We continue to monitor potential trade policy disputes, as well as economic and political developments.

A number of emerging markets are facing economic, political and market pressures, particularly in light of challenges related to the COVID-19 pandemic. Our exposure to emerging market countries is diversified.

     Refer to the “Risk management and control” section of our Annual Report 2020 for more information

 

Exposures to Eurozone countries rated lower than AAA / Aaa by at least one major rating agency

 

USD million

 

30.9.21

 

30.6.21

 

 

Banking products, gross1

 

Traded products

 

Trading inventory

 

Total

 

Total

 

 

Before

hedges

Net of

hedges

 

Before

hedges

Net of

hedges

 

Net long per issuer

 

 

Net of

hedges

 

 

Net of

hedges

France

 

 1,726 

 1,723 

 

 1,601 

 1,478 

 

 3,325 

 

 6,652 

 6,526 

 

 7,724 

 7,595 

Monaco2

 

 1,009 

 1,009 

 

 29 

 29 

 

 8 

 

 1,046 

 1,046 

 

 1,073 

 1,073 

Italy

 

 676 

 643 

 

 313 

 312 

 

 62 

 

 1,050 

 1,018 

 

 1,178 

 1,142 

Austria

 

 260 

 259 

 

 146 

 146 

 

 552 

 

 958 

 957 

 

 1,242 

 1,241 

Ireland

 

 674 

 645 

 

 62 

 62 

 

 166 

 

 902 

 874 

 

 714 

 685 

Spain

 

 433 

 342 

 

 83 

 83 

 

 231 

 

 747 

 656 

 

 731 

 638 

Belgium

 

 220 

 220 

 

 162 

 162 

 

 25 

 

 408 

 408 

 

 333 

 333 

Finland

 

 26 

 26 

 

 49 

 49 

 

 220 

 

 295 

 295 

 

 224 

 224 

Portugal

 

 44 

 32 

 

 10 

 10 

 

 5 

 

 59 

 47 

 

 62 

 62 

Cyprus

 

 27 

 12 

 

 0 

 0 

 

 21 

 

 48 

 33 

 

 48 

 33 

Other3

 

 12 

 10 

 

 19 

 19 

 

 16 

 

 47 

 44 

 

 58 

 53 

Total

 

 5,109 

 4,922 

 

 2,473 

 2,349 

 

 4,630 

 

 12,212 

 11,901 

 

 13,388 

 13,079 

1 Before deduction of IFRS 9 ECL allowances and provisions.    2 Internally rated below AAA / Aaa equivalent. Monaco is not rated by any major rating agency.    3 Represents aggregate exposures to Andorra, Estonia, Greece, Latvia, Lithuania, Malta, Montenegro, San Marino, Slovakia and Slovenia.

 

Operational risk

Operational resilience, conduct and financial crime remain the key non-financial risk themes for UBS and the financial services industry. Operational resilience also continues to be a focus area for regulators globally, with a particular emphasis on measures taken to respond to the ongoing COVID-19 pandemic.

Our global program to continuously enhance our operational resilience capabilities remains in effect and includes addressing developing regulatory requirements in this regard.


The existing resilience built into our operations and the effectiveness of our business continuity management and operational risk procedures (including those which apply to third-party service providers) have been critical in handling the ongoing COVID-19 pandemic and have enabled us to continue to serve our clients without material impact. We have maintained stable operations while complying with governmental measures to contain COVID-19 that have been imposed in many of our principal locations, and we remain focused on the safety and well-being of our staff, with a particular focus on countries severely impacted by COVID-19 outbreaks.

 

33 


Risk, capital, liquidity and funding, and balance sheet | Risk management and control 

Increases in the sophistication of cyberattacks and related frauds are being seen worldwide. Cybersecurity incidents that occurred during the third quarter of 2021 did not have a significant effect on our operations. We continue to seek to enhance our security controls and monitoring of cyber threats.

We maintain our focus on innovation and digitalization to create value for our clients. As part of the resulting transformation, we focus on timely changes to frameworks, including consideration of new or revised controls, working practices and oversight, with the aim of mitigating any new risks introduced.  

Achieving fair outcomes for our clients, upholding market integrity and cultivating the highest standards of employee conduct are of critical importance to the firm. As such, effective management of conduct risk is an integral part of our risk culture. We continue to focus on leveraging the conduct risk framework across our activities, enhancing management information, and maintaining momentum on fostering a strong culture.

Hybrid working arrangements can lead to increased conduct risk, inherent risk of fraudulent activities, potential increases in the number of suspicious transactions, and increased information security risks (in particular, regarding client data and unpublished price-sensitive information). Our increased monitoring and supervision remain in place for remote working, including programs to educate clients and employees on fraud risk, where our protocols for interaction to mitigate this risk have been updated.

In addition to the effects of COVID-19, financial crime (e.g., money laundering, terrorist financing, sanctions violations, fraud, bribery and corruption) continues to present a major risk, as technological innovation and geopolitical developments increase the complexity of doing business and heightened regulatory attention continues.

An effective financial crime prevention program remains essential for UBS. Money laundering and financial fraud techniques are becoming increasingly sophisticated, while geopolitical volatility makes the sanctions landscape more complex, and new risks emerge, such as virtual currencies and related activities or investments.

The Office of the Comptroller of the Currency issued a Cease and Desist Order against the firm in May 2018 related to our US branch know-your-customer (KYC) and anti-money-laundering (AML) programs. In response, we initiated an extensive program for the purpose of ensuring sustainable remediation of US-relevant Bank Secrecy Act / AML issues across all US legal entities. We introduced significant improvements to the framework in 2019 and 2020, and are continuing to implement these improvements, which we believe will yield the planned enhancements to our AML controls.

We continue to focus on strategic enhancements for AML / KYC and sanctions programs on a global scale to cope with evolving risk profiles and regulatory expectations, including the exploration of new technologies and more sophisticated rules-based monitoring, using self-learning systems to identify potentially suspicious transactions and behavior.

  

34 


 

Capital management

The disclosures in this section are provided for UBS Group AG on a consolidated basis and focus on key developments during the reporting period and information in accordance with the Basel III framework, as applicable to Swiss systemically relevant banks (SRBs). They should be read in conjunction with “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020, which provides more information about our capital management objectives, planning and activities, as well as the Swiss SRB total loss-absorbing capacity framework.

Additional regulatory disclosures for UBS Group AG on a consolidated basis are provided in our 30 September 2021 Pillar 3 report. The Pillar 3 report also includes information relating to our significant regulated subsidiaries and sub-groups (UBS AG standalone, UBS Switzerland AG standalone, UBS Europe SE consolidated and UBS Americas Holding LLC consolidated) as of 30 September 2021 and is available under “Pillar 3 disclosures” at ubs.com/investors

Capital and other regulatory information for UBS AG consolidated in accordance with the Basel III framework, as applicable to Swiss SRBs, will be provided in the UBS AG third quarter 2021 report, which will be available as of 29 October 2021 under “Quarterly reporting” at ubs.com/investors. 

UBS Group AG is a holding company and conducts substantially all of its operations through UBS AG and subsidiaries thereof. UBS Group AG and UBS AG have contributed a significant portion of their respective capital to, and provide substantial liquidity to, such subsidiaries. Many of these subsidiaries are subject to regulations requiring compliance with minimum capital, liquidity and similar requirements.

 

35 


Risk, capital, liquidity and funding, and balance sheet | Capital management 

Swiss SRB requirements and information

We are subject to the going and gone concern requirements of the Swiss Capital Adequacy Ordinance (the CAO) that include the too-big-to-fail provisions applicable to Swiss SRBs. Information about the Swiss SRB capital framework, and about Swiss SRB going and gone concern requirements, is provided under “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020

The applicable market share add-on requirements as of 30 September 2021 were 0.72% for risk-weighted asset (RWA) and 0.25% for leverage ratio denominator (LRD) purposes. These add-ons were increased by 0.36% for RWA and 0.125% for LRD in the third quarter of 2021, reflecting an increase in UBS’s market share in the Swiss credit business to more than 17%. The applicable LRD add-on requirements remained unchanged at 0.72% for RWA and 0.25% for LRD purposes, as our Group LRD remained within the same add-on bucket.


Additionally, based on the actions we completed up to December 2020 to improve resolvability, FINMA granted an increase of the rebate on the gone concern requirement from 47.5% to 55.0% of the maximum rebate, effective from 1 July 2021. The capital benefit from this higher rebate is offset by the aforementioned increase in market share add-on requirements and a lower usage of low-trigger tier 2 capital instruments to fulfill gone concern requirements, as one of the instruments ceased to be eligible in the third quarter of 2021 as it had less than one year to maturity.

The aforementioned requirements are also applicable to UBS AG consolidated. UBS Switzerland AG and UBS AG are subject to going and gone concern requirements on a standalone basis, as detailed in our 30 September 2021 Pillar 3 report, which is available under “Pillar 3 disclosures” at ubs.com/investors

The table on the next page provides the RWA- and LRD-based requirements and information as of 30 September 2021.

 

 

36 


Swiss SRB going and gone concern requirements and information

As of 30.9.21

 

RWA

 

LRD

USD million, except where indicated

 

in %

 

 

in %

 

Required going concern capital

 

 

 

 

 

 

Total going concern capital

 

 14.321

 43,309 

 

 5.001

 52,246 

Common equity tier 1 capital

 

 10.02 

 30,305 

 

 3.502

 36,572 

of which: minimum capital

 

 4.50 

 13,609 

 

 1.50 

 15,674 

of which: buffer capital

 

 5.50 

 16,633 

 

 2.00 

 20,898 

of which: countercyclical buffer

 

 0.02 

 62 

 

 

 

Maximum additional tier 1 capital

 

 4.30 

 13,004 

 

 1.50 

 15,674 

of which: additional tier 1 capital

 

 3.50 

 10,585 

 

 1.50 

 15,674 

of which: additional tier 1 buffer capital

 

 0.80 

 2,419 

 

 

 

 

 

 

 

 

 

 

Eligible going concern capital

 

 

 

 

 

 

Total going concern capital

 

 19.96 

 60,369 

 

 5.78 

 60,369 

Common equity tier 1 capital

 

 14.89 

 45,022 

 

 4.31 

 45,022 

Total loss-absorbing additional tier 1 capital3

 

 5.07 

 15,347 

 

 1.47 

 15,347 

of which: high-trigger loss-absorbing additional tier 1 capital

 

 4.26 

 12,874 

 

 1.23 

 12,874 

of which: low-trigger loss-absorbing additional tier 1 capital

 

0.82

 2,473 

 

 0.24 

2,473

 

 

 

 

 

 

 

Required gone concern capital

 

 

 

 

 

 

Total gone concern loss-absorbing capacity4

 

 10.73 

 32,447 

 

 3.77 

 39,433 

of which: base requirement5

 

 12.86 

 38,892 

 

 4.50 

 47,021 

of which: additional requirement for market share and LRD6

 

 1.44 

 4,355 

 

 0.50 

 5,225 

of which: applicable reduction on requirements

 

 (3.57) 

 (10,800) 

 

 (1.23) 

 (12,813) 

of which: rebate granted (equivalent to 55% of maximum rebate)

 

 (3.14) 

 (9,481) 

 

 (1.10) 

 (11,494) 

of which: reduction for usage of low-trigger tier 2 capital instruments

 

 (0.44) 

 (1,319) 

 

 (0.13) 

 (1,319) 

 

 

 

 

 

 

 

Eligible gone concern capital

 

 

 

 

 

 

Total gone concern loss-absorbing capacity

 

 14.03 

 42,428 

 

 4.06 

 42,428 

Total tier 2 capital

 

 1.05 

 3,185 

 

 0.30 

 3,185 

of which: low-trigger loss-absorbing tier 2 capital

 

 0.87 

 2,638 

 

 0.25 

 2,638 

of which: non-Basel III-compliant tier 2 capital

 

 0.18 

 548 

 

 0.05 

 548 

TLAC-eligible senior unsecured debt

 

 12.98 

 39,242 

 

 3.76 

 39,242 

 

 

 

 

 

 

 

Total loss-absorbing capacity

 

 

 

 

 

 

Required total loss-absorbing capacity

 

 25.05 

 75,756 

 

 8.77 

 91,679 

Eligible total loss-absorbing capacity

 

 33.99 

 102,796 

 

 9.84 

 102,796 

 

 

 

 

 

 

 

Risk-weighted assets / leverage ratio denominator

 

 

 

 

 

 

Risk-weighted assets

 

 

 302,426 

 

 

 

Leverage ratio denominator

 

 

 

 

 

 1,044,916 

1 Includes applicable add-ons of 1.44% for RWA and 0.50% for LRD.    2 Our minimum CET1 leverage ratio requirement of 3.5% consists of a 1.5% base requirement, a 1.5% base buffer capital requirement, a 0.25% LRD add-on requirement and a 0.25% market share add-on requirement based on our Swiss credit business.    3 Includes outstanding low-trigger loss-absorbing additional tier 1 (AT1) capital instruments, which are available under the Swiss SRB framework to meet the going concern requirements until their first call date. As of their first call date, these instruments are eligible to meet the gone concern requirements.    4 A maximum of 25% of the gone concern requirements can be met with instruments that have a remaining maturity of between one and two years. Once at least 75% of the minimum gone concern requirement has been met with instruments that have a remaining maturity of greater than two years, all instruments that have a remaining maturity of between one and two years remain eligible to be included in the total gone concern capital.    5 The gone concern requirement after the application of the rebate for resolvability measures and the reduction for the use of higher quality capital instruments is floored at 8.6% and 3% for the RWA- and LRD-based requirements, respectively. This means that the combined reduction may not exceed 5.7 percentage points for the RWA-based requirement of 14.3% and 2.0 percentage points for the LRD-based requirement of 5.0%.    6 A higher add-on requirement for market share was applied in the third quarter of 2021, of which 0.72% was applied for RWA and 0.25% for LRD.

 

37 


Risk, capital, liquidity and funding, and balance sheet | Capital management 

Total loss-absorbing capacity

The table below provides Swiss SRB going and gone concern information based on the Swiss SRB framework and requirements that are discussed under “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020.

  

Swiss SRB going and gone concern information

 

 

 

 

 

 

 

 

 

USD million, except where indicated

 

30.9.21

30.6.21

31.12.20

 

 

 

 

 

Eligible going concern capital

 

 

 

 

Total going concern capital

 

 60,369 

 59,188 

 56,178 

Total tier 1 capital

 

 60,369 

 59,188 

 56,178 

Common equity tier 1 capital

 

 45,022 

 42,583 

 39,890 

Total loss-absorbing additional tier 1 capital

 

 15,347 

 16,605 

 16,288 

of which: high-trigger loss-absorbing additional tier 1 capital

 

 12,874 

 14,096 

 13,711 

of which: low-trigger loss-absorbing additional tier 1 capital

 

 2,473 

 2,509 

 2,577 

 

 

 

 

 

Eligible gone concern capital

 

 

 

 

Total gone concern loss-absorbing capacity

 

 42,428 

 45,110 

 45,545 

Total tier 2 capital

 

 3,185 

 5,232 

 7,744 

of which: low-trigger loss-absorbing tier 2 capital

 

 2,638 

 4,686 

 7,201 

of which: non-Basel III-compliant tier 2 capital

 

 548 

 547 

 543 

TLAC-eligible senior unsecured debt

 

 39,242 

 39,878 

 37,801 

 

 

 

 

 

Total loss-absorbing capacity

 

 

 

 

Total loss-absorbing capacity

 

 102,796 

 104,298 

 101,722 

 

 

 

 

 

Risk-weighted assets / leverage ratio denominator

 

 

 

 

Risk-weighted assets

 

 302,426 

 293,277 

 289,101 

Leverage ratio denominator

 

 1,044,916 

 1,039,939 

 1,037,1501

 

 

 

 

 

Capital and loss-absorbing capacity ratios (%)

 

 

 

 

Going concern capital ratio

 

 20.0 

 20.2 

 19.4 

of which: common equity tier 1 capital ratio

 

 14.9 

 14.5 

 13.8 

Gone concern loss-absorbing capacity ratio

 

 14.0 

 15.4 

 15.8 

Total loss-absorbing capacity ratio

 

 34.0 

 35.6 

 35.2 

 

 

 

 

 

Leverage ratios (%)1

 

 

 

 

Going concern leverage ratio

 

 5.8 

 5.7 

 5.4 

of which: common equity tier 1 leverage ratio

 

 4.31 

 4.09 

 3.85 

Gone concern leverage ratio

 

 4.1 

 4.3 

 4.4 

Total loss-absorbing capacity leverage ratio

 

 9.8 

 10.0 

 9.8 

1 The leverage ratio denominator (LRD) and leverage ratios for 31 December 2020 do not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” and “Application of the temporary COVID-19-related FINMA exemption of central bank sight deposits” in the “Capital, liquidity and funding, and balance sheet” sections of our Annual Report 2020 for more information.

 

38 


 

Total loss-absorbing capacity and movement

Our total loss-absorbing capacity (TLAC) decreased by USD 1.5 billion to USD 102.8 billion in the third quarter of 2021.

Going concern capital and movement

During the third quarter of 2021, our going concern capital increased by USD 1.2 billion to USD 60.4 billion. Our common equity tier 1 (CET1) capital increased by USD 2.4 billion to USD 45.0 billion, mainly reflecting operating profit before tax of USD 2.9 billion, an increase of USD 0.2 billion related to the launch of our new operational partnership entity with Sumitomo Mitsui Trust Holdings, Inc. and USD 0.2 billion higher eligible deferred tax assets on temporary differences. These effects were partly offset by current tax expenses of USD 0.4 billion, accruals for capital returns to shareholders of USD 0.3 billion and negative foreign currency translation effects of USD 0.2 billion. Our share repurchases in the third quarter of 2021 did not materially affect our CET1 capital position, as there was a nearly equivalent reduction in the remaining capital reserve for potential share repurchases. The remaining capital reserve for potential share repurchases was fully utilized during the third quarter of 2021.

Our additional tier 1 (AT1) capital decreased by USD 1.3 billion to USD 15.3 billion, mainly reflecting the call of an AT1 capital instrument with a nominal amount of USD 1.1 billion.

 


Gone concern loss-absorbing capacity and movement

Our total gone concern loss-absorbing capacity decreased by USD 2.7 billion to USD 42.4 billion, due to a USD 2 billion low-trigger loss-absorbing tier 2 capital instrument that ceased to be eligible as it had less than one year to maturity, the call of a EUR 1.75 billion TLAC-eligible senior unsecured debt, and effects from interest rate risk hedges and foreign currency translation, partly offset by a USD 2 billion issuance of TLAC-eligible senior unsecured debt.

     Refer to “Bondholder information” at ubs.com/investors  for more information about the eligibility of capital and senior unsecured debt instruments and about key features and terms and conditions of capital instruments

Loss-absorbing capacity and leverage ratios

Our CET1 capital ratio increased 0.4 percentage points to 14.9%, reflecting an increase in CET1 capital of USD 2.4 billion, partly offset by a USD 9.1 billion increase in RWA.

Our CET1 leverage ratio increased from 4.09% to 4.31%, due to the aforementioned increase in CET1 capital, partly offset by a USD 5 billion increase in LRD.

Our gone concern loss-absorbing capacity ratio decreased from 15.4% to 14.0%, due to the decrease in gone concern loss-absorbing capacity of USD 2.7 billion and the aforementioned increase in RWA.

Our gone concern leverage ratio decreased from 4.3% to 4.1%, reflecting the aforementioned decrease in gone concern loss-absorbing capacity and the increase in LRD.

 

 

Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital

 

 

 

 

USD million

 

30.9.21

30.6.21

31.12.20

Total IFRS equity

 

 60,552 

 59,050 

 59,765 

Equity attributable to non-controlling interests

 

 (333) 

 (284) 

 (319) 

Defined benefit plans, net of tax

 

 (146) 

 (144) 

 (41) 

Deferred tax assets recognized for tax loss carry-forwards

 

 (4,813) 

 (5,183) 

 (5,617) 

Deferred tax assets on temporary differences, excess over threshold

 

 

 

 (5) 

Goodwill, net of tax1

 

 (5,854) 

 (5,883) 

 (6,319) 

Intangible assets, net of tax

 

 (185) 

 (200) 

 (296) 

Compensation-related components (not recognized in net profit)

 

 (1,777) 

 (1,680) 

 (1,349) 

Expected losses on advanced internal ratings-based portfolio less provisions

 

 (479) 

 (463) 

 (330) 

Unrealized (gains) / losses from cash flow hedges, net of tax

 

 (1,044) 

 (1,365) 

 (2,321) 

Own credit related to gains / losses on financial liabilities measured at fair value that existed at the balance sheet date

 

 371 

 279 

 382 

Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date

 

 (47) 

 (50) 

 (45) 

Unrealized gains related to debt instruments at fair value through OCI, net of tax

 

 (88) 

 (89) 

 (152) 

Prudential valuation adjustments

 

 (147) 

 (146) 

 (150) 

Accruals for dividends to shareholders for 2020

 

 

 

 (1,314) 

Capital reserve for potential share repurchases

 

 

 (587) 

 (2,000) 

Other2

 

 (990) 

 (670) 

 0 

Total common equity tier 1 capital

 

 45,022 

 42,583 

 39,890 

1 Includes goodwill related to significant investments in financial institutions of USD 21 million as of 30 September 2021 (30 June 2021: USD 21 million; 31 December 2020: USD 413 million) presented on the balance sheet line Investments in associates.    2 Includes accruals for dividends to shareholders for the current year and other items.    

 

39 


Risk, capital, liquidity and funding, and balance sheet | Capital management 

Swiss SRB total loss-absorbing capacity movement

 

USD million

 

 

 

Going concern capital

Swiss SRB

Common equity tier 1 capital as of 30.6.21

 42,583 

Operating profit before tax

 2,865 

Current tax (expense) / benefit

 (432) 

Foreign currency translation effects

 (209) 

Share repurchase program

 (600) 

Capital reserve for potential share repurchases

 587 

Deferred tax assets on temporary differences

 175 

Other1

 54 

Common equity tier 1 capital as of 30.9.21

 45,022 

Loss-absorbing additional tier 1 capital as of 30.6.21

 16,605 

Call of high-trigger loss-absorbing additional tier 1 capital

 (1,100) 

Interest rate risk hedge, foreign currency translation and other effects

 (158) 

Loss-absorbing additional tier 1 capital as of 30.9.21

 15,347 

Total going concern capital as of 30.6.21

 59,188 

Total going concern capital as of 30.9.21

 60,369 

 

 

Gone concern loss-absorbing capacity

 

Tier 2 capital as of 30.6.21

 5,232 

Debt no longer eligible as gone concern loss-absorbing capacity due to residual tenor falling to below one year

 (2,030) 

Interest rate risk hedge, foreign currency translation and other effects

 (17) 

Tier 2 capital as of 30.9.21

 3,185 

TLAC-eligible senior unsecured debt as of 30.6.21

 39,878 

Issuance of TLAC-eligible senior unsecured debt

 2,000 

Call of TLAC-eligible senior unsecured debt

 (2,027) 

Interest rate risk hedge, foreign currency translation and other effects

 (608) 

TLAC-eligible senior unsecured debt as of 30.9.21

 39,242 

Total gone concern loss-absorbing capacity as of 30.6.21

 45,110 

Total gone concern loss-absorbing capacity as of 30.9.21

 42,428 

 

 

Total loss-absorbing capacity

 

Total loss-absorbing capacity as of 30.6.21

 104,298 

Total loss-absorbing capacity as of 30.9.21

 102,796 

1 Includes movements related to accruals for dividends for the current year and other items.

  

 

40 


Additional information

Sensitivity to currency movements

Risk-weighted assets

We estimate that a 10% depreciation of the US dollar against other currencies would have increased our RWA by USD 13 billion and our CET1 capital by USD 1.4  billion as of 30 September 2021 (30 June 2021: USD 13 billion and USD 1.3 billion, respectively) and decreased our CET1 capital ratio 16 basis points (30 June 2021: 16 basis points). Conversely, we estimate that a 10% appreciation of the US dollar against other currencies would have decreased our RWA by USD 12 billion and our CET1 capital by USD 1.3  billion (30 June 2021: USD 11 billion and USD 1.2 billion, respectively) and increased our CET1 capital ratio 16 basis points (30 June 2021: 16 basis points).

Leverage ratio denominator

We estimate that a 10% depreciation of the US dollar against other currencies would have increased our LRD by USD 62 billion as of 30 September 2021 (30 June 2021: USD 63 billion) and decreased our Swiss SRB going concern leverage ratio 16 basis points (30 June 2021: 17 basis points). Conversely, we estimate that a 10% appreciation of the US dollar against other currencies would have decreased our LRD by USD 56 billion (30 June 2021: USD 57 billion) and increased our Swiss SRB going concern leverage ratio 16 basis points (30 June 2021: 17 basis points)

The aforementioned sensitivities do not consider foreign currency translation effects related to defined benefit plans other than those related to the currency translation of the net equity of foreign operations.

     Refer to “Active management of sensitivity to currency movements” under “Capital management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020 for more information


Estimated effect on capital from litigation, regulatory and similar matters subject to provisions and contingent liabilities

We have estimated the loss in capital that we could incur as a result of the risks associated with the matters described in “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report. We have used for this purpose the advanced measurement approach (AMA) methodology that we apply when determining the capital requirements associated with operational risks, based on a 99.9% confidence level over a 12-month horizon. The methodology takes into consideration UBS and industry experience for the AMA operational risk categories to which those matters correspond, as well as the external environment affecting risks of these types, in isolation from other areas. On this standalone basis, we estimate the maximum loss in capital that we could incur over a 12-month period as a result of our risks associated with these operational risk categories at USD 4.0 billion as of 30 September 2021. This estimate is not related to and does not take into account any provisions recognized for any of these matters and does not constitute a subjective assessment of our actual exposure in any of these matters.

     Refer to “Operational risk” in the “Risk management and control” section of our Annual Report 2020 for more information

     Refer to “Note 14  Provisions and contingent liabilities” in the “Consolidated financial statements” section of this report for more information

  

41 


Risk, capital, liquidity and funding, and balance sheet | Capital management 

Risk-weighted assets

During the third quarter of 2021, RWA increased by USD 9.1 billion to USD 302.4 billion, driven by increases from regulatory add-ons of USD 7.0 billion, asset size and other movements of USD 3.2 billion, and model updates of USD 0.6 billion, partly offset by a decrease from currency effects of USD 1.6 billion, as well as methodology and policy changes of USD 0.1 billion.

 

Movement in risk-weighted assets by key driver

USD billion

 

RWA as of 30.6.21

Currency

effects

Methodology and policy changes

Model updates / changes

Regulatory add-ons

Asset size and other1

RWA as of 30.9.21

Credit and counterparty credit risk2

 

 186.4 

 (1.5) 

 (0.1) 

 0.9 

 1.5 

 1.8 

 189.0 

Non-counterparty-related risk3

 

 23.3 

 (0.1) 

 

 

 

 0.4 

 23.6 

Market risk

 

 7.8 

 

 

 (0.2) 

 5.5 

 1.0 

 14.0 

Operational risk

 

 75.8 

 

 

 

 

 

 75.8 

Total

 

 293.3 

 (1.6) 

 (0.1) 

 0.6 

 7.0 

 3.2 

 302.4 

1 Includes the Pillar 3 categories “Asset size,” “Credit quality of counterparties,” “Acquisitions and disposals” and “Other.” For more information, refer to our 31 December 2020 Pillar 3 report, which is available under “Pillar 3 disclosures” at ubs.com/investors.    2 Includes settlement risk, credit valuation adjustments, equity exposures in the banking book, investments in funds and securitization exposures in the banking book.    3 Non-counterparty-related risk includes deferred tax assets recognized for temporary differences, property, equipment, software and other items.

 

Credit and counterparty credit risk

Credit and counterparty credit risk RWA increased by USD 2.6 billion to USD 189.0 billion as of 30 September 2021. The increase of USD 2.6 billion included a decrease of USD 1.5 billion related to currency effects.

Asset size and other movements resulted in a USD 1.8 billion increase in RWA.

      Global Wealth Management RWA increased by USD 1.6 billion, mainly driven by increases in Lombard and other loans.

      Investment Bank RWA increased by USD 0.6 billion, mainly driven by higher RWA from derivatives.

      Asset Management RWA decreased by USD 0.3 billion.

      Personal & Corporate Banking RWA decreased by USD 0.1 billion

 

Asset size and other movements referenced above included changes to credit ratings and loss given default (LGD), excluding model updates, which resulted in a net decrease of around USD 1 billion in RWA during the third quarter of 2021.

Regulatory add-ons drove an increase in RWA of USD 1.5 billion, of which USD 1.2 billion was for prime brokerage clients and the remainder for clients leasing aircraft and industrial goods.

The third quarter of 2021 also included an RWA increase of USD 0.9 billion from model updates, primarily due to a USD 0.7 billion quarterly phase-in impact for structured margin loans and similar products in Global Wealth Management, as well as a USD 0.5 billion quarterly phase-in impact of new probability of default (PD) and LGD models for the mortgage portfolio in the US. This was partly offset by a USD 0.3 billion reduction related to the introduction of new models for the leasing of aircraft and industrial goods.

We expect that further methodology changes, model updates and regulatory add-ons will increase credit and counterparty credit risk RWA by around USD 5 billion in the fourth quarter of 2021. Among other items, this includes regulatory add-ons of around USD 2 billion for prime brokerage clients, as well as the quarterly phase-in impacts on the exposures mentioned above.

The extent and timing of RWA changes may vary as methodology changes and model updates are completed and
receive regulatory approval. In addition, changes in the composition of the relevant portfolios and other market factors will affect RWA.

     Refer to the “Risk management and control” section of this report and our 30 September 2021 Pillar 3 report, available under “Pillar 3 disclosures” at ubs.com/investors for more information

     Refer to “Credit risk models” in the “Risk management and control” section of our Annual Report 2020 for more information

Market risk

Market risk RWA increased by USD 6.2 billion to USD 14.0 billion in the third quarter of 2021, primarily due to the introduction of a regulatory add-on of USD 5.5 billion, which considers profit or loss resulting from time decay in addition to the regulatory value-at-risk (VaR) and stressed VaR. The add-on reflects the outcome of discussions with FINMA regarding our regulatory VaR model, which started in late 2019. The integration of time decay into the regulatory VaR model, which would replace the add-on, is subject to further discussions between FINMA and UBS. The market risk RWA increase was also driven by a USD 1.0 billion increase from portfolio and market movements primarily in the Investment Bank’s Global Markets business.

     Refer to the “Risk management and control” section of this report and our 30 September 2021 Pillar 3 report, available under “Pillar 3 disclosures” at ubs.com/investors,  for more information

     Refer to ”Market risk” in the “Risk management and control” section of our Annual Report 2020 for more information

Operational risk

Operational risk RWA were USD 75.8 billion as of 30 September 2021, unchanged from 30 June 2021.

     Refer to “Operational risk” in the “Risk management and control” section of our Annual Report 2020 for information about the advanced measurement approach model

 

42 


 

Risk-weighted assets by business division and Group Functions

USD billion

 

Global Wealth

Management

Personal &

Corporate

Banking

Asset

Manage-

ment

Investment

Bank

Group Functions

Total

RWA

 

 

30.9.21

Credit and counterparty credit risk1

 

 55.2 

 62.2 

 3.7 

 61.0 

 6.9 

 189.0 

Non-counterparty-related risk2

 

 6.2 

 2.0 

 0.6 

 3.4 

 11.4 

 23.6 

Market risk

 

 1.6 

 0.0 

 0.0 

 10.9 

 1.6 

 14.0 

Operational risk

 

 32.8 

 7.2 

 3.3 

 23.1 

 9.4 

 75.8 

Total

 

 95.7 

 71.4 

 7.6 

 98.5 

 29.3 

 302.4 

 

 

 

 

 

 

 

 

 

 

30.6.21

Credit and counterparty credit risk1

 

 51.9 

 62.4 

 4.0 

 60.0 

 8.1 

 186.4 

Non-counterparty-related risk2

 

 6.2 

 2.1 

 0.6 

 3.4 

 10.9 

 23.3 

Market risk

 

 1.1 

 0.0 

 0.0 

 5.7 

 1.0 

 7.8 

Operational risk

 

 32.8 

 7.2 

 3.3 

 23.2 

 9.3 

 75.8 

Total

 

 92.0 

 71.7 

 7.9 

 92.3 

 29.4 

 293.3 

 

 

 

 

 

 

 

 

 

 

30.9.21 vs 30.6.21

Credit and counterparty credit risk1

 

 3.3 

 (0.3) 

 (0.3) 

 1.0 

 (1.1) 

 2.6 

Non-counterparty-related risk2

 

 0.0 

 0.0 

 0.0 

 0.0 

 0.4 

 0.3 

Market risk

 

 0.5 

 0.0 

 0.0 

 5.2 

 0.5 

 6.2 

Operational risk

 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

Total

 

 3.7 

 (0.3) 

 (0.3) 

 6.2 

 (0.1) 

 9.1 

1 Includes settlement risk, credit valuation adjustments, equity exposures in the banking book, investments in funds and securitization exposures in the banking book.    2 Non-counterparty-related risk includes deferred tax assets recognized for temporary differences (30 September 2021: USD 10.8 billion; 30 June 2021: USD 10.4 billion), property, equipment, software and other items (30 September 2021: USD 12.8 billion; 30 June 2021: USD 12.9 billion).

43 


Risk, capital, liquidity and funding, and balance sheet | Capital management 

Leverage ratio denominator

During the third quarter of 2021, LRD increased by USD 5 billion to USD 1,045 billion, reflecting an increase in asset size and other movements of USD 12 billion, partly offset by a decrease due to currency effects of USD 7 billion.

  

Movement in leverage ratio denominator by key driver

USD billion

 

LRD as of

30.6.21

Currency

effects

Asset size and

other

LRD as of

30.9.21

On-balance sheet exposures (excluding derivative exposures and SFTs)1

 

 801.5 

 (5.5) 

 18.4 

 814.4 

Derivative exposures

 

 97.7 

 (0.9) 

 3.6 

 100.4 

Securities financing transactions

 

 121.5 

 (0.8) 

 (10.5) 

 110.3 

Off-balance sheet items

 

 31.1 

 (0.2) 

 0.4 

 31.3 

Deduction items

 

 (12.0) 

 0.0 

 0.4 

 (11.6) 

Total

 

 1,039.9 

 (7.4) 

 12.4 

 1,044.9 

1 The exposures exclude derivative financial instruments, cash collateral receivables on derivative instruments, receivables from SFTs, and margin loans, as well as prime brokerage receivables and financial assets at fair value not held for trading, both related to SFTs. These exposures are presented separately under Derivative exposures and Securities financing transactions in this table.   

 

The LRD movements described below exclude currency effects.

On-balance sheet exposures increased by USD 18 billion, mainly driven by higher central bank balances in Group Treasury and trading assets in the Investment Bank, as well as an increase in lending balances in Global Wealth Management, partly offset by lower high-quality liquid asset (HQLA) securities.

Derivative exposures increased by USD 4 billion, mainly reflecting higher client volumes and market-driven movements in the Investment Bank.


Securities financing transactions (SFTs) decreased by USD 10 billion, mainly due to excess cash reinvestment trade roll-offs and a reduction in collateral sourcing requirements in Group Treasury, as well as lower brokerage receivables and a decrease in borrowing activities in the Investment Bank.

     Refer to the “Balance sheet and off-balance sheet” section of this report for more information about balance sheet movements

  

44 


 

Leverage ratio denominator by business division and Group Functions

USD billion

 

Global Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group Functions

Total

 

 

30.9.21

Total IFRS assets

 

 387.1 

 218.4 

 25.2 

 345.5 

 112.6 

 1,088.8 

Difference in scope of consolidation1

 

 (0.1) 

 0.0 

 (21.1) 

 (0.1) 

 0.1 

 (21.3) 

Less: derivative exposures and SFTs2

 

 (27.4) 

 (12.3) 

 (0.1) 

 (161.2) 

 (52.0) 

 (253.0) 

On-balance sheet exposures

 

 359.6 

 206.0 

 4.0 

 184.2 

 60.6 

 814.4 

Derivative exposures

 

 7.0 

 2.0 

 0.0 

 86.1 

 5.3 

 100.4 

Securities financing transactions

 

 23.5 

 11.0 

 0.1 

 46.8 

 28.9 

 110.3 

Off-balance sheet items

 

 6.6 

 16.7 

 0.0 

 7.7 

 0.3 

 31.3 

Items deducted from Swiss SRB tier 1 capital

 

 (5.3) 

 (0.2) 

 (1.2) 

 (0.2) 

 (4.7) 

 (11.6) 

Total

 

 391.3 

 235.6 

 2.8 

 324.6 

 90.5 

 1,044.9 

 

 

 

 

 

 

 

 

 

 

30.6.21

Total IFRS assets

 

 375.1 

 222.0 

 29.5 

 343.9 

 116.1 

 1,086.5 

Difference in scope of consolidation1

 

 (0.1) 

 0.0 

 (22.3) 

 0.0 

 0.1 

 (22.3) 

Less: derivative exposures and SFTs2

 

 (29.3) 

 (15.1) 

 (0.7) 

 (162.7) 

 (54.9) 

 (262.7) 

On-balance sheet exposures

 

 345.6 

 206.9 

 6.5 

 181.3 

 61.3 

 801.5 

Derivative exposures

 

 6.7 

 2.5 

 0.0 

 82.4 

 6.1 

 97.7 

Securities financing transactions

 

 25.4 

 13.4 

 0.7 

 53.5 

 28.5 

 121.5 

Off-balance sheet items

 

 6.8 

 16.0 

 0.0 

 8.0 

 0.3 

 31.1 

Items deducted from Swiss SRB tier 1 capital

 

 (5.3) 

 (0.2) 

 (1.3) 

 (0.2) 

 (5.0) 

 (12.0) 

Total

 

 379.2 

 238.7 

 6.0 

 324.9 

 91.2 

 1,039.9 

 

 

 

30.9.21 vs 30.6.21

Total IFRS assets

 

 12.1 

 (3.6) 

 (4.3) 

 1.6 

 (3.6) 

 2.3 

Difference in scope of consolidation1

 

 0.0 

 0.0 

 1.1 

 (0.2) 

 0.0 

 0.9 

Less: derivative exposures and SFTs2

 

 1.9 

 2.7 

 0.7 

 1.5 

 2.9 

 9.7 

On-balance sheet exposures

 

 14.0 

 (0.9) 

 (2.5) 

 2.9 

 (0.7) 

 12.9 

Derivative exposures

 

 0.3 

 (0.5) 

 0.0 

 3.7 

 (0.7) 

 2.7 

Securities financing transactions

 

 (1.9) 

 (2.4) 

 (0.7) 

 (6.7) 

 0.4 

 (11.2) 

Off-balance sheet items

 

 (0.2) 

 0.7 

 0.0 

 (0.2) 

 0.0 

 0.2 

Items deducted from Swiss SRB tier 1 capital

 

 0.0 

 0.0 

 0.0 

 0.0 

 0.4 

 0.4 

Total

 

 12.1 

 (3.0) 

 (3.1) 

 (0.3) 

 (0.7) 

 5.0 

1 Represents the difference between the IFRS and the regulatory scope of consolidation, which is the applicable scope for the LRD calculation.    2 The exposures consist of derivative financial instruments, cash collateral receivables on derivative instruments, receivables from SFTs, and margin loans, as well as prime brokerage receivables and financial assets at fair value not held for trading, both related to SFTs, all of which are in accordance with the regulatory scope of consolidation. These exposures are presented separately under Derivative exposures and Securities financing transactions in this table.

 

  

45 


Risk, capital, liquidity and funding, and balance sheet | Capital management 

Equity attribution and return on attributed equity

Under our equity attribution framework, tangible equity is attributed based on a weighting of 50% each for average risk-weighted assets (RWA) and average leverage ratio denominator (LRD), which both include resource allocations from Group Functions to the business divisions (the BDs). Average RWA and LRD are converted to common equity tier 1 (CET1) capital equivalents using capital ratios of 12.5% and 3.75%, respectively. If the attributed tangible equity calculated under the weighted-driver approach is less than the CET1 capital equivalent of risk-based capital (RBC) for any BD, the CET1 capital equivalent of RBC is used as a floor for that BD.

In addition to tangible equity, we allocate equity to the BDs to support goodwill and intangible assets.

Furthermore, we allocate to the BDs attributed equity related to certain CET1 deduction items, such as compensation-related components and expected losses on the advanced internal ratings-based portfolio, less general provisions.


We attribute all remaining Basel III capital deduction items to Group Functions. These items include deferred tax assets (DTAs) recognized for tax loss carry-forwards, DTAs on temporary differences in excess of the threshold, accruals for shareholder returns, and unrealized gains from cash flow hedges.

     Refer to the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020 for more information about the equity attribution framework

     Refer to the “Balance sheet and off-balance sheet” section of this report for more information about movements in equity attributable to shareholders

 

 

Average attributed equity

 

 

 

 

 

 

 

 

 

For the quarter ended

 

Year-to-date

USD billion

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Global Wealth Management

 

 19.0 

 18.5 

 17.4 

 

 18.6 

 16.8 

Personal & Corporate Banking

 

 9.2 

 9.1 

 9.0 

 

 9.1 

 8.8 

Asset Management

 

 1.9 

 2.1 

 2.0 

 

 2.1 

 1.9 

Investment Bank

 

 12.7 

 13.0 

 12.7 

 

 12.9 

 12.6 

Group Functions

 

 16.8 

 15.7 

 17.2 

 

 16.2 

 17.2 

of which: deferred tax assets1

 

 5.8 

 6.1 

 6.7 

 

 6.1 

 6.8 

of which: related to retained RWA and LRD2,3

 

 3.2 

 3.1 

 3.5 

 

 3.2 

 3.4 

of which: accruals for shareholder returns and others4

 

 7.8 

 6.4 

 6.9 

 

 6.9 

 6.9 

Average equity attributed to business divisions and Group Functions

 

 59.5 

 58.4 

 58.2 

 

 58.9 

 57.3 

1 Includes average attributed equity related to the Basel III capital deduction items for deferred tax assets (deferred tax assets recognized for tax loss carry-forwards and deferred tax assets on temporary differences, excess over threshold), as well as retained RWA and LRD related to deferred tax assets.    2 Excludes average attributed equity related to retained RWA and LRD related to deferred tax assets.    3 The temporary exemption that applied from 25 March 2020 until 1 January 2021 and that was granted by FINMA in connection with COVID-19 was not applied when calculating average attributed equity for the respective periods in 2020. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    4 Includes attributed equity related to dividend accruals, share repurchase reserves built up in 2020, unrealized gains from cash flow hedges, and a balancing item for capital held in excess of the 12.5% / 3.75% capital and leverage ratio calibration thresholds for equity attribution.

 

 

Return on attributed equity1

 

 

 

 

 

For the quarter ended

 

Year-to-date

USD billion

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Global Wealth Management

 

 31.9 

 27.9 

 24.3 

 

 30.2 

 25.0 

Personal & Corporate Banking

 

 20.8 

 21.8 

 14.9 

 

 19.9 

 13.7 

Asset Management

 

 46.3 

 49.0 

 147.5 

 

 45.2 

 74.0 

Investment Bank

 

 26.4 

 20.6 

 19.9 

 

 19.9 

 20.7 

1 Return on attributed equity for Group Functions is not shown, as it is not meaningful.

46 


 

Liquidity and funding management

Strategy, objectives and governance  

This section provides liquidity and funding management information and should be read in conjunction with “Liquidity and funding management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020, which provides more information about the Group’s strategy, objectives and governance in connection with liquidity and funding management.

 

Liquidity coverage ratio

 

 

 

USD billion, except where indicated

 

Average 3Q211

Average 2Q211

High-quality liquid assets

 

 231 

 232 

Net cash outflows

 

 147 

 149 

Liquidity coverage ratio (%)2

 

 157 

 156 

1 Calculated based on an average of 65 data points in the third quarter of 2021 and 64 data points in the second quarter of 2021.    2 Calculated after the application of haircuts and inflow and outflow rates, as well as, where applicable, caps on Level 2 assets and cash inflows.

 

 

Liquidity coverage ratio

The UBS Group quarterly average liquidity coverage ratio (LCR) increased 1 percentage point to 157%, remaining above the prudential requirement communicated by the Swiss Financial Market Supervisory Authority (FINMA). The increase in average LCR was driven by a decrease in average total net cash outflows of USD 2 billion to USD 147 billion, mainly due to decreases in outflows from secured financing transactions. Average high-quality liquid assets (HQLA) decreased by USD 1 billion to USD 231 billion, driven by an increase in assets subject to local transfer restrictions.

     Refer to our 30 September 2021 Pillar 3 report, available under “Pillar 3 disclosures” at ubs.com/investors, and to “Liquidity and funding management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020 for more information about LCR


Net stable funding ratio

As of 30 September 2021, our net stable funding ratio (NSFR) was 118%, an increase of 3 percentage points compared with the estimated pro forma NSFR as of 30 June 2021. This reflected a USD 3 billion increase in available stable funding, mainly driven by an increase in customer deposits. Required stable funding decreased by USD 9 billion, mainly due to calculation refinements related to securities and derivatives.

The NSFR regulation was finalized in the fourth quarter of 2020 with the release of the revised FINMA Circular 2015/2 “Liquidity risks – banks.” Our NSFR disclosure is based on the final regulation, which became effective on 1 July 2021.

     Refer to our 30 September 2021 Pillar 3 report, available under “Pillar 3 disclosures” at ubs.com/investors, and to “Liquidity and funding management” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020 for more information about NSFR

 

Net stable funding ratio

 

 

 

USD billion, except where indicated

 

30.9.21

30.6.211

Available stable funding

 

 559 

 556 

Required stable funding

 

 473 

 482 

Net stable funding ratio (%)

 

 118 

 115 

1 Prior-period “Net stable funding ratio” is based on estimated pro forma reporting.

  

47 


Risk, capital, liquidity and funding, and balance sheet | Balance sheet and off-balance sheet 

Balance sheet and off-balance sheet

Strategy, objectives and governance

This section provides balance sheet and off-balance sheet information and should be read in conjunction with “Balance sheet and off-balance sheet” in the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020, which provides more information about the Group’s balance sheet and off-balance sheet positions.

Balances disclosed in this report represent quarter-end positions, unless indicated otherwise. Intra-quarter balances fluctuate in the ordinary course of business and may differ from quarter-end positions.

Balance sheet assets (30 September 2021 vs 30 June 2021)

Total assets increased by USD 2 billion to USD 1,089 billion as of 30 September 2021.

Cash and balances at central banks increased by USD 14 billion, mainly driven by net roll-offs of securities financing transactions, higher customer deposits, and disposals of high-quality liquid asset (HQLA) securities. Trading portfolio assets increased by USD 3 billion, mainly due to higher inventory levels held to hedge client positions in our Financing business in the Investment Bank. Derivatives and cash collateral receivables on derivative instruments increased by USD 1 billion, mainly in our Financing business.

These increases were largely offset by a decrease in Securities financing transactions at amortized cost of USD 9 billion, predominantly reflecting net roll-offs of positions in the quarter. Other financial assets measured at amortized cost and fair value decreased by USD 3 billion, mainly driven by disposals in the HQLA portfolio. Brokerage receivables decreased by USD 2 billion due to lower lending. Non-financial assets and financial assets for unit-linked investment contracts decreased by USD 2 billion, mainly reflecting market-driven decreases and net new money outflows from unit-linked investment contracts in Asset Management.

     Refer to the “Consolidated financial statements” section of this report for more information

 

Assets

 

 

 

 

 

 

 

As of

 

% change from

USD billion

 

30.9.21

30.6.21

 

30.6.21

Cash and balances at central banks

 

 174.5 

 160.7 

 

 9 

Lending1

 

 406.7 

 406.6 

 

 0 

Securities financing transactions at amortized cost

 

 74.5 

 83.5 

 

 (11) 

Trading portfolio2

 

 125.5 

 122.5 

 

 2 

Derivatives and cash collateral receivables on derivative instruments

 

 152.8 

 151.4 

 

 1 

Brokerage receivables

 

 20.7 

 23.0 

 

 (10) 

Other financial assets measured at amortized cost and fair value3

 

 75.5 

 78.3 

 

 (4) 

Non-financial assets and financial assets for unit-linked investment contracts

 

 58.5 

 60.5 

 

 (3) 

Total assets

 

 1,088.8 

 1,086.5 

 

 0 

1 Consists of loans and advances to customers and banks.    2 Consists of financial assets at fair value held for trading.    3 Consists of financial assets at fair value not held for trading, financial assets measured at fair value through other comprehensive income and other financial assets measured at amortized cost, but excludes financial assets for unit-linked investment contracts.

 

 

Balance sheet liabilities (30 September 2021 vs 30 June 2021)

Total liabilities increased by USD 1 billion to USD 1,028 billion as of 30 September 2021.

Brokerage payables increased by USD 6 billion, mainly in our Financing business in the Investment Bank, with lower lending resulting in a decrease in netting effects. Customer deposits increased by USD 4 billion, reflecting higher levels of cash held by clients mainly in Global Wealth Management Americas, partly offset by currency effects. Trading portfolio liabilities increased by USD 1 billion, driven by the Investment Bank, mainly reflecting an increase in short positions ahead of the Japanese dividend season.


These increases were largely offset by a USD 6 billion decrease in short-term borrowings, mainly driven by net maturities of commercial paper in Group Treasury and other short-term debt in Global Wealth Management, as well as lower amounts due to banks in Personal & Corporate Banking. In addition, debt issued designated at fair value and long-term debt issued measured at amortized cost decreased by USD 5 billion, mainly reflecting net redemptions and market-driven movements on debt measured at fair value in our Derivatives & Solutions business in the Investment Bank, as well as the call of one high-trigger loss-absorbing additional tier 1 capital instrument in Group Treasury.

The “Liabilities by product and currency” table in this section provides more information about our funding sources.

     Refer to “Bondholder information” at ubs.com/investors  for more information about capital and senior debt instruments

     Refer to the “Consolidated financial statements” section of this report for more information

 

 

48 


 

Equity (30 September 2021 vs 30 June 2021)

Equity attributable to shareholders increased by USD 1,454 million to USD 60,219 million as of 30 September 2021.

The increase of USD 1,454 million was mainly driven by total comprehensive income attributable to shareholders of positive USD 1,683 million, reflecting net profit of USD 2,279 million and negative other comprehensive income (OCI) of USD 596 million. OCI mainly included negative cash flow hedge OCI of USD 316 million, negative OCI related to foreign currency translation of USD 156 million, and negative OCI related to own credit of USD 98 million. In addition, share premium increased by USD 297 million, mainly reflecting an increase of USD 155 million related to the launch of our new operational partnership entity with Sumitomo Mitsui Trust Holdings, Inc., as well as USD 155 million related to the amortization of deferred share-based compensation awards.


These increases were partly offset by net treasury share activity, which decreased equity by USD 525 million. This was mainly due to repurchases of USD 600 million of shares under our 2021–2024 share repurchase program.

     Refer to the “Recent developments” section of this report for more information about the partnership with Sumitomo Mitsui Trust Holdings, Inc.

     Refer to the “Group performance” and “Consolidated financial statements” sections of this report for more information

     Refer to the “Share information and earnings per share” section of this report for more information about the share repurchase program

 

 

Liabilities and equity

 

 

 

 

 

 

 

As of

 

% change from

USD billion

 

30.9.21

30.6.21

 

30.6.21

Short-term borrowings1

 

 51.8 

 57.3 

 

 (10) 

Securities financing transactions at amortized cost

 

 5.3 

 6.0 

 

 (12) 

Customer deposits

 

 517.7 

 513.3 

 

 1 

Debt issued designated at fair value and long-term debt issued measured at amortized cost2

 

 167.1 

 172.3 

 

 (3) 

Trading portfolio3

 

 34.6 

 33.3 

 

 4 

Derivatives and cash collateral payables on derivative instruments

 

 154.2 

 153.9 

 

 0 

Brokerage payables

 

 45.6 

 39.1 

 

 16 

Other financial liabilities measured at amortized cost and fair value4

 

 18.7 

 18.6 

 

 1 

Non-financial liabilities and financial liabilities related to unit-linked investment contracts

 

 33.2 

 33.6 

 

 (1) 

Total liabilities

 

 1,028.2 

 1,027.5 

 

 0 

Share capital

 

 0.3 

 0.3 

 

 0 

Share premium

 

 15.8 

 15.5 

 

 2 

Treasury shares

 

 (3.8) 

 (3.3) 

 

 16 

Retained earnings

 

 42.3 

 40.1 

 

 5 

Other comprehensive income5

 

 5.6 

 6.1 

 

 (8) 

Total equity attributable to shareholders

 

 60.2 

 58.8 

 

 2 

Equity attributable to non-controlling interests

 

 0.3 

 0.3 

 

 17 

Total equity

 

 60.6 

 59.0 

 

 3 

Total liabilities and equity

 

 1,088.8 

 1,086.5 

 

 0 

1 Consists of short-term debt issued measured at amortized cost and amounts due to banks.    2 The classification of debt issued measured at amortized cost into short-term and long-term is based on original contractual maturity and therefore long-term debt also includes debt with a remaining time to maturity of less than one year. This classification does not consider any early redemption features.    3 Consists of financial liabilities at fair value held for trading.    4 Consists of other financial liabilities measured at amortized cost and other financial liabilities designated at fair value, but excludes financial liabilities related to unit-linked investment contracts.    5 Excludes other comprehensive income related to defined benefit plans and own credit, which is recorded directly in Retained earnings.

49 


Risk, capital, liquidity and funding, and balance sheet | Balance sheet and off-balance sheet 

Liabilities by product and currency

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

USD billion

 

As a percentage of total liabilities

 

 

All currencies

 

All currencies

 

USD

 

CHF

 

EUR

 

Other

 

 

30.9.21

30.6.21

 

30.9.21

30.6.21

 

30.9.21

30.6.21

 

30.9.21

30.6.21

 

30.9.21

30.6.21

 

30.9.21

30.6.21

Short-term borrowings

 

51.8

57.3

 

5.0

5.6

 

2.6

3.0

 

0.5

0.6

 

0.6

0.8

 

1.4

1.3

of which: due to banks

 

13.3

14.6

 

1.3

1.4

 

0.3

0.4

 

0.5

0.5

 

0.1

0.1

 

0.4

0.4

of which: short-term debt issued1

 

38.5

42.7

 

3.7

4.2

 

2.3

2.6

 

0.0

0.0

 

0.5

0.7

 

0.9

0.9

Securities financing transactions at amortized cost

 

5.3

6.0

 

0.5

0.6

 

0.5

0.5

 

0.0

0.0

 

0.0

0.0

 

0.0

0.0

Customer deposits

 

517.7

513.3

 

50.3

50.0

 

22.4

21.2

 

18.3

18.8

 

5.0

5.3

 

4.6

4.6

of which: demand deposits

 

245.6

244.2

 

23.9

23.8

 

9.1

8.5

 

6.8

7.0

 

4.3

4.5

 

3.7

3.8

of which: retail savings / deposits

 

223.6

220.7

 

21.7

21.5

 

10.0

9.4

 

11.2

11.6

 

0.5

0.5

 

0.0

0.0

of which: time deposits

 

33.6

32.9

 

3.3

3.2

 

2.3

2.2

 

0.2

0.2

 

0.0

0.0

 

0.8

0.8

of which: fiduciary deposits

 

14.8

15.5

 

1.4

1.5

 

1.1

1.1

 

0.1

0.1

 

0.2

0.2

 

0.0

0.1

Debt issued designated at fair value and long-term debt issued measured at amortized cost2

 

167.1

172.3

 

16.2

16.8

 

9.6

9.5

 

1.7

1.7

 

3.4

3.9

 

1.6

1.7

Trading portfolio

 

34.6

33.3

 

3.4

3.2

 

1.1

1.4

 

0.1

0.1

 

0.8

0.8

 

1.4

0.9

Derivatives and cash collateral payables on derivative instruments

 

154.2

153.9

 

15.0

15.0

 

12.2

12.2

 

0.3

0.2

 

1.5

1.6

 

1.1

1.0

Brokerage payables

 

45.6

39.1

 

4.4

3.8

 

3.3

2.8

 

0.0

0.0

 

0.3

0.2

 

0.8

0.7

Other financial liabilities measured at amortized cost and fair value3

 

18.7

18.6

 

1.8

1.8

 

0.9

1.0

 

0.2

0.2

 

0.4

0.3

 

0.3

0.3

Non-financial liabilities and financial liabilities related to unit-linked investment contracts

 

33.2

33.6

 

3.2

3.3

 

0.5

0.5

 

0.2

0.2

 

0.2

0.2

 

2.3

2.4

Total liabilities

 

1,028.2

1,027.5

 

100.0

100.0

 

53.2

52.2

 

21.2

21.9

 

12.2

13.1

 

13.4

12.9

1 Short-term debt issued consists of certificates of deposit, commercial paper, acceptances and promissory notes, and other money market paper.    2 The classification of debt issued measured at amortized cost into short-term and long-term is based on original contractual maturity and therefore long-term debt also includes debt with a remaining time to maturity of less than one year. This classification does not consider any early redemption features.    3 Consists of other financial liabilities measured at amortized cost and other financial liabilities designated at fair value, but excludes financial liabilities related to unit-linked investment contracts.

 

 

Off-balance sheet (30 September 2021 vs 30 June 2021)

Guarantees increased by USD 2 billion, mainly in Group Treasury, as well as in Personal & Corporate Banking related to guarantees issued to corporate clients. Forward starting reverse repurchase agreements and forward starting repurchase agreements decreased by USD 5 billion and USD 1 billion, respectively, primarily in Group Treasury, reflecting fluctuations in business division activity in short-dated securities financing transactions. Loan commitments and committed unconditionally revocable credit lines were broadly unchanged as of 30 September 2021 compared with 30 June 2021.

 

 

Off-balance sheet

 

 

 

 

 

 

 

As of

 

% change from

USD billion

 

30.9.21

30.6.21

 

30.6.21

Guarantees1,2

 

 17.2 

 15.6 

 

 10 

Loan commitments1,3

 

 38.1 

 37.8 

 

 1 

Committed unconditionally revocable credit lines

 

 39.1 

 38.8 

 

 1 

Forward starting reverse repurchase agreements3

 

 3.7 

 8.2 

 

 (55) 

Forward starting repurchase agreements3

 

 0.8 

 1.8 

 

 (58) 

1 Guarantees and loan commitments are shown net of sub-participations.    2 Includes guarantees measured at fair value through profit or loss.    3 Derivative loan commitments, as well as forward starting repurchase and reverse repurchase agreements, measured at fair value through profit or loss are not included. Refer to “Note 9 Derivative instruments” in the “Consolidated financial statements” section of this report for more information.

  

50 


 

Share information and earnings per share

UBS Group AG shares are listed on the SIX Swiss Exchange (SIX). They are also listed on the New York Stock Exchange (the NYSE) as global registered shares. Each share has a nominal value of CHF 0.10 per share. Shares issued were unchanged in the third quarter of 2021.

We held 257 million shares as of 30 September 2021, of which 138 million shares are primarily held to hedge our share delivery obligations related to employee share-based compensation and participation plans. The remaining 119 million shares were acquired under our 2021–2024 share repurchase program for cancelation purposes.


Treasury shares held increased by 31 million shares in the third quarter of 2021. This largely reflected repurchases of 36.1 million shares under our 2021–2024 program.

Shares acquired under our 2021–2024 program totaled 119 million as of 30 September 2021 for a total acquisition cost of CHF 1,741 million (USD 1,900 million). Under this program, we intend to repurchase up to USD 0.6 billion of shares during the fourth quarter of 2021.

     Refer to the “Return on equity and CET1 capital” table in the “Group performance” section of this report for more information about equity attributable to shareholders and tangible equity attributable to shareholders

 

 

 

 

As of or for the quarter ended

 

As of or year-to-date

 

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

Basic and diluted earnings (USD million)

 

 

 

 

 

 

 

Net profit / (loss) attributable to shareholders for basic EPS

 

 2,279 

 2,006 

 2,093 

 

 6,109 

 4,921 

Less: (profit) / loss on own equity derivative contracts

 

 0 

 (1) 

 (1) 

 

 (2) 

 (1) 

Net profit / (loss) attributable to shareholders for diluted EPS

 

 2,279 

 2,005 

 2,093 

 

 6,108 

 4,920 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

Weighted average shares outstanding for basic EPS1

 

 3,463,572,205 

 3,502,478,236 

 3,587,340,552 

 

 3,501,490,976 

 3,587,905,206 

Effect of dilutive potential shares resulting from notional employee shares, in-the-money options and warrants outstanding2

 

 141,509,280 

 138,873,741 

 128,915,499 

 

 143,658,122 

 116,748,320 

Weighted average shares outstanding for diluted EPS

 

 3,605,081,485 

 3,641,351,977 

 3,716,256,051 

 

 3,645,149,098 

 3,704,653,526 

 

 

 

 

 

 

 

 

Earnings per share

 

 

 

 

 

 

 

Basic earnings per share (USD)

 

 0.66 

 0.57 

 0.58 

 

 1.74 

 1.37 

Basic earnings per share (CHF)3

 

 0.60 

 0.52 

 0.53 

 

 1.59 

 1.29 

Diluted earnings per share (USD)

 

 0.63 

 0.55 

 0.56 

 

 1.68 

 1.33 

Diluted earnings per share (CHF)3

 

 0.58 

 0.50 

 0.52 

 

 1.53 

 1.25 

 

 

 

 

 

 

 

 

Shares outstanding and potentially dilutive instruments

 

 

 

 

 

 

 

Shares issued

 

 3,702,422,995 

 3,702,422,995 

 3,859,055,395 

 

 3,702,422,995 

 3,859,055,395 

Treasury shares4

 

 256,853,565 

 225,877,281 

 271,111,411 

 

 256,853,565 

 271,111,411 

of which: related to share repurchase program 2018–2021

 

 

 

 148,975,800 

 

 

 148,975,800 

of which: related to share repurchase program 2021–2024

 

 119,201,773 

 83,090,525 

 

 

 119,201,773 

 

Shares outstanding

 

 3,445,569,430 

 3,476,545,714 

 3,587,943,984 

 

 3,445,569,430 

 3,587,943,984 

Potentially dilutive instruments5

 

 14,796,870 

 10,459,279 

 29,833,221 

 

 13,846,870 

 30,586,967 

 

 

 

 

 

 

 

 

Other key figures

 

 

 

 

 

 

 

Total book value per share (USD)

 

 17.48 

 16.90 

 16.57 

 

 17.48 

 16.57 

Tangible book value per share (USD)

 

 15.62 

 15.05 

 14.78 

 

 15.62 

 14.78 

Share price (USD)6

 

 16.09 

 15.31 

 11.18 

 

 16.09 

 11.18 

Market capitalization (USD million)

 

 55,423 

 53,218 

 40,113 

 

 55,423 

 40,113 

1 The weighted average shares outstanding for basic EPS are calculated by taking the number of shares at the beginning of the period, adjusted by the number of shares acquired or issued during the period, multiplied by a time-weighted factor for the period outstanding. As a result, balances are affected by the timing of acquisitions and issuances during the period.    2 The weighted average number of shares for notional employee awards with performance conditions reflects all potentially dilutive shares that are expected to vest under the terms of the awards.    3 Basic and diluted earnings per share in Swiss francs are calculated based on a translation of net profit / (loss) under our US dollar presentation currency.    4 Based on a settlement date view.    5 Reflects potential shares that could dilute basic earnings per share in the future, but were not dilutive for the periods presented. It mainly includes equity derivative contracts.    6 Represents the share price as listed on the SIX Swiss Exchange, translated to US dollars using the closing exchange rate as of the respective date.

 

 

Ticker symbols UBS Group AG

 

 

 

 

Trading exchange

SIX / NYSE

Bloomberg

Reuters

SIX Swiss Exchange

UBSG

UBSG SW

UBSG.S

New York Stock Exchange

UBS

UBS UN

UBS.N


Security identification codes

ISIN

 

CH0244767585

Valoren

 

24 476 758

CUSIP

 

CINS H42097 10 7

  


 

 


 

Consolidated financial statements

Unaudited

 

 

 


 

Table of contents

 

UBS Group AG interim consolidated financial
statements (unaudited)

 

 

55

Income statement

56

Statement of comprehensive income

58

Balance sheet

60

Statement of changes in equity

62

Statement of cash flows

 

 

64

1     Basis of accounting and other financial reporting
       effects

66

2     Segment reporting

67

3     Net interest income

67

4     Net fee and commission income

68

5     Personnel expenses

68

6     General and administrative expenses

68

7     Expected credit loss measurement

74

8     Fair value measurement

83

9     Derivative instruments

84

10   Other assets and liabilities

85

11   Debt issued designated at fair value

86

12   Debt issued measured at amortized cost

87

13   Interest rate benchmark reform

90

14   Provisions and contingent liabilities

96

15   Currency translation rates

 

 

 

UBS AG interim consolidated financial information
(unaudited)

 

 

97

Comparison between UBS Group AG consolidated and
UBS AG consolidated

  

 


 

UBS Group AG interim consolidated financial statements (unaudited)

Income statement

 

 

 

 

 

 

 

 

 

 

 

 

 

For the quarter ended

 

Year-to-date

USD million

 

Note

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Interest income from financial instruments measured at amortized cost and fair value through

other comprehensive income

 

3

 

 2,178 

 2,106 

 2,111 

 

 6,381 

 6,699 

Interest expense from financial instruments measured at amortized cost

 

3

 

 (822) 

 (836) 

 (912) 

 

 (2,491) 

 (3,390) 

Net interest income from financial instruments measured at fair value through profit or loss

 

3

 

338

357

318

 

1,044

930

Net interest income

 

3

 

 1,693 

 1,628 

 1,517 

 

 4,934 

 4,240 

Other net income from financial instruments measured at fair value through profit or loss

 

 

 

 1,697 

 1,479 

 1,769 

 

 4,485 

 5,507 

Credit loss (expense) / release

 

7

 

 14 

 80 

 (89) 

 

 121 

 (628) 

Fee and commission income

 

4

 

 6,119 

 6,041 

 5,211 

 

 18,330 

 15,418 

Fee and commission expense

 

4

 

 (510) 

 (484) 

 (440) 

 

 (1,472) 

 (1,316) 

Net fee and commission income

 

4

 

 5,610 

 5,557 

 4,771 

 

 16,858 

 14,103 

Other income

 

 

 

 115 

 233 

 967 

 

 412 

 1,052 

Total operating income

 

 

 

 9,128 

 8,976 

 8,935 

 

 26,810 

 24,273 

Personnel expenses

 

5

 

 4,598 

 4,772 

 4,631 

 

 14,170 

 13,235 

General and administrative expenses

 

6

 

 1,148 

 1,103 

 1,173 

 

 3,340 

 3,369 

Depreciation and impairment of property, equipment and software

 

 

 

 511 

 500 

 538 

 

 1,520 

 1,452 

Amortization and impairment of goodwill and intangible assets

 

 

 

7

9

15

 

24

47

Total operating expenses

 

 

 

 6,264 

 6,384 

 6,357 

 

 19,054 

 18,103 

Operating profit / (loss) before tax

 

 

 

 2,865 

 2,593 

 2,578 

 

 7,755 

 6,169 

Tax expense / (benefit)

 

 

 

 576 

 581 

 485 

 

 1,629 

 1,242 

Net profit / (loss)

 

 

 

 2,289 

 2,012 

 2,094 

 

 6,127 

 4,927 

Net profit / (loss) attributable to non-controlling interests

 

 

 

 9 

 6 

 0 

 

 18 

 6 

Net profit / (loss) attributable to shareholders

 

 

 

 2,279 

 2,006 

 2,093 

 

 6,109 

 4,921 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share (USD)

 

 

 

 

 

 

 

 

 

Basic

 

 

 

 0.66 

 0.57 

 0.58 

 

 1.74 

 1.37 

Diluted

 

 

 

 0.63 

 0.55 

 0.56 

 

 1.68 

 1.33 

 

 

55 


UBS Group AG interim consolidated financial statements (unaudited) 

 

Statement of comprehensive income

 

 

 

 

 

 

 

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

Comprehensive income attributable to shareholders1

 

 

 

 

 

 

 

Net profit / (loss)

 

 2,279 

 2,006 

 2,093 

 

 6,109 

 4,921 

 

 

 

 

 

 

 

 

Other comprehensive income that may be reclassified to the income statement

 

 

 

 

 

 

 

Foreign currency translation

 

 

 

 

 

 

 

Foreign currency translation movements related to net assets of foreign operations, before tax

 

 (392) 

 463 

 782 

 

 (1,391) 

 961 

Effective portion of changes in fair value of hedging instruments designated as net investment hedges, before tax

 

 175 

 (202) 

 (343) 

 

 681 

 (397) 

Foreign currency translation differences on foreign operations reclassified to the income statement

 

 7 

 (10) 

 (7) 

 

 (2) 

 (7) 

Effective portion of changes in fair value of hedging instruments designated as net investment hedges reclassified to the income statement

 

 0 

 8 

 9 

 

 7 

 2 

Income tax relating to foreign currency translations, including the impact of net investment hedges

 

 53 

 (4) 

 (13) 

 

 59 

 (15) 

Subtotal foreign currency translation, net of tax

 

 (156) 

 255 

 428 

 

 (646) 

 544 

Financial assets measured at fair value through other comprehensive income

 

 

 

 

 

 

 

Net unrealized gains / (losses), before tax

 

 (44) 

 21 

 (3) 

 

 (154) 

 223 

Realized gains reclassified to the income statement from equity

 

 0 

 (3) 

 (13) 

 

 (11) 

 (36) 

Realized losses reclassified to the income statement from equity

 

 0 

 0 

 0 

 

 2 

 0 

Income tax relating to net unrealized gains / (losses)

 

 11 

 (4) 

 4 

 

 42 

 (50) 

Subtotal financial assets measured at fair value through other comprehensive income, net of tax

 

 (33) 

 14 

 (12) 

 

 (121) 

 137 

Cash flow hedges of interest rate risk

 

 

 

 

 

 

 

Effective portion of changes in fair value of derivative instruments designated as cash flow hedges, before tax

 

 (112) 

 542 

 (41) 

 

 (742) 

 2,204 

Net (gains) / losses reclassified to the income statement from equity

 

 (282) 

 (268) 

 (240) 

 

 (804) 

 (515) 

Income tax relating to cash flow hedges

 

 77 

 (51) 

 52 

 

 292 

 (318) 

Subtotal cash flow hedges, net of tax

 

 (316) 

 222 

 (229) 

 

 (1,254) 

 1,371 

Cost of hedging

 

 

 

 

 

 

 

Change in fair value of cost of hedging, before tax

 

 1 

 (24) 

 (27) 

 

 (36) 

 (38) 

Amortization of initial cost of hedging to the income statement

 

 4 

 7 

 19 

 

 18 

 26 

Income tax relating to cost of hedging

 

 0 

 0 

 0 

 

 0 

 0 

Subtotal cost of hedging, net of tax

 

 5 

 (16) 

 (8) 

 

 (18) 

 (12) 

Total other comprehensive income that may be reclassified to the income statement, net of tax

 

 (500) 

 475 

 179 

 

 (2,037) 

 2,039 

 

 

 

 

 

 

 

 

Other comprehensive income that will not be reclassified to the income statement

 

 

 

 

 

 

 

Defined benefit plans

 

 

 

 

 

 

 

Gains / (losses) on defined benefit plans, before tax

 

 10 

 (21) 

 46 

 

 (146) 

 (364) 

Income tax relating to defined benefit plans

 

 (9) 

 4 

 (3) 

 

 18 

 60 

Subtotal defined benefit plans, net of tax

 

 2 

 (17) 

 44 

 

 (128) 

 (304) 

Own credit on financial liabilities designated at fair value

 

 

 

 

 

 

 

Gains / (losses) from own credit on financial liabilities designated at fair value, before tax

 

 (98) 

 118 

 (144) 

 

 (8) 

 (82) 

Income tax relating to own credit on financial liabilities designated at fair value

 

 0 

 0 

 0 

 

 0 

 0 

Subtotal own credit on financial liabilities designated at fair value, net of tax

 

 (98) 

 118 

 (144) 

 

 (8) 

 (82) 

Total other comprehensive income that will not be reclassified to the income statement, net of tax

 

 (96) 

 102 

 (100) 

 

 (136) 

 (385) 

 

 

 

 

 

 

 

 

Total other comprehensive income

 

 (596) 

 576 

 80 

 

 (2,174) 

 1,654 

Total comprehensive income attributable to shareholders

 

 1,683 

 2,582 

 2,173 

 

 3,935 

 6,575 

 

56 


 

Statement of comprehensive income (continued)

 

 

 

 

 

 

 

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

 

 

 

 

 

 

 

 

Comprehensive income attributable to non-controlling interests

 

 

 

 

 

 

 

Net profit / (loss)

 

 9 

 6 

 0 

 

 18 

 6 

 

 

 

 

 

 

 

 

Other comprehensive income that will not be reclassified to the income statement

 

 

 

 

 

 

 

Foreign currency translation movements, before tax

 

 (14) 

 14 

 6 

 

 (12) 

 3 

Income tax relating to foreign currency translation movements

 

 0 

 0 

 0 

 

 0 

 0 

Subtotal foreign currency translation, net of tax

 

 (14) 

 14 

 6 

 

 (12) 

 3 

Total other comprehensive income that will not be reclassified to the income statement, net of tax

 

 (14) 

 14 

 6 

 

 (12) 

 3 

Total comprehensive income attributable to non-controlling interests

 

 (5) 

 20 

 7 

 

 6 

 9 

 

 

 

 

 

 

 

 

Total comprehensive income

 

 

 

 

 

 

 

Net profit / (loss)

 

 2,289 

 2,012 

 2,094 

 

 6,127 

 4,927 

Other comprehensive income

 

 (610) 

 591 

 86 

 

 (2,186) 

 1,657 

of which: other comprehensive income that may be reclassified to the income statement

 

 (500) 

 475 

 179 

 

 (2,037) 

 2,039 

of which: other comprehensive income that will not be reclassified to the income statement

 

 (110) 

 116 

 (93) 

 

 (149) 

 (383) 

Total comprehensive income

 

 1,678 

 2,602 

 2,180 

 

 3,941 

 6,584 

1 Refer to the “Group performance” section of this report for more information.

 

57 


UBS Group AG interim consolidated financial statements (unaudited) 

Balance sheet

 

 

 

 

 

 

USD million

 

Note

 

30.9.21

30.6.21

31.12.20

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Cash and balances at central banks

 

 

 

 174,478 

 160,672 

 158,231 

Loans and advances to banks

 

 

 

 16,378 

 16,500 

 15,444 

Receivables from securities financing transactions

 

 

 

 74,476 

 83,494 

 74,210 

Cash collateral receivables on derivative instruments

 

 9 

 

 31,654 

 29,785 

 32,737 

Loans and advances to customers

 

 7 

 

 390,369 

 390,126 

 379,528 

Other financial assets measured at amortized cost

 

 10 

 

 27,082 

 27,143 

 27,194 

Total financial assets measured at amortized cost

 

 

 

 714,437 

 707,720 

 687,345 

Financial assets at fair value held for trading

 

 8 

 

 125,471 

 122,482 

 125,397 

of which: assets pledged as collateral that may be sold or repledged by counterparties

 

 

 

 47,683 

 44,333 

 47,098 

Derivative financial instruments

 

8, 9

 

 121,189 

 121,622 

 159,617 

Brokerage receivables

 

 8 

 

 20,746 

 23,010 

 24,659 

Financial assets at fair value not held for trading

 

 8 

 

 60,799 

 65,393 

 80,364 

Total financial assets measured at fair value through profit or loss

 

 

 

 328,205 

 332,507 

 390,037 

Financial assets measured at fair value through other comprehensive income

 

 8 

 

 8,397 

 7,775 

 8,258 

Investments in associates

 

 

 

 1,188 

 1,198 

 1,557 

Property, equipment and software

 

 

 

 12,827 

 12,895 

 13,109 

Goodwill and intangible assets

 

 

 

 6,401 

 6,452 

 6,480 

Deferred tax assets

 

 

 

 8,830 

 8,988 

 9,212 

Other non-financial assets

 

 10 

 

 8,489 

 8,982 

 9,768 

Total assets

 

 

 

 1,088,773 

 1,086,519 

 1,125,765 

 

58 


 

Balance sheet (continued)

 

 

 

 

 

 

USD million

 

Note

 

30.9.21

30.6.21

31.12.20

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Amounts due to banks

 

 

 

 13,292 

 14,615 

 11,050 

Payables from securities financing transactions

 

 

 

 5,256 

 5,972 

 6,321 

Cash collateral payables on derivative instruments

 

 9 

 

 33,062 

 32,193 

 37,312 

Customer deposits

 

 

 

 517,697 

 513,290 

 524,605 

Debt issued measured at amortized cost

 

 12 

 

 133,662 

 139,911 

 139,232 

Other financial liabilities measured at amortized cost

 

 10 

 

 9,569 

 10,189 

 9,729 

Total financial liabilities measured at amortized cost

 

 

 

 712,537 

 716,169 

 728,250 

Financial liabilities at fair value held for trading

 

 8 

 

 34,650 

 33,348 

 33,595 

Derivative financial instruments

 

8, 9

 

 121,162 

 121,686 

 161,102 

Brokerage payables designated at fair value

 

 8 

 

 45,557 

 39,129 

 38,742 

Debt issued designated at fair value

 

8, 11

 

 71,898 

 75,065 

 61,243 

Other financial liabilities designated at fair value

 

8, 10

 

 30,248 

 30,642 

 30,387 

Total financial liabilities measured at fair value through profit or loss

 

 

 

 303,515 

 299,869 

 325,069 

Provisions

 

 14 

 

 2,810 

 2,855 

 2,828 

Other non-financial liabilities

 

 10 

 

 9,359 

 8,576 

 9,854 

Total liabilities

 

 

 

 1,028,221 

 1,027,469 

 1,066,000 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

Share capital

 

 

 

 322 

 322 

 338 

Share premium

 

 

 

 15,828 

 15,531 

 16,753 

Treasury shares

 

 

 

 (3,847) 

 (3,322) 

 (4,068) 

Retained earnings

 

 

 

 42,330 

 40,143 

 38,776 

Other comprehensive income recognized directly in equity, net of tax

 

 

 

 5,586 

 6,091 

 7,647 

Equity attributable to shareholders

 

 

 

 60,219 

 58,765 

 59,445 

Equity attributable to non-controlling interests

 

 

 

 333 

 284 

 319 

Total equity

 

 

 

 60,552 

 59,050 

 59,765 

Total liabilities and equity

 

 

 

 1,088,773 

 1,086,519 

 1,125,765 

 

59 


UBS Group AG interim consolidated financial statements (unaudited) 

 

Statement of changes in equity

 

 

 

 

USD million

Share

capital

Share

premium

Treasury

shares

Retained

earnings

Balance as of 1 January 2020

 338 

 18,064 

 (3,326) 

 34,122 

Acquisition of treasury shares

 

 

 (1,037)2

 

Delivery of treasury shares under share-based compensation plans

 

 (622) 

 695 

 

Other disposal of treasury shares

 

 (9) 

 902

 

Share-based compensation expensed in the income statement

 

 600 

 

 

Tax (expense) / benefit

 

 16 

 

 

Dividends

 

 (654)3

 

 (654)3

Translation effects recognized directly in retained earnings

 

 

 

 (28) 

Share of changes in retained earnings of associates and joint ventures

 

 

 

 (40) 

New consolidations / (deconsolidations) and other increases / (decreases)

 

 (73) 

 

 

Total comprehensive income for the period

 

 

 

 4,535 

of which: net profit / (loss)

 

 

 

 4,921 

of which: OCI that may be reclassified to the income statement, net of tax

 

 

 

 

of which: OCI that will not be reclassified to the income statement, net of tax – defined benefit plans

 

 

 

 (304) 

of which: OCI that will not be reclassified to the income statement, net of tax – own credit

 

 

 

 (82) 

of which: OCI that will not be reclassified to the income statement, net of tax – foreign currency translation

 

 

 

 

Balance as of 30 September 2020

 338 

 17,321 

 (3,578) 

 37,936 

 

 

 

 

 

Balance as of 1 January 2021

 338 

 16,753 

 (4,068) 

 38,776 

Acquisition of treasury shares

 

 

 (2,663)2

 

Delivery of treasury shares under share-based compensation plans

 

 (673) 

 768 

 

Other disposal of treasury shares

 

 5 

 722

 

Cancelation of treasury shares related to the 2018–2021 share repurchase program4

 (16) 

 (236) 

 2,044 

 (1,792) 

Share-based compensation expensed in the income statement

 

 501 

 

 

Tax (expense) / benefit

 

 (56) 

 

 

Dividends

 

 (651)3

 

 (651)3

Translation effects recognized directly in retained earnings

 

 

 

 23 

Share of changes in retained earnings of associates and joint ventures

 

 

 

 1 

New consolidations / (deconsolidations) and other increases / (decreases)5

 

 185 

 

 

Total comprehensive income for the period

 

 

 

 5,973 

of which: net profit / (loss)

 

 

 

 6,109 

of which: OCI that may be reclassified to the income statement, net of tax

 

 

 

 

of which: OCI that will not be reclassified to the income statement, net of tax – defined benefit plans

 

 

 

 (128) 

of which: OCI that will not be reclassified to the income statement, net of tax – own credit

 

 

 

 (8) 

of which: OCI that will not be reclassified to the income statement, net of tax – foreign currency translation

 

 

 

 

Balance as of 30 September 2021

 322 

 15,828 

 (3,847) 

 42,330 

1 Excludes other comprehensive income related to defined benefit plans and own credit that is recorded directly in Retained earnings.    2 Includes treasury shares acquired and disposed of by the Investment Bank in its capacity as a market maker with regard to UBS shares and related derivatives, and to hedge certain issued structured debt instruments. These acquisitions and disposals are reported based on the sum of the net monthly movements.    3 Reflects the payment of an ordinary cash dividend of USD 0.37 per dividend-bearing share in April 2021 (2020: USD 0.365 per dividend-bearing share paid in May 2020; a second tranche of the 2020 dividend of USD 0.365 per dividend-bearing share was paid in November 2020). From 2020 onward, Swiss tax law effective 1 January 2020 requires Switzerland-domiciled companies with shares listed on a Swiss stock exchange pay no more than 50% of dividends from capital contribution reserves, with the remainder required to be paid from retained earnings.    4 Reflects the cancelation of 156,632,400 shares purchased under UBS’s 2018–2021 share repurchase program as approved by shareholders at the 2021 Annual General Meeting. For shares repurchased from 2020 onward, Swiss tax law effective 1 January 2020 requires Switzerland-domiciled companies with shares listed on a Swiss stock exchange reduce capital contribution reserves by at least 50% of the total capital reduction amount exceeding the nominal value upon cancelation of the shares.    5 Includes the effects related to the launch of UBS’s new operational partnership entity with Sumitomo Mitsui Trust Holdings, Inc. Refer to the “Recent developments” section of this report for more information.

 

60 


 

 

 

 

 

 

 

 

 

Other comprehensive

income recognized

directly in equity,

net of tax1

of which:

foreign currency translation

of which:

financial assets

measured at fair value through OCI

of which:

cash flow hedges

of which:

cost of hedging

Total equity

attributable to

shareholders

Non-controlling

interests

Total equity

 5,303 

 4,028 

 14 

 1,260 

 

 54,501 

 174 

 54,675 

 

 

 

 

 

 (1,037) 

 

 (1,037) 

 

 

 

 

 

 72 

 

 72 

 

 

 

 

 

 81 

 

 81 

 

 

 

 

 

 600 

 

 600 

 

 

 

 

 

 16 

 

 16 

 

 

 

 

 

 (1,308) 

 (4) 

 (1,312) 

 28 

 

 0 

 28 

 

 0 

 

 0 

 

 

 

 

 

 (40) 

 

 (40) 

 65 

 65 

 

 

 

 (8) 

 113 

 105 

 2,039 

 544 

 137 

 1,371 

 (12) 

 6,575 

 9 

 6,584 

 

 

 

 

 

 4,921 

 6 

 4,927 

 2,039 

 544 

 137 

 1,371 

 (12) 

 2,039 

 

 2,039 

 

 

 

 

 

 (304) 

 

 (304) 

 

 

 

 

 

 (82) 

 

 (82) 

 

 

 

 

 

 0 

 3 

 3 

 7,435 

 4,637 

 151 

 2,659 

 (12) 

 59,451 

 293 

 59,744 

 

 

 

 

 

 

 

 

 7,647 

 5,188 

 151 

 2,321 

 (13) 

 59,445 

 319 

 59,765 

 

 

 

 

 

 (2,663) 

 

 (2,663) 

 

 

 

 

 

 96 

 

 96 

 

 

 

 

 

 77 

 

 77 

 

 

 

 

 

 0 

 

 0 

 

 

 

 

 

 501 

 

 501 

 

 

 

 

 

 (56) 

 

 (56) 

 

 

 

 

 

 (1,301) 

 (4) 

 (1,305) 

 (23) 

 

 0 

 (23) 

 0 

 0 

 

 0 

 

 

 

 

 

 1 

 

 1 

 

 

 

 

 

 185 

 11 

 196 

 (2,037) 

 (646) 

 (121) 

 (1,254) 

 (18) 

 3,935 

 6 

 3,941 

 

 

 

 

 

 6,109 

 18 

 6,127 

 (2,037) 

 (646) 

 (121) 

 (1,254) 

 (18) 

 (2,037) 

 

 (2,037) 

 

 

 

 

 

 (128) 

 

 (128) 

 

 

 

 

 

 (8) 

 

 (8) 

 

 

 

 

 

 0 

 (12) 

 (12) 

 5,586 

 4,543 

 30 

 1,044 

 (30) 

 60,219 

 333 

 60,552 

 

 

 

 

 

 

 

 

 

61 


UBS Group AG interim consolidated financial statements (unaudited) 

 

Statement of cash flows

 

 

 

 

 

Year-to-date

USD million

 

30.9.21

30.9.20

 

 

 

 

Cash flow from / (used in) operating activities

 

 

 

Net profit / (loss)

 

 6,127 

 4,927 

Non-cash items included in net profit and other adjustments:

 

 

 

Depreciation and impairment of property, equipment and software

 

 1,520 

 1,452 

Amortization and impairment of goodwill and intangible assets

 

 24 

 47 

Credit loss expense / (release)

 

 (121) 

 628 

Share of net profits of associates and joint ventures and impairment related to associates

 

 (72) 

 (71) 

Deferred tax expense / (benefit)

 

 429 

 328 

Net loss / (gain) from investing activities

 

 (322) 

 (842) 

Net loss / (gain) from financing activities

 

 (217) 

 (4,006) 

Other net adjustments

 

 5,407 

 (1,799) 

Net change in operating assets and liabilities:

 

 

 

Loans and advances to banks and amounts due to banks

 

 2,626 

 2,729 

Securities financing transactions

 

 (1,926) 

 2,478 

Cash collateral on derivative instruments

 

 (3,171) 

 (1,402) 

Loans and advances to customers

 

 (22,677) 

 (23,762) 

Customer deposits

 

 7,484 

 23,815 

Financial assets and liabilities at fair value held for trading and derivative financial instruments

 

 (3,787) 

 29,644 

Brokerage receivables and payables

 

 10,715 

 (1,264) 

Financial assets at fair value not held for trading, other financial assets and liabilities

 

 18,106 

 1,759 

Provisions, other non-financial assets and liabilities

 

 1,909 

 (435) 

Income taxes paid, net of refunds

 

 (760) 

 (719) 

Net cash flow from / (used in) operating activities

 

 21,292 

 33,508 

 

 

 

 

Cash flow from / (used in) investing activities

 

 

 

Purchase of subsidiaries, associates and intangible assets

 

 (1) 

 (29) 

Disposal of subsidiaries, associates and intangible assets1

 

 564 

 674 

Purchase of property, equipment and software

 

 (1,354) 

 (1,329) 

Disposal of property, equipment and software

 

 268 

 358 

Purchase of financial assets measured at fair value through other comprehensive income

 

 (3,118) 

 (5,506) 

Disposal and redemption of financial assets measured at fair value through other comprehensive income

 

 2,798 

 3,121 

Net (purchase) / redemption of debt securities measured at amortized cost

 

 223 

 (4,565) 

Net cash flow from / (used in) investing activities

 

 (622) 

 (7,275) 

 

 

62 


 

Statement of cash flows (continued)

 

 

 

 

 

Year-to-date

USD million

 

30.9.21

30.9.20

 

 

 

 

Cash flow from / (used in) financing activities

 

 

 

Net short-term debt issued / (repaid)

 

 (7,717) 

 14,944 

Net movements in treasury shares and own equity derivative activity

 

 (2,511) 

 (888) 

Distributions paid on UBS shares

 

 (1,301) 

 (1,308) 

Issuance of debt designated at fair value and long-term debt measured at amortized cost

 

 80,801 

 64,723 

Repayment of debt designated at fair value and long-term debt measured at amortized cost

 

 (65,458) 

 (64,452) 

Net cash flows from other financing activities

 

 (145) 

 (426) 

Net cash flow from / (used in) financing activities

 

 3,668 

 12,593 

 

 

 

 

Total cash flow

 

 

 

Cash and cash equivalents at the beginning of the period

 

 173,531 

 119,873 

Net cash flow from / (used in) operating, investing and financing activities

 

 24,338 

 38,826 

Effects of exchange rate differences on cash and cash equivalents

 

 (6,896) 

 5,594 

Cash and cash equivalents at the end of the period2

 

 190,973 

 164,293 

of which: cash and balances at central banks3

 

 174,350 

 149,052 

of which: loans and advances to banks

 

 15,044 

 13,285 

of which: money market paper

 

 1,579 

 1,957 

 

 

 

 

Additional information

 

 

 

Net cash flow from / (used in) operating activities includes:

 

 

 

Interest received in cash

 

 8,285 

 9,169 

Interest paid in cash

 

 3,901 

 5,452 

Dividends on equity investments, investment funds and associates received in cash

 

 1,969 

 1,590 

1 Includes cash proceeds from the sale of UBS’s investment in Clearstream Fund Centre AG (previously Fondcenter AG). UBS’s majority stake was sold in 2020 and the remaining minority investment was sold in the second quarter of 2021.     2 USD 3,823 million and USD 4,250 million of cash and cash equivalents (mainly reflected in Loans and advances to banks) were restricted as of 30 September 2021 and 30 September 2020, respectively. Refer to “Note 23 Restricted and transferred financial assets” in the “Consolidated financial statements” section of the Annual Report 2020 for more information.    3 Includes only balances with an original maturity of three months or less.

  

63 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

Notes to the UBS Group AG interim
consolidated financial statements (unaudited)

Note 1   Basis of accounting and other financial reporting effects

Basis of preparation

The consolidated financial statements (the financial statements) of UBS Group AG and its subsidiaries (together, “UBS” or the “Group”) are prepared in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board (the IASB), and are presented in US dollars (USD). These interim financial statements are prepared in accordance with IAS 34, Interim Financial Reporting

In preparing these interim financial statements, the same accounting policies and methods of computation have been applied as in the UBS Group AG consolidated annual financial statements for the period ended 31 December 2020, except for the changes described in this Note. These interim financial statements are unaudited and should be read in conjunction with UBS Group AG’s audited consolidated financial statements in the Annual Report 2020 and the “Management report” sections of this report, including the disclosure of the “Sale of our domestic wealth management business in Spain” post-balance sheet event in “Recent developments.” In the opinion of management, all necessary adjustments were made for a fair presentation of the Group’s financial position, results of operations and cash flows.

Preparation of these interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, income, expenses and disclosures of contingent assets and liabilities. These estimates and assumptions are based on the best available information. Actual results in the future could differ from such estimates and differences may be material to the financial statements. Revisions to estimates, based on regular reviews, are recognized in the period in which they occur. For more information about areas of estimation uncertainty that are considered to require critical judgment, refer to “Note 1a Significant accounting policies” in the “Consolidated financial statements” section of the Annual Report 2020.


Amendments to IFRS 9, IAS 39 and IFRS 7 (Interest Rate Benchmark Reform – Phase 2)

On 1 January 2021, UBS adopted Interest Rate Benchmark Reform – Phase 2 (Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16), addressing a number of issues in financial reporting areas that arise when interbank offered rates (IBORs) are reformed or replaced.

The amendments provide a practical expedient that permits certain changes in the contractual cash flows of debt instruments attributable to the replacement of IBORs with alternative reference rates (ARRs) to be accounted for prospectively by updating a given instrument’s effective interest rate (EIR), provided (i) the change is necessary as a direct consequence of IBOR reform and (ii) the new basis for determining the contractual cash flows is economically equivalent to the previous basis.

UBS has adopted the amendments, which have no material effect on the Group’s financial statements.

 

64 


 

Note 1   Basis of accounting and other financial reporting effects (continued)

Furthermore, the amendments provide various hedge accounting reliefs, with the following expected to benefit UBS.

      Risk components

The amendments permit UBS to designate an alternative benchmark rate as a non-contractually specified risk component, even if it is not separately identifiable at the date when it is designated, provided UBS can reasonably expect that it will meet the requirements within 24 months of the first designation and the risk component is reliably measurable. As of 30 September 2021, the alternative benchmark rates that UBS has designated as the hedged risk in fair value hedges of interest rate risk related to debt instruments, mortgages and cash flow hedges of forecast transactions were the Secured Overnight Financing Rate (SOFR), the Swiss Average Rate Overnight (SARON) and the Sterling Overnight Index Average (SONIA). The designated notionals were USD 14.2 billion, USD 3.1 billion and USD 0.7 billion, respectively.

      Hedge designation

Following amendments to the hedge documentation to reflect the change in designation relating to IBOR reform, UBS will continue its hedge relationships provided the other hedge accounting criteria and requirements of the phase 2 amendment are met. As of 30 September 2021, no such changes have been made.

      Amounts accumulated in the cash flow hedge reserve

Upon changing the hedge designation as set out above, the accumulated amounts in the cash flow hedge reserve are assumed to be based on the alternative benchmark rate. For discontinued hedging relationships, when the interest rate benchmark on which the hedged future cash flows were based is changed as required by IBOR reform, the amount accumulated in the cash flow hedge reserve is also assumed to be based on the alternative benchmark rate for the purpose of assessing whether the hedged future cash flows are still expected to occur. As of 30 September 2021, no such changes have been made.

      Retrospective effectiveness assessment as applied to hedges designated under IAS 39        
Upon the end of the phase 1 relief for effectiveness assessment UBS may elect to reset to zero the cumulative fair value changes of the hedged item and hedging instrument for the purpose of assessing the retrospective effectiveness of a hedging relationship. As of 30 September 2021, no such election has been made.

     Refer to “Note 25 Hedge accounting” in the “Consolidated financial statements” section of the Annual Report 2020 for details about phase 1 accounting reliefs

 

The amendments also introduced additional disclosure requirements regarding the Group’s management of the transition to alternative benchmark rates, its progress as at the reporting date and the risks to which it is exposed arising from financial instruments because of the transition.

     Refer to Note 13 for more information

 

  

65 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

Note   Segment reporting

UBS’s businesses are organized globally into four business divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management and the Investment Bank. All four business divisions are supported by Group Functions and qualify as reportable segments for the purpose of segment reporting. Together with Group Functions they reflect the management structure of the Group.

     Refer to “Note 2 Segment reporting” in the “Consolidated financial statements” section of the Annual Report 2020 for more information about the Group’s reporting segments


  


 

 

USD million

Global Wealth Management

Personal & Corporate Banking

Asset

Management

Investment Bank

Group Functions

UBS

 

 

 

 

 

 

 

For the nine months ended 30 September 2021

 

 

 

 

 

 

Net interest income

 3,130 

 1,577 

 (11) 

 318 

 (81) 

 4,934 

Non-interest income

 11,467 

 1,609 

 1,907 

 6,917 

 (145) 

 21,754 

Income

 14,598 

 3,187 

 1,896 

 7,235 

 (226) 

 26,689 

Credit loss (expense) / release

 27 

 76 

 0 

 19 

 0 

 121 

Total operating income

 14,625 

 3,263 

 1,895 

 7,253 

 (226) 

 26,810 

Total operating expenses

 10,405 

 1,897 

 1,199 

 5,337 

 217 

 19,054 

Operating profit / (loss) before tax

 4,220 

 1,366 

 696 

 1,917 

 (443) 

 7,755 

Tax expense / (benefit)

 

 

 

 

 

 1,629 

Net profit / (loss)

 

 

 

 

 

 6,127 

 

 

 

 

 

 

 

As of 30 September 2021

 

 

 

 

 

 

Total assets

 387,130 

 218,368 

 25,202 

 345,509 

 112,564 

 1,088,773 

 

 

 

 

 

 

 

USD million

Global Wealth Management

Personal & Corporate Banking

Asset

Management

Investment Bank

Group Functions

UBS

 

 

 

 

 

 

 

For the nine months ended 30 September 2020

 

 

 

 

 

 

Net interest income

 3,016 

 1,546 

 (13) 

 116 

 (425) 

 4,240 

Non-interest income

 9,848 

 1,392 

 2,215 

 7,301 

 (94) 

 20,661 

Income

 12,865 

 2,938 

 2,202 

 7,417 

 (520) 

 24,901 

Credit loss (expense) / release

 (96) 

 (279) 

 (2) 

 (215) 

 (37) 

 (628) 

Total operating income

 12,769 

 2,658 

 2,200 

 7,202 

 (557) 

 24,273 

Total operating expenses

 9,614 

 1,752 

 1,146 

 5,249 

 342 

 18,103 

Operating profit / (loss) before tax

 3,155 

 907 

 1,054 

 1,953 

 (899) 

 6,169 

Tax expense / (benefit)

 

 

 

 

 

 1,242 

Net profit / (loss)

 

 

 

 

 

 4,927 

 

 

 

 

 

 

 

As of 31 December 2020

 

 

 

 

 

 

Total assets

 367,714 

 231,657 

 28,589 

 369,683 

 128,122 

 1,125,765 

 


 

 

Note 3  Net interest income

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income

 

 

 

 

 

 

 

Interest income from loans and deposits1

 

 1,645 

 1,612 

 1,586 

 

 4,841 

 5,086 

Interest income from securities financing transactions2

 

 132 

 126 

 150 

 

 393 

 719 

Interest income from other financial instruments measured at amortized cost

 

 71 

 68 

 86 

 

 213 

 262 

Interest income from debt instruments measured at fair value through other comprehensive income

 

 33 

 16 

 30 

 

 84 

 83 

Interest income from derivative instruments designated as cash flow hedges

 

 297 

 284 

 260 

 

 849 

 550 

Total interest income from financial instruments measured at amortized cost and fair value through other comprehensive income

 

 2,178 

 2,106 

 2,111 

 

 6,381 

 6,699 

Interest expense on loans and deposits3

 

 128 

 136 

 164 

 

 401 

 871 

Interest expense on securities financing transactions4

 

 299 

 293 

 211 

 

 850 

 654 

Interest expense on debt issued

 

 370 

 381 

 509 

 

 1,163 

 1,781 

Interest expense on lease liabilities

 

 25 

 26 

 27 

 

 78 

 83 

Total interest expense from financial instruments measured at amortized cost

 

 822 

 836 

 912 

 

 2,491 

 3,390 

Total net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income

 

 1,356 

 1,270 

 1,199 

 

 3,890 

 3,309 

Net interest income from financial instruments measured at fair value through profit or loss

 

 

 

 

 

 

 

Net interest income from financial instruments at fair value held for trading

 

 202 

 193 

 188 

 

 595 

 631 

Net interest income from brokerage balances

 

 205 

 216 

 176 

 

 617 

 494 

Net interest income from securities financing transactions at fair value not held for trading5

 

 13 

 12 

 13 

 

 37 

 64 

Interest income from other financial instruments at fair value not held for trading

 

 68 

 75 

 119 

 

 238 

 474 

Interest expense on other financial instruments designated at fair value

 

 (150) 

 (138) 

 (178) 

 

 (444) 

 (733) 

Total net interest income from financial instruments measured at fair value through profit or loss

 

 338 

 357 

 318 

 

 1,044 

 930 

Total net interest income

 

 1,693 

 1,628 

 1,517 

 

 4,934 

 4,240 

1 Consists of interest income from cash and balances at central banks, loans and advances to banks and customers, and cash collateral receivables on derivative instruments, as well as negative interest on amounts due to banks, customer deposits, and cash collateral payables on derivative instruments.    2 Includes interest income on receivables from securities financing transactions and negative interest, including fees, on payables from securities financing transactions.    3 Consists of interest expense on amounts due to banks, cash collateral payables on derivative instruments, and customer deposits, as well as negative interest on cash and balances at central banks, loans and advances to banks, and cash collateral receivables on derivative instruments.    4 Includes interest expense on payables from securities financing transactions and negative interest, including fees, on receivables from securities financing transactions.    5 Includes interest expense on securities financing transactions designated at fair value.

 

 

 

Note Net fee and commission income

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Fee and commission income

 

 

 

 

 

 

 

Underwriting fees

 

 348 

 387 

 296 

 

 1,128 

 752 

of which: equity underwriting fees

 

 229 

 262 

 184 

 

 766 

 414 

of which: debt underwriting fees

 

 119 

 126 

 111 

 

 362 

 338 

M&A and corporate finance fees

 

 315 

 330 

 185 

 

 883 

 520 

Brokerage fees

 

 1,016 

 1,037 

 970 

 

 3,411 

 3,174 

Investment fund fees

 

 1,428 

 1,405 

 1,323 

 

 4,269 

 3,815 

Portfolio management and related services

 

 2,517 

 2,426 

 1,993 

 

 7,227 

 5,864 

Other

 

 495 

 455 

 445 

 

 1,412 

 1,293 

Total fee and commission income1

 

 6,119 

 6,041 

 5,211 

 

 18,330 

 15,418 

of which: recurring

 

 3,952 

 3,823 

 3,272 

 

 11,395 

 9,593 

of which: transaction-based

 

 2,133 

 2,176 

 1,851 

 

 6,764 

 5,623 

of which: performance-based

 

 34 

 42 

 88 

 

 171 

 202 

Fee and commission expense

 

 

 

 

 

 

 

Brokerage fees paid

 

 53 

 74 

 54 

 

 195 

 203 

Distribution fees paid

 

 159 

 153 

 155 

 

 444 

 456 

Other

 

 298 

 258 

 231 

 

 833 

 657 

Total fee and commission expense

 

 510 

 484 

 440 

 

 1,472 

 1,316 

Net fee and commission income

 

 5,610 

 5,557 

 4,771 

 

 16,858 

 14,103 

of which: net brokerage fees

 

 963 

 963 

 916 

 

 3,216 

 2,970 

1 Reflects third-party fee and commission income for the third quarter of 2021 of USD 3,663 million for Global Wealth Management (second quarter of 2021: USD 3,585 million; third quarter of 2020: USD 3,093 million), USD 429 million for Personal & Corporate Banking (second quarter of 2021: USD 399 million; third quarter of 2020: USD 353 million), USD 815 million for Asset Management (second quarter of 2021: USD 805 million; third quarter of 2020: USD 778 million), USD 1,209 million for the Investment Bank (second quarter of 2021: USD 1,243 million; third quarter of 2020: USD 957 million) and USD 3 million for Group Functions (second quarter of 2021: USD 9 million; third quarter of 2020: USD 31 million).

 

67 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

Note Personnel expenses

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Salaries and variable compensation

 

 2,659 

 2,945 

 2,948 

 

 8,475 

 8,206 

Financial advisor compensation1

 

 1,239 

 1,183 

 980 

 

 3,592 

 3,015 

Contractors

 

 91 

 98 

 96 

 

 288 

 271 

Social security

 

 259 

 241 

 250 

 

 767 

 689 

Post-employment benefit plans

 

 205 

 1732

 203 

 

 644 

 642 

Other personnel expenses

 

 144 

 132 

 155 

 

 404 

 414 

Total personnel expenses

 

 4,598 

 4,772 

 4,631 

 

 14,170 

 13,235 

1 Financial advisor compensation consists of grid-based compensation based directly on compensable revenues generated by financial advisors and supplemental compensation calculated on the basis of financial advisor productivity, firm tenure, assets and other variables. It also includes expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements.    2 Includes curtailment gains of USD 59 million, which represent a reduction in the defined benefit obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities.

 

 

 

NoteGeneral and administrative expenses

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Outsourcing costs

 

 225 

 206 

 234 

 

 632 

 656 

IT expenses

 

 255 

 256 

 242 

 

 777 

 694 

Consulting, legal and audit fees

 

 124 

 130 

 151 

 

 354 

 461 

Real estate and logistics costs

 

 162 

 151 

 156 

 

 464 

 479 

Market data services

 

 102 

 105 

 103 

 

 309 

 303 

Marketing & communication

 

 53 

 52 

 44 

 

 148 

 120 

Travel and entertainment

 

 18 

 13 

 8 

 

 39 

 67 

Litigation, regulatory & similar matters1

 

 12 

 63 

 41 

 

 84 

 49 

Other

 

 197 

 126 

 194 

 

 534 

 540 

of which: UK and German bank levies

 

 (9) 

 (11) 

 0 

 

 20 

 17 

Total general and administrative expenses

 

 1,148 

 1,103 

 1,173 

 

 3,340 

 3,369 

1 Reflects the net increase in / (release of) provisions for litigation, regulatory and similar matters recognized in the income statement. Refer to Note 14 for more information.

 

 

 

Note Expected credit loss measurement

 

a) Credit loss expense / release

Total net credit loss releases were USD 14 million in the third quarter of 2021, reflecting USD 11 million net credit loss releases related to stage 1 and 2 positions and USD 3 million net credit loss releases related to credit-impaired (stage 3) positions.

The USD 11 million stage 1 and 2 net releases primarily included book size and book quality movements in Global Wealth Management, as well as model changes, mainly in the Investment Bank, largely offset by a net increase in post-model adjustment.

Stage 3 net credit loss releases were USD 3 million, including USD 7 million net expenses in the Investment Bank and USD 8 million net releases in Personal & Corporate Banking, across various corporate lending positions.

 

 

Credit loss (expense) / release1

 

 

 

 

 

 

USD million

Global

Wealth

Management

Personal &

Corporate

Banking

Asset

Management

Investment

Bank

Group

Functions

Total

For the quarter ended 30.9.21

 

 

 

 

 

 

Stages 1 and 2

 9 

 (1) 

 0 

 2 

 0 

 11 

Stage 3

 2 

 8 

 0 

 (7) 

 0 

 3 

Total credit loss (expense) / release

 11 

 7 

 0 

 (5) 

 0 

 14 

1 Refer to the “Group performance” section of this report for year-to-date and comparative total credit loss (expense) / release information.

 

68 


 

 

Note Expected credit loss measurement (continued)

 

b) Changes to ECL models, scenarios, scenario weights and key inputs

Scenarios

The expected credit loss (ECL) scenarios, along with the related macroeconomic factors, were updated and reviewed in light of the economic and political conditions prevailing in the third quarter of 2021 through a series of governance meetings, with input and feedback from UBS risk and finance experts across the business divisions and regions.

The baseline and severe downside scenarios included several forward-looking assumptions that are slightly less optimistic, compared with those applied in the second quarter of 2021, mainly due to better-than-expected macroeconomic data in the first half of 2021, resulting in improved forecast starting levels.

Effective from the second quarter of 2021, UBS has included an upside scenario and a mild downside scenario in the ECL calculation. The upside scenario assumes that underlying macroeconomic conditions improve and asset values increase substantially.

The mild downside scenario assumes that rising inflation and long-term rates lead to market volatility and a mild global recession.

There were no significant revisions to any scenario during the third quarter of 2021.

The baseline scenario assumptions on a calendar-year basis are included in the table below and are generally more optimistic on a year-to-date basis in 2021 compared with 2020

Scenario weights and post-model adjustments

UBS kept the scenario weights unchanged for the third quarter of 2021: upside at 5%, baseline at 55%, mild downside at 10% and severe downside at 30%. Given the continued level of uncertainty, with some macro factors slightly improving in the quarter (e.g., Swiss unemployment data), alongside other more adverse developments (e.g., maturing government support measures, new COVID-19 variants and supply chain issues), the post-model adjustment was increased from USD 183 million to USD 219 million. This includes the effects from scenario updates and other developments in the third quarter of 2021 that would otherwise have resulted in ECL releases.

 

 

 

Baseline

Key parameters

 

2020

2021

2022

Real GDP growth (annual percentage change)

 

 

 

 

United States

 

 (3.6) 

 6.5 

 6.0 

Eurozone

 

 (7.4) 

 5.1 

 5.3 

Switzerland

 

 (4.5) 

 3.4 

 3.0 

Unemployment rate (%, annual average)

 

 

 

 

United States

 

 8.1 

 5.5 

 4.4 

Eurozone

 

 8.5 

 8.1 

 7.7 

Switzerland

 

 3.2 

 3.2 

 2.9 

Real estate (annual percentage change, Q4)

 

 

 

 

United States

 

 3.4 

 10.2 

 2.3 

Eurozone

 

 (0.3) 

 6.0 

 3.0 

Switzerland

 

 4.0 

 5.0 

 1.0 

 

Economic scenarios and weights applied

ECL scenario

Assigned weights in %

 

30.9.21

30.6.21

31.12.20

Upside

5.0

5.0

0.0

Baseline

55.0

55.0

60.0

Mild downside

10.0

10.0

0.0

Severe downside

30.0

30.0

40.0


 

69 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note Expected credit loss measurement (continued)

 

c) ECL-relevant balance sheet and off-balance sheet positions including ECL allowances and provisions

The following tables provide information about financial instruments and certain non-financial instruments that are subject to ECL requirements. For amortized-cost instruments, the carrying amount represents the maximum exposure to credit risk, taking into account the allowance for credit losses. Financial assets measured at fair value through other comprehensive income (FVOCI) are also subject to ECL; however, unlike amortized-cost instruments, the allowance for credit losses for FVOCI instruments does not reduce the carrying amount of these financial assets. Instead, the carrying amount of financial assets measured at FVOCI represents the maximum exposure to credit risk.

In addition to recognized financial assets, certain off-balance sheet and other credit lines are also subject to ECL. The maximum exposure to credit risk for off-balance sheet financial instruments is calculated based on the maximum contractual amounts.

 

 

USD million

 

30.9.21

 

 

Carrying amount¹ / Total exposure

 

ECL allowances / provisions

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

 174,478 

 174,478 

 0 

 0 

 

 0 

 0 

 0 

 0 

Loans and advances to banks

 

 16,378 

 16,352 

 26 

 0 

 

 (9) 

 (7) 

 (1) 

 (1) 

Receivables from securities financing transactions

 

 74,476 

 74,476 

 0 

 0 

 

 (2) 

 (2) 

 0 

 0 

Cash collateral receivables on derivative instruments

 

 31,654 

 31,654 

 0 

 0 

 

 0 

 0 

 0 

 0 

Loans and advances to customers

 

 390,369 

 370,769 

 17,789 

 1,810 

 

 (915) 

 (120) 

 (153) 

 (642) 

of which: Private clients with mortgages

 

 148,681 

 139,458 

 8,453 

 769 

 

 (130) 

 (27) 

 (67) 

 (35) 

of which: Real estate financing

 

 42,548 

 37,915 

 4,623 

 10 

 

 (60) 

 (18) 

 (43) 

 0 

of which: Large corporate clients

 

 13,154 

 11,502 

 1,242 

 410 

 

 (229) 

 (20) 

 (16) 

 (194) 

of which: SME clients

 

 14,158 

 11,835 

 1,804 

 519 

 

 (276) 

 (18) 

 (16) 

 (242) 

of which: Lombard

 

 147,273 

 147,253 

 0 

 20 

 

 (34) 

 (6) 

 0 

 (28) 

of which: Credit cards

 

 1,668 

 1,299 

 341 

 28 

 

 (35) 

 (10) 

 (9) 

 (16) 

of which: Commodity trade finance

 

 3,384 

 3,360 

 7 

 17 

 

 (103) 

 (5) 

 0 

 (97) 

Other financial assets measured at amortized cost

 

 27,082 

 26,311 

 457 

 314 

 

 (119) 

 (25) 

 (11) 

 (83) 

of which: Loans to financial advisors

 

 2,499 

 1,986 

 227 

 287 

 

 (96) 

 (18) 

 (7) 

 (72) 

Total financial assets measured at amortized cost

 

 714,437 

 694,041 

 18,272 

 2,125 

 

 (1,045) 

 (154) 

 (164) 

 (727) 

Financial assets measured at fair value through other comprehensive income

 

 8,397 

 8,397 

 0 

 0 

 

 0 

 0 

 0 

 0 

Total on-balance sheet financial assets in scope of ECL requirements

 

 722,834 

 702,438 

 18,272 

 2,125 

 

 (1,045) 

 (154) 

 (164) 

 (727) 

Off-balance sheet (in scope of ECL)

 

 

 

 

 

 

 

 

 

 

Guarantees

 

 19,126 

 17,595 

 1,364 

 167 

 

 (50) 

 (17) 

 (8) 

 (25) 

of which: Large corporate clients

 

 3,586 

 2,581 

 884 

 122 

 

 (14) 

 (3) 

 (3) 

 (8) 

of which: SME clients

 

 1,320 

 1,087 

 187 

 45 

 

 (11) 

 (1) 

 (1) 

 (10) 

of which: Financial intermediaries and hedge funds

 

 8,632 

 8,479 

 153 

 0 

 

 (16) 

 (12) 

 (4) 

 0 

of which: Lombard

 

 2,216 

 2,215 

 0 

 0 

 

 (1) 

 0 

 0 

 (1) 

of which: Commodity trade finance

 

 2,362 

 2,362 

 0 

 0 

 

 (2) 

 (1) 

 0 

 (1) 

Irrevocable loan commitments

 

 38,065 

 35,239 

 2,716 

 109 

 

 (113) 

 (70) 

 (44) 

 0 

of which: Large corporate clients

 

 22,902 

 20,440 

 2,428 

 34 

 

 (99) 

 (63) 

 (36) 

 0 

Forward starting reverse repurchase and securities borrowing agreements

 

 3,740 

 3,740 

 0 

 0 

 

 0 

 0 

 0 

 0 

Committed unconditionally revocable credit lines

 

 39,086 

 35,959 

 3,063 

 64 

 

 (37) 

 (28) 

 (10) 

 0 

of which: Real estate financing

 

 6,981 

 6,476 

 506 

 0 

 

 (6) 

 (5) 

 (1) 

 0 

of which: Large corporate clients

 

 4,517 

 3,440 

 1,054 

 23 

 

 (7) 

 (4) 

 (3) 

 0 

of which: SME clients

 

 5,111 

 4,597 

 481 

 33 

 

 (14) 

 (11) 

 (3) 

 0 

of which: Lombard

 

 8,350 

 8,350 

 0 

 0 

 

 0 

 0 

 0 

 0 

of which: Credit cards

 

 9,218 

 8,762 

 448 

 8 

 

 (6) 

 (5) 

 (2) 

 0 

of which: Commodity trade finance

 

 169 

 169 

 0 

 0 

 

 0 

 0 

 0 

 0 

Irrevocable committed prolongation of existing loans

 

 5,767 

 5,692 

 53 

 22 

 

 (2) 

 (2) 

 0 

 0 

Total off-balance sheet financial instruments and other credit lines

 

 105,784 

 98,225 

 7,196 

 363 

 

 (203) 

 (116) 

 (62) 

 (25) 

Total allowances and provisions

 

 

 

 

 

 

 (1,248) 

 (270) 

 (225) 

 (752) 

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.

 

 


 

 

Note Expected credit loss measurement (continued)

 

USD million

 

30.6.21

 

 

Carrying amount¹ / Total exposure

 

ECL allowances / provisions

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

 160,672 

 160,672 

 0 

 0 

 

 0 

 0 

 0 

 0 

Loans and advances to banks

 

 16,500 

 16,457 

 42 

 0 

 

 (8) 

 (6) 

 (1) 

 (1) 

Receivables from securities financing transactions

 

 83,494 

 83,494 

 0 

 0 

 

 (3) 

 (3) 

 0 

 0 

Cash collateral receivables on derivative instruments

 

 29,785 

 29,785 

 0 

 0 

 

 0 

 0 

 0 

 0 

Loans and advances to customers

 

 390,126 

 369,810 

 18,403 

 1,913 

 

 (950) 

 (124) 

 (156) 

 (670) 

of which: Private clients with mortgages

 

 147,827 

 137,851 

 9,140 

 836 

 

 (139) 

 (26) 

 (76) 

 (37) 

of which: Real estate financing

 

 42,627 

 37,950 

 4,663 

 14 

 

 (49) 

 (17) 

 (32) 

 0 

of which: Large corporate clients

 

 14,294 

 12,671 

 1,229 

 395 

 

 (246) 

 (20) 

 (19) 

 (207) 

of which: SME clients

 

 14,116 

 11,753 

 1,814 

 549 

 

 (291) 

 (20) 

 (19) 

 (253) 

of which: Lombard

 

 146,167 

 146,135 

 0 

 32 

 

 (35) 

 (6) 

 0 

 (29) 

of which: Credit cards

 

 1,611 

 1,255 

 327 

 28 

 

 (34) 

 (9) 

 (9) 

 (16) 

of which: Commodity trade finance

 

 3,399 

 3,345 

 38 

 16 

 

 (103) 

 (5) 

 0 

 (98) 

Other financial assets measured at amortized cost

 

 27,143 

 26,398 

 436 

 309 

 

 (124) 

 (30) 

 (9) 

 (86) 

of which: Loans to financial advisors

 

 2,415 

 1,924 

 197 

 295 

 

 (103) 

 (23) 

 (6) 

 (74) 

Total financial assets measured at amortized cost

 

 707,720 

 686,616 

 18,882 

 2,222 

 

 (1,085) 

 (163) 

 (166) 

 (757) 

Financial assets measured at fair value through other comprehensive income

 

 7,775 

 7,775 

 0 

 0 

 

 0 

 0 

 0 

 0 

Total on-balance sheet financial assets in scope of ECL requirements

 

 715,496 

 694,392 

 18,882 

 2,222 

 

 (1,085) 

 (163) 

 (166) 

 (757) 

Off-balance sheet (in scope of ECL)

 

 

 

 

 

 

 

 

 

 

Guarantees

 

 17,457 

 15,719 

 1,580 

 158 

 

 (52) 

 (15) 

 (9) 

 (27) 

of which: Large corporate clients

 

 3,142 

 1,995 

 1,035 

 112 

 

 (13) 

 (3) 

 (3) 

 (7) 

of which: SME clients

 

 1,269 

 1,002 

 222 

 46 

 

 (13) 

 (1) 

 (1) 

 (12) 

of which: Financial intermediaries and hedge funds

 

 7,465 

 7,257 

 208 

 0 

 

 (16) 

 (10) 

 (5) 

 0 

of which: Lombard

 

 2,166 

 2,166 

 0 

 0 

 

 (1) 

 0 

 0 

 (1) 

of which: Commodity trade finance

 

 2,372 

 2,342 

 30 

 0 

 

 (2) 

 (1) 

 0 

 (1) 

Irrevocable loan commitments

 

 37,751 

 34,505 

 3,064 

 181 

 

 (118) 

 (69) 

 (49) 

 0 

of which: Large corporate clients

 

 22,464 

 19,621 

 2,718 

 125 

 

 (103) 

 (61) 

 (42) 

 0 

Forward starting reverse repurchase and securities borrowing agreements

 

 8,253 

 8,253 

 0 

 0 

 

 0 

 0 

 0 

 0 

Committed unconditionally revocable credit lines

 

 38,796 

 35,201 

 3,526 

 68 

 

 (36) 

 (28) 

 (8) 

 0 

of which: Real estate financing

 

 6,542 

 6,135 

 407 

 0 

 

 (5) 

 (4) 

 (1) 

 0 

of which: Large corporate clients

 

 4,383 

 2,924 

 1,434 

 25 

 

 (7) 

 (4) 

 (3) 

 0 

of which: SME clients

 

 5,173 

 4,498 

 643 

 32 

 

 (14) 

 (12) 

 (2) 

 0 

of which: Lombard

 

 8,632 

 8,632 

 0 

 0 

 

 0 

 0 

 0 

 0 

of which: Credit cards

 

 9,298 

 8,825 

 464 

 9 

 

 (6) 

 (5) 

 (2) 

 0 

of which: Commodity trade finance

 

 251 

 251 

 0 

 0 

 

 0 

 0 

 0 

 0 

Irrevocable committed prolongation of existing loans

 

 5,281 

 5,260 

 20 

 1 

 

 (3) 

 (2) 

 (1) 

 0 

Total off-balance sheet financial instruments and other credit lines

 

 107,537 

 98,938 

 8,191 

 408 

 

 (209) 

 (114) 

 (67) 

 (27) 

Total allowances and provisions

 

 

 

 

 

 

 (1,294) 

 (277) 

 (233) 

 (784) 

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.

 

71 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note Expected credit loss measurement (continued)

 

USD million

 

31.12.20

 

 

Carrying amount¹ / Total exposure

 

ECL allowances / provisions

Financial instruments measured at amortized cost

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Cash and balances at central banks

 

 158,231 

 158,231 

 0 

 0 

 

 0 

 0 

 0 

 0 

Loans and advances to banks

 

 15,444 

 15,260 

 184 

 0 

 

 (16) 

 (9) 

 (5) 

 (1) 

Receivables from securities financing transactions

 

 74,210 

 74,210 

 0 

 0 

 

 (2) 

 (2) 

 0 

 0 

Cash collateral receivables on derivative instruments

 

 32,737 

 32,737 

 0 

 0 

 

 0 

 0 

 0 

 0 

Loans and advances to customers

 

 379,528 

 356,948 

 20,341 

 2,240 

 

 (1,060) 

 (142) 

 (215) 

 (703) 

of which: Private clients with mortgages

 

 148,175 

 138,769 

 8,448 

 959 

 

 (166) 

 (35) 

 (93) 

 (39) 

of which: Real estate financing

 

 43,429 

 37,568 

 5,838 

 23 

 

 (63) 

 (15) 

 (44) 

 (4) 

of which: Large corporate clients

 

 15,161 

 12,658 

 2,029 

 474 

 

 (279) 

 (27) 

 (40) 

 (212) 

of which: SME clients

 

 14,872 

 11,990 

 2,254 

 628 

 

 (310) 

 (19) 

 (23) 

 (268) 

of which: Lombard

 

 133,850 

 133,795 

 0 

 55 

 

 (36) 

 (5) 

 0 

 (31) 

of which: Credit cards

 

 1,558 

 1,198 

 330 

 30 

 

 (38) 

 (11) 

 (11) 

 (16) 

of which: Commodity trade finance

 

 3,269 

 3,214 

 43 

 12 

 

 (106) 

 (5) 

 0 

 (101) 

Other financial assets measured at amortized cost

 

 27,194 

 26,377 

 348 

 469 

 

 (133) 

 (34) 

 (9) 

 (90) 

of which: Loans to financial advisors

 

 2,569 

 1,982 

 137 

 450 

 

 (108) 

 (27) 

 (5) 

 (76) 

Total financial assets measured at amortized cost

 

 687,345 

 663,763 

 20,873 

 2,709 

 

 (1,211) 

 (187) 

 (229) 

 (795) 

Financial assets measured at fair value through other comprehensive income

 

 8,258 

 8,258 

 0 

 0 

 

 0 

 0 

 0 

 0 

Total on-balance sheet financial assets in scope of ECL requirements

 

 695,603 

 672,021 

 20,873 

 2,709 

 

 (1,211) 

 (187) 

 (229) 

 (795) 

 

 

 

 

 

 

 

 

 

 

 

Off-balance sheet (in scope of ECL)

 

 

 

 

 

 

 

 

 

 

Guarantees

 

 17,081 

 14,687 

 2,225 

 170 

 

 (63) 

 (14) 

 (15) 

 (34) 

of which: Large corporate clients

 

 3,710 

 2,048 

 1,549 

 113 

 

 (20) 

 (4) 

 (5) 

 (12) 

of which: SME clients

 

 1,310 

 936 

 326 

 48 

 

 (13) 

 (1) 

 (1) 

 (11) 

of which: Financial intermediaries and hedge funds

 

 7,637 

 7,413 

 224 

 0 

 

 (17) 

 (7) 

 (9) 

 0 

of which: Lombard

 

 641 

 633 

 0 

 8 

 

 (2) 

 0 

 0 

 (2) 

of which: Commodity trade finance

 

 1,441 

 1,416 

 25 

 0 

 

 (2) 

 (1) 

 0 

 0 

Irrevocable loan commitments

 

 41,372 

 36,894 

 4,374 

 104 

 

 (142) 

 (74) 

 (68) 

 0 

of which: Large corporate clients

 

 24,209 

 20,195 

 3,950 

 64 

 

 (121) 

 (63) 

 (58) 

 0 

Forward starting reverse repurchase and securities borrowing agreements

 

 3,247 

 3,247 

 0 

 0 

 

 0 

 0 

 0 

 0 

Committed unconditionally revocable credit lines

 

 40,134 

 35,233 

 4,792 

 108 

 

 (50) 

 (29) 

 (21) 

 0 

of which: Real estate financing

 

 6,328 

 5,811 

 517 

 0 

 

 (12) 

 (5) 

 (7) 

 0 

of which: Large corporate clients

 

 4,909 

 2,783 

 2,099 

 27 

 

 (9) 

 (2) 

 (7) 

 0 

of which: SME clients

 

 5,827 

 4,596 

 1,169 

 63 

 

 (16) 

 (12) 

 (4) 

 0 

of which: Lombard

 

 9,671 

 9,671 

 0 

 0 

 

 0 

 (1) 

 0 

 0 

of which: Credit cards

 

 8,661 

 8,220 

 430 

 11 

 

 (8) 

 (6) 

 (2) 

 0 

of which: Commodity trade finance

 

 242 

 242 

 0 

 0 

 

 0 

 0 

 0 

 0 

Irrevocable committed prolongation of existing loans

 

 3,282 

 3,277 

 5 

 0 

 

 (2) 

 (2) 

 0 

 0 

Total off-balance sheet financial instruments and other credit lines

 

 105,116 

 93,337 

 11,396 

 382 

 

 (257) 

 (119) 

 (104) 

 (34) 

Total allowances and provisions

 

 

 

 

 

 

 (1,468) 

 (306) 

 (333) 

 (829) 

1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective ECL allowances.

 

72 


 

 

Note Expected credit loss measurement (continued)

The table below provides information about the ECL gross exposure and the ECL coverage ratio for our core loan portfolios (i.e., Loans and advances to customers and  Loans to financial advisors) and relevant off-balance sheet exposures. Cash and balances at central banks, Loans and advances to banks, Receivables from securities financing transactions, Cash collateral receivables on derivative instruments and Financial assets measured at fair value through other comprehensive income are not included in the table below, due to their lower sensitivity to ECL.

ECL coverage ratios are calculated by dividing ECL allowances and provisions by the gross carrying amount of the exposures.

 

Coverage ratios for core loan portfolio

 

30.9.21

 

 

Gross carrying amount (USD million)  

 

ECL coverage (bps)

On-balance sheet

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Private clients with mortgages

 

 148,810 

 139,485 

 8,520 

 805 

 

 9 

 2 

 79 

 440 

Real estate financing

 

 42,608 

 37,933 

 4,665 

 10 

 

 14 

 5 

 91 

 80 

Large corporate clients

 

 13,383 

 11,522 

 1,257 

 604 

 

 171 

 17 

 124 

 3,210 

SME clients

 

 14,434 

 11,853 

 1,821 

 761 

 

 191 

 15 

 89 

 3,177 

Lombard

 

 147,306 

 147,259 

 0 

 47 

 

 2 

 0 

 0 

 5,849 

Credit cards

 

 1,702 

 1,309 

 350 

 44 

 

 203 

 73 

 257 

 3,652 

Commodity trade finance

 

 3,487 

 3,365 

 7 

 115 

 

 295 

 16 

 2 

 8,491 

Other loans and advances to customers

 

 19,553 

 18,164 

 1,322 

 67 

 

 25 

 9 

 14 

 4,487 

Loans to financial advisors

 

 2,596 

 2,003 

 234 

 358 

 

 371 

 89 

 295 

 1,998 

Total1

 

 393,880 

 372,893 

 18,176 

 2,811 

 

 26 

 4 

 88 

 2,540 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross exposure (USD million)

 

ECL coverage (bps)

Off-balance sheet

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Private clients with mortgages

 

 7,867 

 7,600 

 264 

 3 

 

 4 

 4 

 8 

 103 

Real estate financing

 

 8,843 

 8,317 

 526 

 0 

 

 9 

 7 

 54 

 0 

Large corporate clients

 

 31,039 

 26,494 

 4,366 

 179 

 

 38 

 26 

 96 

 466 

SME clients

 

 8,209 

 7,197 

 843 

 168 

 

 41 

 19 

 118 

 572 

Lombard

 

 14,309 

 14,309 

 0 

 0 

 

 2 

 1 

 0 

 0 

Credit cards

 

 9,218 

 8,762 

 448 

 8 

 

 7 

 5 

 35 

 0 

Commodity trade finance

 

 2,532 

 2,531 

 0 

 0 

 

 8 

 5 

 0 

 0 

Financial intermediaries and hedge funds

 

 8,579 

 8,249 

 330 

 0 

 

 20 

 16 

 137 

 0 

Other off-balance sheet commitments

 

 11,449 

 11,025  

 419  

 5 

 

 10 

 5 

 21 

 0 

Total2

 

 102,044 

 94,485 

 7,196 

 363 

 

 20 

 12 

 86 

 695 

1 Includes Loans and advances to customers of USD 391,284 million and Loans to financial advisors of USD 2,596 million, which are presented on the balance sheet line Other assets measured at amortized cost.    2 Excludes Forward starting reverse repurchase and securities borrowing agreements.

 

Coverage ratios for core loan portfolio

 

30.6.21

 

 

Gross carrying amount (USD million)  

 

ECL coverage (bps)

On-balance sheet

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Private clients with mortgages

 

 147,966 

 137,877 

 9,216 

 874 

 

 9 

 2 

 82 

 427 

Real estate financing

 

 42,677 

 37,967 

 4,696 

 14 

 

 12 

 4 

 69 

 101 

Large corporate clients

 

 14,540 

 12,691 

 1,247 

 602 

 

 169 

 16 

 151 

 3,446 

SME clients

 

 14,407 

 11,772 

 1,833 

 802 

 

 202 

 17 

 102 

 3,152 

Lombard

 

 146,202 

 146,141 

 0 

 61 

 

 2 

 0 

 0 

 4,698 

Credit cards

 

 1,644 

 1,264 

 336 

 44 

 

 205 

 72 

 261 

 3,608 

Commodity trade finance

 

 3,503 

 3,350 

 38 

 114 

 

 295 

 15 

 2 

 8,605 

Other loans and advances to customers

 

 20,137 

 18,871 

 1,193 

 73 

 

 26 

 11 

 13 

 4,051 

Loans to financial advisors

 

 2,518 

 1,946 

 202 

 369 

 

 408 

 116 

 290 

 2,016 

Total1

 

 393,594 

 371,880 

 18,762 

 2,952 

 

 27 

 4 

 86 

 2,521 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross exposure (USD million)

 

ECL coverage (bps)

Off-balance sheet

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Private clients with mortgages

 

 8,063 

 7,809 

 251 

 3 

 

 4 

 4 

 7 

 349 

Real estate financing

 

 8,048 

 7,596 

 452 

 0 

 

 9 

 7 

 49 

 0 

Large corporate clients

 

 29,990 

 24,540 

 5,187 

 262 

 

 41 

 27 

 91 

 278 

SME clients

 

 8,273 

 7,099 

 1,040 

 134 

 

 43 

 20 

 91 

 878 

Lombard

 

 14,736 

 14,735 

 0 

 0 

 

 1 

 0 

 0 

 0 

Credit cards

 

 9,298 

 8,825 

 464 

 9 

 

 7 

 5 

 33 

 0 

Commodity trade finance

 

 2,623 

 2,593 

 30 

 0 

 

 8 

 5 

 50 

 0 

Financial intermediaries and hedge funds

 

 10,576 

 10,110 

 466 

 0 

 

 17 

 12 

 120 

 0 

Other off-balance sheet commitments

 

 7,678 

 7,377  

 301  

 0 

 

 17 

 8 

 21 

 0 

Total2

 

 99,284 

 90,685 

 8,191 

 408 

 

 21 

 13 

 82 

 671 

1 Includes Loans and advances to customers of USD 391,076 million and Loans to financial advisors of USD 2,518 million, which are presented on the balance sheet line Other assets measured at amortized cost.    2 Excludes Forward starting reverse repurchase and securities borrowing agreements.

 

73 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note Expected credit loss measurement (continued)

 

Coverage ratios for core loan portfolio

 

31.12.20

 

 

Gross carrying amount (USD million)  

 

ECL coverage (bps)

On-balance sheet

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Private clients with mortgages

 

 148,341 

 138,803 

 8,540 

 998 

 

 11 

 2 

 108 

 390 

Real estate financing

 

 43,492 

 37,583 

 5,883 

 27 

 

 15 

 4 

 75 

 1,414 

Large corporate clients

 

 15,440 

 12,684 

 2,069 

 686 

 

 181 

 21 

 192 

 3,089 

SME clients

 

 15,183 

 12,010 

 2,277 

 896 

 

 204 

 16 

 101 

 2,991 

Lombard

 

 133,886 

 133,800 

 0 

 86 

 

 3 

 0 

 0 

 3,592 

Credit cards

 

 1,596 

 1,209 

 342 

 46 

 

 240 

 91 

 333 

 3,488 

Commodity trade finance

 

 3,375 

 3,219 

 43 

 113 

 

 315 

 16 

 2 

 8,939 

Other loans and advances to customers

 

 19,274 

 17,781 

 1,402 

 91 

 

 31 

 14 

 25 

 3,563 

Loans to financial advisors

 

 2,677 

 2,009 

 142 

 526 

 

 404 

 135 

 351 

 1,446 

Total1

 

 383,266 

 359,099 

 20,697 

 3,470 

 

 30 

 5 

 106 

 2,247 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross exposure (USD million)

 

ECL coverage (bps)

Off-balance sheet

 

Total

Stage 1

Stage 2

Stage 3

 

Total

Stage 1

Stage 2

Stage 3

Private clients with mortgages

 

 6,285 

 6,083 

 198 

 3 

 

 7 

 6 

 16 

 197 

Real estate financing

 

 7,056 

 6,576 

 481 

 0 

 

 21 

 9 

 185 

 0 

Large corporate clients

 

 32,828 

 25,026 

 7,598 

 205 

 

 46 

 27 

 92 

 565 

SME clients

 

 9,121 

 7,239 

 1,734 

 148 

 

 40 

 19 

 63 

 779 

Lombard

 

 14,178 

 14,170 

 0 

 8 

 

 2 

 1 

 0 

 1,941 

Credit cards

 

 8,661 

 8,220 

 430 

 11 

 

 9 

 8 

 44 

 0 

Commodity trade finance

 

 1,683 

 1,658 

 25 

 0 

 

 10 

 8 

 15 

 0 

Financial intermediaries and hedge funds

 

 7,690 

 7,242 

 448 

 0 

 

 26 

 13 

 248 

 166 

Other off-balance sheet commitments

 

 14,366 

 13,876  

 482  

 8 

 

 13 

 7 

 11 

 0 

Total2

 

 101,869 

 90,090 

 11,396 

 382 

 

 25 

 13 

 91 

 894 

1 Includes Loans and advances to customers of USD 380,589 million and Loans to financial advisors of USD 2,677 million, which are presented on the balance sheet line Other assets measured at amortized cost.    2 Excludes Forward starting reverse repurchase and securities borrowing agreements.

 

  

Note 8  Fair value measurement

This Note provides fair value measurement information for both financial and non-financial instruments and should be read in conjunction with “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2020, which provides more information about valuation principles, valuation governance, fair value hierarchy classification, valuation adjustments, valuation techniques and inputs, sensitivity of fair value measurements, and methods applied to calculate fair values for financial instruments not measured at fair value.

     Refer to the “Balance sheet and off-balance sheet” section of this report for more information about quarter-on-quarter balance sheet movements


All financial and non-financial assets and liabilities measured or disclosed at fair value are categorized into one of three fair value hierarchy levels. When the inputs used to measure fair value may fall within different levels of the fair value hierarchy, the level in the hierarchy within which each instrument is classified in its entirety is based on the lowest-level input that is significant to the position’s fair value measurement:

      Level 1 – quoted prices (unadjusted) in active markets for identical assets and liabilities;

      Level 2 – valuation techniques for which all significant inputs are, or are based on, observable market data; or

      Level 3 – valuation techniques for which significant inputs are not based on observable market data.


 

74 


 

 

Note   Fair value measurement (continued)

a) Fair value hierarchy

The fair value hierarchy classification of financial and non-financial assets and liabilities measured at fair value is summarized in the table below.

 

Determination of fair values from quoted market prices or valuation techniques1

 

 

 

 

 

 

 

30.9.21

 

30.6.21

 

31.12.20

USD million

 

Level 1

Level 2

Level 3

Total

 

Level 1

Level 2

Level 3

Total

 

Level 1

Level 2

Level 3

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets measured at fair value on a recurring basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets at fair value held for trading

 

 108,962 

 14,719 

 1,791 

 125,471 

 

 103,684 

 16,675 

 2,123 

 122,482 

 

 107,507 

 15,553 

 2,337 

 125,397 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity instruments

 

 93,180 

 861 

 103 

 94,145 

 

 86,722 

 1,336 

 128 

 88,186 

 

 90,307 

 1,101 

 171 

 91,579 

Government bills / bonds

 

 7,319 

 1,555 

 31 

 8,905 

 

 8,123 

 1,776 

 10 

 9,910 

 

 9,028 

 2,207 

 10 

 11,245 

Investment fund units

 

 7,700 

 1,335 

 13 

 9,048 

 

 8,048 

 1,707 

 18 

 9,773 

 

 7,374 

 1,794 

 23 

 9,192 

Corporate and municipal bonds

 

 756 

 8,733 

 831 

 10,320 

 

 784 

 8,417 

 821 

 10,022 

 

 789 

 8,356 

 817 

 9,961 

Loans

 

 0 

 1,898 

 672 

 2,570 

 

 0 

 3,115 

 1,000 

 4,114 

 

 0 

 1,860 

 1,134 

 2,995 

Asset-backed securities

 

 6 

 337 

 141 

 484 

 

 7 

 323 

 147 

 478 

 

 8 

 236 

 181 

 425 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

 1,299 

 118,526 

 1,364 

 121,189 

 

 795 

 119,348 

 1,479 

 121,622 

 

 795 

 157,068 

 1,754 

 159,617 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

 602 

 50,263 

 8 

 50,873 

 

 296 

 49,154 

 6 

 49,456 

 

 319 

 68,424 

 5 

 68,749 

Interest rate contracts

 

 0 

 33,677 

 285 

 33,962 

 

 0 

 38,104 

 342 

 38,446 

 

 0 

 50,353 

 537 

 50,890 

Equity / index contracts

 

 0 

 31,581 

 696 

 32,278 

 

 1 

 28,383 

 801 

 29,185 

 

 0 

 33,990 

 853 

 34,842 

Credit derivative contracts

 

 0 

 1,185 

 343 

 1,528 

 

 0 

 1,739 

 303 

 2,043 

 

 0 

 2,008 

 350 

 2,358 

Commodity contracts

 

 0 

 1,691 

 27 

 1,718 

 

 0 

 1,832 

 24 

 1,856 

 

 0 

 2,211 

 6 

 2,217 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brokerage receivables

 

 0 

 20,746 

 0 

 20,746 

 

 0 

 23,010 

 0 

 23,010 

 

 0 

 24,659 

 0 

 24,659 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets at fair value not held for trading

 

 26,249 

 30,263 

 4,287 

 60,799 

 

 29,125 

 31,809 

 4,459 

 65,393 

 

 40,986 

 35,435 

 3,942 

 80,364 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets for unit-linked investment contracts

 

 20,793 

 6 

 4 

 20,803 

 

 21,974 

 9 

 8 

 21,991 

 

 20,628 

 101 

 2 

 20,731 

Corporate and municipal bonds

 

 138 

 14,930 

 323 

 15,391 

 

 88 

 16,009 

 333 

 16,430 

 

 290 

 16,957 

 372 

 17,619 

Government bills / bonds

 

 4,908 

 3,114 

 0 

 8,022 

 

 6,640 

 3,331 

 0 

 9,971 

 

 19,704 

 3,593 

 0 

 23,297 

Loans

 

 0 

 4,523 

 902 

 5,425 

 

 0 

 5,626 

 1,087 

 6,712 

 

 0 

 7,699 

 862 

 8,561 

Securities financing transactions

 

 0 

 7,084 

 202 

 7,286 

 

 0 

 6,203 

 201 

 6,404 

 

 0 

 6,629 

 122 

 6,751 

Auction rate securities

 

 0 

 0 

 1,573 

 1,573 

 

 0 

 0 

 1,563 

 1,563 

 

 0 

 0 

 1,527 

 1,527 

Investment fund units

 

 307 

 607 

 118 

 1,031 

 

 317 

 613 

 120 

 1,051 

 

 278 

 447 

 105 

 831 

Equity instruments

 

 102 

 0 

 632 

 734 

 

 105 

 18 

 594 

 717 

 

 86 

 0 

 544 

 631 

Other

 

 0 

 0 

 533 

 533 

 

 0 

 0 

 554 

 554 

 

 0 

 10 

 408 

 418 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets measured at fair value through other comprehensive income on a recurring basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets measured at fair value through other comprehensive income

 

 2,804 

 5,593 

 0 

 8,397 

 

 2,165 

 5,611 

 0 

 7,775 

 

 1,144 

 7,114 

 0 

 8,258 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset-backed securities

 

 0 

 5,205 

 0 

 5,205 

 

 0 

 5,200 

 0 

 5,200 

 

 0 

 6,624 

 0 

 6,624 

Government bills / bonds

 

 2,758 

 33 

 0 

 2,791 

 

 2,121 

 44 

 0 

 2,165 

 

 1,103 

 47 

 0 

 1,150 

Corporate and municipal bonds

 

 45 

 355 

 0 

 400 

 

 44 

 367 

 0 

 411 

 

 40 

 444 

 0 

 485 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-financial assets measured at fair value on a recurring basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Precious metals and other physical commodities

 

 5,027 

 0 

 0 

 5,027 

 

 5,470 

 0 

 0 

 5,470 

 

 6,264 

 0 

 0 

 6,264 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-financial assets measured at fair value on a non-recurring basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other non-financial assets2

 

 0 

 0 

 66 

 66 

 

 0 

 1 

 67 

 68 

 

 0 

 1 

 245 

 246 

Total assets measured at fair value

 

 144,340 

 189,848 

 7,508 

 341,696 

 

 141,238 

 196,453 

 8,129 

 345,820 

 

 156,696 

 239,831 

 8,278 

 404,805 

 

75 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note 8  Fair value measurement (continued)

Determination of fair values from quoted market prices or valuation techniques (continued)1

 

 

 

 

 

 

 

30.9.21

 

30.6.21

 

31.12.20

USD million

 

Level 1

Level 2

Level 3

Total

 

Level 1

Level 2

Level 3

Total

 

Level 1

Level 2

Level 3

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities measured at fair value on a recurring basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities at fair value held for trading

 

 28,339 

 6,215 

 96 

 34,650 

 

 27,038 

 6,216 

 94 

 33,348 

 

 26,888 

 6,652 

 55 

 33,595 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity instruments

 

 22,480 

 364 

 80 

 22,924 

 

 20,826 

 387 

 75 

 21,288 

 

 22,519 

 425 

 40 

 22,985 

Corporate and municipal bonds

 

 36 

 4,426 

 11 

 4,473 

 

 37 

 4,592 

 13 

 4,642 

 

 31 

 4,048 

 9 

 4,089 

Government bills / bonds

 

 5,414 

 787 

 0 

 6,201 

 

 5,727 

 620 

 0 

 6,347 

 

 3,642 

 1,036 

 0 

 4,678 

Investment fund units

 

 405 

 602 

 5 

 1,013 

 

 442 

 581 

 6 

 1,028 

 

 696 

 1,127 

 5 

 1,828 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

 1,271 

 117,347 

 2,543 

 121,162 

 

 754 

 117,983 

 2,950 

 121,686 

 

 746 

 156,884 

 3,471 

 161,102 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

 576 

 49,584 

 19 

 50,180 

 

 280 

 47,048 

 59 

 47,387 

 

 316 

 70,149 

 61 

 70,527 

Interest rate contracts

 

 0 

 28,415 

 534 

 28,949 

 

 0 

 32,177 

 526 

 32,703 

 

 0 

 43,389 

 527 

 43,916 

Equity / index contracts

 

 0 

 35,701 

 1,606 

 37,307 

 

 9 

 34,431 

 1,902 

 36,342 

 

 0 

 38,870 

 2,306 

 41,176 

Credit derivative contracts

 

 0 

 1,427 

 296 

 1,723 

 

 0 

 2,000 

 392 

 2,392 

 

 0 

 2,403 

 528 

 2,931 

Commodity contracts

 

 0 

 2,055 

 67 

 2,122 

 

 0 

 2,034 

 51 

 2,085 

 

 0 

 2,003 

 24 

 2,027 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities designated at fair value on a recurring basis

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brokerage payables designated at fair value

 

 0 

 45,557 

 0 

 45,557 

 

 0 

 39,129 

 0 

 39,129 

 

 0 

 38,742 

 0 

 38,742 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt issued designated at fair value

 

 0 

 56,360 

 15,538 

 71,898 

 

 0 

 60,321 

 14,744 

 75,065 

 

 0 

 50,273 

 10,970 

 61,243 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other financial liabilities designated at fair value

 

 0 

 29,545 

 703 

 30,248 

 

 0 

 30,032 

 610 

 30,642 

 

 0 

 29,671 

 716 

 30,387 

of which:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities related to unit-linked investment contracts

 

 0 

 21,078 

 0 

 21,078 

 

 0 

 22,217 

 0 

 22,217 

 

 0 

 20,975 

 0 

 20,975 

Securities financing transactions

 

 0 

 7,142 

 13 

 7,156 

 

 0 

 6,181 

 3 

 6,184 

 

 0 

 7,317 

 0 

 7,317 

Over-the-counter debt instruments

 

 0 

 1,241 

 670 

 1,911 

 

 0 

 1,550 

 592 

 2,142 

 

 0 

 1,363 

 697 

 2,060 

Total liabilities measured at fair value

 

 29,611 

 255,024 

 18,880 

 303,515 

 

 27,791 

 253,679 

 18,398 

 299,869 

 

 27,635 

 282,222 

 15,212 

 325,069 

1 Bifurcated embedded derivatives are presented on the same balance sheet lines as their host contracts and are not included in this table. The fair value of these derivatives was not material for the periods presented.    2 Other non-financial assets primarily consist of properties and other non-current assets held for sale, which are measured at the lower of their net carrying amount or fair value less costs to sell.

 

b) Valuation adjustments and other items

The table below summarizes the valuation adjustment reserves recognized on the balance sheet. Details about each category are provided further below.

 

Valuation adjustment reserves on the balance sheet

 

 

 

 

 

 

As of

Life-to-date gain / (loss), USD million

 

30.9.21

30.6.21

31.12.20

Deferred day-1 profit or loss reserves

 

429

 405 

269

Own credit adjustments on financial liabilities designated at fair value

 

(371)

 (278) 

(381)

CVAs, FVAs, DVAs and other valuation adjustments

 

(948)

(956)

(959)

 

Deferred day-1 profit or loss reserves

The table below summarizes the changes in deferred day-1 profit or loss reserves during the relevant period.


Deferred day-1 profit or loss is generally released into Other net income from financial instruments measured at fair value through profit or loss when pricing of equivalent products or the underlying parameters become observable or when the transaction is closed out.

 

Deferred day-1 profit or loss reserves

 

 

 

 

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

Reserve balance at the beginning of the period

 

 405 

 387 

 243 

 

 269 

 146 

Profit / (loss) deferred on new transactions

 

 102 

 97 

 48 

 

 380 

 287 

(Profit) / loss recognized in the income statement

 

 (78) 

 (79) 

 (60) 

 

 (220) 

 (201) 

Foreign currency translation

 

 (1) 

 0 

 0 

 

 (1) 

 (1) 

Reserve balance at the end of the period

 

 429 

 405 

 231 

 

 429 

 231 

 

76 


 

 

Note 8  Fair value measurement (continued)

Own credit

The valuation of financial liabilities designated at fair value requires consideration of the own credit component of fair value. Own credit risk is reflected in the valuation of UBS’s fair value option liabilities where this component is considered relevant for valuation purposes by UBS’s counterparties and other market participants. However, own credit risk is not reflected in the valuation of UBS’s liabilities that are fully collateralized or for other obligations for which it is established market practice to not include an own credit component.


A description of UBS’s methodology to estimate own credit and the related accounting principles is included in “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2020.

In the third quarter of 2021, other comprehensive income related to own credit on financial liabilities designated at fair value was negative USD 98 million, primarily due to a tightening of UBS’s credit spreads.

 

Own credit adjustments on financial liabilities designated at fair value

 

 

 

 

 

 

 

 

 

 

Included in Other comprehensive income

 

 

For the quarter ended

 

Year-to-date

USD million

 

30.9.21

 

30.6.21

30.9.20

 

30.9.21

30.9.20

Recognized during the period:

 

 

 

 

 

 

 

 

Realized gain / (loss)

 

 (3) 

 

 (5) 

 (5) 

 

 (14) 

 5 

Unrealized gain / (loss)

 

 (95) 

 

 123 

 (139) 

 

 6 

 (86) 

Total gain / (loss), before tax

 

 (98) 

 

 118 

 (144) 

 

 (8) 

 (82) 

 

 

 

 

 

 

 

 

 

 

 

As of

 

 

 

USD million

 

30.9.21

 

30.6.21

31.12.20

 

 

 

Recognized on the balance sheet as of the end of the period:

 

 

 

 

 

 

 

 

Unrealized life-to-date gain / (loss)

 

 (371) 

 

 (278) 

 (381) 

 

 

 

 

Credit, funding, debit and other valuation adjustments

A description of UBS’s methodology for estimating credit valuation adjustments (CVAs), funding valuation adjustments (FVAs), debit valuation adjustments (DVAs) and other valuation adjustments is included in “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2020.

 

Valuation adjustments on financial instruments

 

 

 

 

 

 

As of

Life-to-date gain / (loss), USD million

 

30.9.21

30.6.21

31.12.20

Credit valuation adjustments1

 

 (48) 

 (51) 

 (66) 

Funding valuation adjustments

 

 (53) 

 (58) 

 (73) 

Debit valuation adjustments

 

 2 

 1 

 0 

Other valuation adjustments

 

 (849) 

 (848) 

 (820) 

of which: liquidity

 

 (321) 

 (327) 

 (340) 

of which: model uncertainty

 

 (527) 

 (521) 

 (479) 

1 Amounts do not include reserves against defaulted counterparties.

 

c) Transfers between Level 1 and Level 2

During the first nine months of 2021, assets and liabilities transferred from Level 2 to Level 1, or from Level 1 to Level 2, that were held for the entire reporting period were not material.

 

77 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note 8  Fair value measurement (continued)

d) Level 3 instruments: valuation techniques and inputs

The table below presents material Level 3 assets and liabilities, together with the valuation techniques used to measure fair value, the inputs used in a given valuation technique that are considered significant as of 30 September 2021 and unobservable, and a range of values for those unobservable inputs.

The range of values represents the highest- and lowest-level inputs used in the valuation techniques. Therefore the range does not reflect the level of uncertainty regarding a particular input or an assessment of the reasonableness of the Group’s estimates and assumptions, but rather the different underlying characteristics of the relevant assets and liabilities held by the Group. The ranges will therefore vary from period to period and parameter to parameter based on characteristics of the instruments held at each balance sheet date. Furthermore, the ranges of unobservable inputs may differ across other financial institutions, reflecting the diversity of the products in each firm’s inventory.

The significant unobservable inputs disclosed in the table below are consistent with those included in “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2020. A description of the potential effect that a change in each unobservable input in isolation may have on a fair value measurement, including information to facilitate an understanding of factors that give rise to the input ranges shown, is also provided in “Note 21 Fair value measurement” in the “Consolidated financial statements” section of the Annual Report 2020.

 

 

Valuation techniques and inputs used in the fair value measurement of Level 3 assets and liabilities

 

Fair value

 

 

 

Significant unobservable input(s)1

Range of inputs

 

Assets

 

Liabilities

 

Valuation technique(s)

 

30.9.21

 

31.12.20

 

USD billion

30.9.21

31.12.20

 

30.9.21

31.12.20

 

 

low

high

weighted average2

 

low

high

weighted average2

unit1

Financial assets and liabilities at fair value held for trading and Financial assets at fair value not held for trading

Corporate and municipal bonds

 1.2 

 1.2 

 

 0.0 

 0.0 

 

Relative value to market comparable

 

Bond price equivalent

 26 

 143 

 99 

 

 1 

 143 

 100 

points

 

 

 

 

 

 

 

Discounted expected cash flows

 

Discount margin

 379 

 379 

 

 

 268 

 268 

 

basis points

Traded loans, loans measured at fair value, loan commitments and guarantees

 2.1 

 2.4 

 

 0.0 

 0.0 

 

Relative value to market comparable

 

Loan price equivalent

 1 

 101 

 100 

 

 0 

 101 

 99 

points

 

 

 

 

 

 

 

Discounted expected cash flows

 

Credit spread

 180 

 800 

 442 

 

 190 

 800 

 398 

basis points

 

 

 

 

 

 

 

Market comparable and securitization model

 

Credit spread

 28 

 1,545 

 237 

 

 40 

 1,858 

 333 

basis points

Auction rate securities

 1.6 

 1.5 

 

 

 

 

Discounted expected cash flows

 

Credit spread

 115 

 213 

 159 

 

 100 

 188 

 140 

basis points

Investment fund units3

 0.1 

 0.1 

 

 0.0 

 0.0 

 

Relative value to market comparable

 

Net asset value

 

 

 

 

 

 

 

 

Equity instruments3

 0.7 

 0.7 

 

 0.1 

 0.0 

 

Relative value to market comparable

 

Price

 

 

 

 

 

 

 

 

Debt issued designated at fair value4

 

 

 

 15.5 

 11.0 

 

 

 

 

 

 

 

 

 

 

 

 

Other financial liabilities designated at fair value

 

 

 

 0.7 

 0.7 

 

Discounted expected cash flows

 

Funding spread

 25 

 175 

 

 

 42 

 175 

 

basis points

Derivative financial instruments

Interest rate contracts

 0.3 

 0.5 

 

 0.5 

 0.5 

 

Option model

 

Volatility of interest rates

 48 

 77 

 

 

 29 

 69 

 

basis points

Credit derivative contracts

 0.3 

 0.3 

 

 0.3 

 0.5 

 

Discounted expected cash flows

 

Credit spreads

 1 

 417 

 

 

 1 

 489 

 

basis points

 

 

 

 

 

 

 

 

 

Bond price equivalent

 3 

 104 

 

 

 0 

 100 

 

points

Equity / index contracts

 0.7 

 0.9 

 

 1.6 

 2.3 

 

Option model

 

Equity dividend yields

 0 

 17 

 

 

 0 

 13 

 

%

 

 

 

 

 

 

 

 

 

Volatility of equity stocks, equity and other indices

 4 

 94 

 

 

 4 

 100 

 

%

 

 

 

 

 

 

 

 

 

Equity-to-FX correlation

 (29) 

 76 

 

 

 (34) 

 65 

 

%

 

 

 

 

 

 

 

 

 

Equity-to-equity correlation

 (25) 

 100 

 

 

 (16) 

 100 

 

%

1 The ranges of significant unobservable inputs are represented in points, percentages and basis points. Points are a percentage of par (e.g., 100 points would be 100% of par).    2 Weighted averages are provided for most non-derivative financial instruments and were calculated by weighting inputs based on the fair values of the respective instruments. Weighted averages are not provided for inputs related to Other financial liabilities designated at fair value and Derivative financial instruments, as this would not be meaningful.    3 The range of inputs is not disclosed, as there is a dispersion of values given the diverse nature of the investments.    4 Debt issued designated at fair value is composed primarily of UBS structured notes, which include variable maturity notes with various equity and foreign exchange underlying risks, rates-linked and credit-linked notes, all of which have embedded derivative parameters that are considered to be unobservable. The equivalent derivative instrument parameters are presented in the respective derivative financial instruments lines in this table.

 

78 


 

 

Note 8  Fair value measurement (continued)

e) Level 3 instruments: sensitivity to changes in unobservable input assumptions

The table below summarizes those financial assets and liabilities classified as Level 3 for which a change in one or more of the unobservable inputs to reflect reasonably possible alternative assumptions would change fair value significantly, and the estimated effect thereof. The table presents the favorable and unfavorable effects for each class of financial assets and liabilities for which the potential change in fair value is considered significant. The sensitivity of fair value measurements for debt issued designated at fair value and over-the-counter debt instruments designated at fair value is reported together with the equivalent derivative or securities financing instrument.


The sensitivity data shown below presents an estimation of valuation uncertainty based on reasonably possible alternative values for Level 3 inputs at the balance sheet date and does not represent the estimated effect of stress scenarios. Typically, these financial assets and liabilities are sensitive to a combination of inputs from Levels 1–3. Although well-defined interdepend-encies may exist between Levels 1–2 and Level 3 parameters (e.g., between interest rates, which are generally Level 1 or Level 2, and prepayments, which are generally Level 3), these have not been incorporated in the table. Furthermore, direct interrelationships between the Level 3 parameters are not a significant element of the valuation uncertainty.

 

Sensitivity of fair value measurements to changes in unobservable input assumptions

 

 

 

 

 

 

 

 

30.9.21

 

30.6.21

 

31.12.20

USD million

 

Favorable

changes

Unfavorable

changes

 

Favorable

changes

Unfavorable

changes

 

Favorable

changes

Unfavorable

changes

Traded loans, loans designated at fair value, loan commitments and guarantees

 

 19 

 (10) 

 

 22 

 (13) 

 

 29 

 (28) 

Securities financing transactions

 

 43 

 (62) 

 

 69 

 (68) 

 

 40 

 (52) 

Auction rate securities

 

 831

 (83)1

 

 114 

 (114) 

 

 105 

 (105) 

Asset-backed securities

 

 26 

 (29) 

 

 48 

 (34) 

 

 41 

 (41) 

Equity instruments

 

 165 

 (138) 

 

 150 

 (120) 

 

 129 

 (96) 

Interest rate derivative contracts, net

 

 32 

 (18) 

 

 25 

 (14) 

 

 11 

 (16) 

Credit derivative contracts, net

 

 6 

 (8) 

 

 8 

 (10) 

 

 10 

 (14) 

Foreign exchange derivative contracts, net

 

 21 

 (16) 

 

 15 

 (9) 

 

 20 

 (15) 

Equity / index derivative contracts, net

 

 362 

 (326) 

 

 344 

 (324) 

 

 318 

 (294) 

Other

 

 53 

 (76) 

 

 58 

 (77) 

 

 91 

 (107) 

Total

 

 810 

 (766) 

 

 852 

 (782) 

 

 794 

 (768) 

1 Includes refinements applied in estimating valuation uncertainty across various parameters and a change in assumptions regarding the underlying statistical distribution.

 

f) Level 3 instruments: movements during the period

Significant changes in Level 3 instruments

The table on the following pages presents additional information about material Level 3 assets and liabilities measured at fair value on a recurring basis. Level 3 assets and liabilities may be hedged with instruments classified as Level 1 or Level 2 in the fair value hierarchy and, as a result, realized and unrealized gains and losses included in the table may not include the effect of related hedging activity. Furthermore, the realized and unrealized gains and losses presented in the table are not limited solely to those arising from Level 3 inputs, as valuations are generally derived from both observable and unobservable parameters.

Assets and liabilities transferred into or out of Level 3 are presented as if those assets or liabilities had been transferred at the beginning of the year.

 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note 8  Fair value measurement (continued)

Movements of Level 3 instruments

 

 

 

 

 

 

 

 

 

 

 

 

Total gains / losses included in comprehensive income

 

 

 

 

 

 

 

 

USD billion

Balance

as of 31 December 2019

Net gains / losses included in income1

of which: related to Level 3 instruments held at the end of the reporting period

Purchases

Sales

Issuances

Settlements

Transfers

into

Level 3

Transfers

out of

Level 3

Foreign currency translation

Balance

as of

30 September 2020

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets at fair value held for trading

 1.8 

 0.0 

 0.0 

 0.6 

 (1.4) 

 0.5 

 0.0 

 0.2 

 0.0 

 0.0 

 1.6 

of which:

 

 

 

 

 

 

 

 

 

 

 

Investment fund units

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

Corporate and municipal bonds

 0.5 

 0.1 

 0.0 

 0.4 

 (0.5) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.5 

Loans

 0.8 

 0.0 

 0.0 

 0.0 

 (0.6) 

 0.5 

 0.0 

 0.0 

 0.0 

 0.0 

 0.7 

Other

 0.4 

 (0.1) 

 (0.1) 

 0.1 

 (0.2) 

 0.0 

 0.0 

 0.1 

 0.0 

 0.0 

 0.3 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments – assets

 1.3 

 0.2 

 0.2 

 0.0 

 0.0 

 0.6 

 (0.9) 

 0.5 

 (0.1) 

 0.0 

 1.5 

of which:

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 0.3 

 0.1 

 0.1 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.3 

Equity / index contracts

 0.6 

 0.0 

 0.1 

 0.0 

 0.0 

 0.5 

 (0.7) 

 0.4 

 (0.1) 

 0.0 

 0.8 

Credit derivative contracts

 0.4 

 0.0 

 0.0 

 0.0 

 0.0 

 0.1 

 (0.2) 

 0.0 

 0.0 

 0.0 

 0.3 

Other

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets at fair value not held for trading

 4.0 

 (0.2) 

 (0.1) 

 0.8 

 (0.8) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 3.8 

of which:

 

 

 

 

 

 

 

 

 

 

 

Loans

 1.2 

 0.0 

 0.1 

 0.3 

 (0.7) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.8 

Auction rate securities

 1.5 

 (0.1) 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 1.4 

Equity instruments

 0.5 

 0.0 

 0.0 

 0.1 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.5 

Other

 0.7 

 0.0 

 0.0 

 0.4 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 1.0 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial instruments – liabilities

 2.0 

 0.8 

 0.7 

 0.0 

 0.0 

 0.7 

 (0.7) 

 0.5 

 (0.5) 

 0.0 

 2.8 

of which:

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 0.1 

 0.5 

 0.5 

 0.0 

 0.0 

 0.1 

 (0.1) 

 0.3 

 (0.1) 

 0.0 

 0.7 

Equity / index contracts

 1.3 

 0.4 

 0.2 

 0.0 

 0.0 

 0.5 

 (0.5) 

 0.1 

 (0.2) 

 0.0 

 1.6 

Credit derivative contracts

 0.5 

 0.0 

 0.0 

 0.0 

 0.0 

 0.1 

 0.0 

 0.1 

 (0.2) 

 0.0 

 0.5 

Other

 0.1 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.1 

 

 

 

 

 

 

 

 

 

 

 

 

Debt issued designated at fair value

 9.9 

 (0.6) 

 (0.5) 

 0.0 

 0.0 

 6.2 

 (4.4) 

 0.4 

 (1.5) 

 0.0 

 10.0 

 

 

 

 

 

 

 

 

 

 

 

 

Other financial liabilities designated at fair value

 0.8 

 0.1 

 0.1 

 0.0 

 0.0 

 0.4 

 (0.4) 

 0.0 

 0.0 

 0.0 

 0.9 

1 Net gains / losses included in comprehensive income are composed of Net interest income, Other net income from financial instruments measured at fair value through profit or loss and Other income.    2 Total Level 3 assets as of 30 September 2021 were USD 7.5 billion (31 December 2020: USD 8.3 billion). Total Level 3 liabilities as of 30 September 2021 were USD 18.9 billion (31 December 2020: USD 15.2 billion).

 

80 


 

 

Note  Fair value measurement (continued)

 

 

 

 

 

 

 

 

 

 

 

 

Total gains / losses included in comprehensive income

 

 

 

 

 

 

 

 

Balance

as of

31 December 20202

Net gains / losses included in income1

of which: related to Level 3 instruments held at the end of the reporting period

Purchases

Sales

Issuances

Settlements

Transfers

into

Level 3

Transfers

out of

Level 3

Foreign

currency

translation

Balance

as of

30 September 20212

 

 

 

 

 

 

 

 

 

 

 

 2.3 

 0.0 

 0.0 

 0.3 

 (1.0) 

 0.2 

 0.0 

 0.2 

 (0.2) 

 0.0 

 1.8 

 

 

 

 

 

 

 

 

 

 

 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.8 

 0.0 

 0.0 

 0.2 

 (0.2) 

 0.0 

 0.0 

 0.0 

 (0.1) 

 0.0 

 0.8 

 1.1 

 0.0 

 0.0 

 0.0 

 (0.6) 

 0.2 

 0.0 

 0.0 

 (0.2) 

 0.0 

 0.7 

 0.4 

 (0.1) 

 (0.1) 

 0.0 

 (0.2) 

 0.0 

 0.0 

 0.1 

 0.0 

 0.0 

 0.3 

 

 

 

 

 

 

 

 

 

 

 

 1.8 

 (0.2) 

 (0.2) 

 0.0 

 0.0 

 0.5 

 (0.5) 

 0.1 

 (0.1) 

 0.0 

 1.4 

 

 

 

 

 

 

 

 

 

 

 

 0.5 

 (0.1) 

 (0.1) 

 0.0 

 0.0 

 0.0 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.3 

 0.9 

 0.0 

 0.0 

 0.0 

 0.0 

 0.3 

 (0.4) 

 0.0 

 (0.1) 

 0.0 

 0.7 

 0.3 

 (0.1) 

 (0.1) 

 0.0 

 0.0 

 0.1 

 0.0 

 0.1 

 0.0 

 0.0 

 0.3 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 

 

 

 

 

 

 

 

 

 

 

 3.9 

 0.1 

 0.1 

 0.8 

 (0.4) 

 0.0 

 0.0 

 0.1 

 (0.3) 

 0.0 

 4.3 

 

 

 

 

 

 

 

 

 

 

 

 0.9 

 0.0 

 0.0 

 0.4 

 (0.2) 

 0.0 

 0.0 

 0.0 

 (0.3) 

 0.0 

 0.9 

 1.5 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 1.6 

 0.5 

 0.1 

 0.1 

 0.1 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 0.6 

 1.0 

 0.0 

 (0.1) 

 0.3 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.0 

 0.0 

 1.2 

 

 

 

 

 

 

 

 

 

 

 

 3.5 

 0.2 

 0.0 

 0.0 

 0.0 

 0.8 

 (1.6) 

 0.0 

 (0.3) 

 0.0 

 2.5 

 

 

 

 

 

 

 

 

 

 

 

 0.5 

 0.0 

 0.0 

 0.0 

 0.0 

 0.1 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.5 

 2.3 

 0.4 

 0.1 

 0.0 

 0.0 

 0.6 

 (1.4) 

 0.0 

 (0.2) 

 0.0 

 1.6 

 0.5 

 (0.2) 

 (0.2) 

 0.0 

 0.0 

 0.1 

 0.0 

 0.0 

 (0.1) 

 0.0 

 0.3 

 0.1 

 0.1 

 0.0 

 0.0 

 0.0 

 0.0 

 (0.1) 

 0.0 

 0.0 

 0.0 

 0.1 

 

 

 

 

 

 

 

 

 

 

 

 11.0 

 0.2 

 0.2 

 0.0 

 0.0 

 8.6 

 (3.4) 

 0.2 

 (0.9) 

 (0.2) 

 15.5 

 

 

 

 

 

 

 

 

 

 

 

 0.7 

 0.0 

 0.0 

 0.0 

 0.0 

 0.3 

 (0.3) 

 0.0 

 0.0 

 0.0 

 0.7 

 

81 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note  Fair value measurement (continued)

g) Financial instruments not measured at fair value

The table below reflects the estimated fair values of financial instruments not measured at fair value.

 

Financial instruments not measured at fair value

 

 

 

 

 

30.9.21

 

30.6.21

 

31.12.20

USD billion

 

Carrying amount

Fair value

 

Carrying amount

Fair value

 

Carrying amount

Fair value

Assets

 

 

 

 

 

 

 

 

 

Cash and balances at central banks

 

 174.5 

 174.5 

 

 160.7 

 160.7 

 

 158.2 

 158.2 

Loans and advances to banks

 

 16.4 

 16.4 

 

 16.5 

 16.5 

 

 15.4 

 15.4 

Receivables from securities financing transactions

 

 74.5 

 74.5 

 

 83.5 

 83.5 

 

 74.2 

 74.2 

Cash collateral receivables on derivative instruments

 

 31.7 

 31.7 

 

 29.8 

 29.8 

 

 32.7 

 32.7 

Loans and advances to customers

 

 390.4 

 389.4 

 

 390.1 

 389.8 

 

 379.5 

 380.8 

Other financial assets measured at amortized cost

 

 27.1 

 27.5 

 

 27.1 

 27.6 

 

 27.2 

 28.0 

Liabilities

 

 

 

 

 

 

 

 

 

Amounts due to banks

 

 13.3 

 13.3 

 

 14.6 

 14.6 

 

 11.0 

 11.0 

Payables from securities financing transactions

 

 5.3 

 5.3 

 

 6.0 

 6.0 

 

 6.3 

 6.3 

Cash collateral payables on derivative instruments

 

 33.1 

 33.1 

 

 32.2 

 32.2 

 

 37.3 

 37.3 

Customer deposits

 

 517.7 

 517.7 

 

 513.3 

 513.3 

 

 524.6 

 524.7 

Debt issued measured at amortized cost

 

 133.7 

 136.0 

 

 139.9 

 142.4 

 

 139.2 

 141.9 

Other financial liabilities measured at amortized cost1

 

 5.9 

 5.9 

 

 6.4 

 6.4 

 

 5.8 

 5.8 

1 Excludes lease liabilities.

 

The fair values included in the table above have been calculated for disclosure purposes only. The valuation techniques and assumptions relate only to UBS’s financial instruments not otherwise measured at fair value. Other institutions may use different methods and assumptions for their fair value estimation, and therefore such fair value disclosures cannot necessarily be compared from one financial institution to another.

 

  


 

Note Derivative instruments

a) Derivative instruments

As of 30.9.21, USD billion

 

Derivative

financial

assets

Notional values

related to derivative

financial assets1

Derivative

financial

liabilities

Notional values

related to derivative

financial liabilities1

Other

notional

values2

Derivative financial instruments

 

 

 

 

 

 

Interest rate contracts

 

 34.0 

 969 

 28.9 

 894 

 9,086 

Credit derivative contracts

 

 1.5 

 50 

 1.7 

 52 

 0 

Foreign exchange contracts

 

 50.9 

 3,163 

 50.2 

 2,957 

 1 

Equity / index contracts

 

 32.3 

 520 

 37.3 

 641 

 90 

Commodity contracts

 

 1.7 

 60 

 2.1 

 58 

 16 

Loan commitments measured at FVTPL

 

 0.0 

 1 

 0.0 

 10 

 

Unsettled purchases of non-derivative financial instruments3

 

 0.3 

 29 

 0.4 

 29 

 

Unsettled sales of non-derivative financial instruments3

 

 0.5 

 42 

 0.5 

 21 

 

Total derivative financial instruments, based on IFRS netting4

 

 121.2 

 4,833 

 121.2 

 4,662 

 9,193 

Further netting potential not recognized on the balance sheet5

 

 (107.1) 

 

 (106.9) 

 

 

of which: netting of recognized financial liabilities / assets

 

 (88.0) 

 

 (87.9) 

 

 

of which: netting with collateral received / pledged

 

 (19.1) 

 

 (19.0) 

 

 

Total derivative financial instruments, after consideration of further netting potential

 

 14.1 

 

 14.3 

 

 

 

 

 

 

 

 

 

As of 30.6.21, USD billion

 

 

 

 

 

 

Derivative financial instruments

 

 

 

 

 

 

Interest rate contracts

 

 38.4 

 995 

 32.7 

 912 

 9,918 

Credit derivative contracts

 

 2.0 

 54 

 2.4 

 54 

 0 

Foreign exchange contracts

 

 49.5 

 3,074 

 47.4 

 2,869 

 2 

Equity / index contracts

 

 29.2 

 458 

 36.3 

 615 

 90 

Commodity contracts

 

 1.9 

 59 

 2.1 

 58 

 15 

Loan commitments measured at FVTPL

 

 0.0 

 1 

 0.0 

 11 

 

Unsettled purchases of non-derivative financial instruments3

 

 0.3 

 29 

 0.3 

 26 

 

Unsettled sales of non-derivative financial instruments3

 

 0.3 

 39 

 0.4 

 23 

 

Total derivative financial instruments, based on IFRS netting4

 

 121.6 

 4,708 

 121.7 

 4,569 

 10,024 

Further netting potential not recognized on the balance sheet5

 

 (107.5) 

 

 (106.8) 

 

 

of which: netting of recognized financial liabilities / assets

 

 (86.8) 

 

 (86.8) 

 

 

of which: netting with collateral received / pledged

 

 (20.6) 

 

 (20.0) 

 

 

Total derivative financial instruments, after consideration of further netting potential

 

 14.2 

 

 14.9 

 

 

 

 

 

 

 

 

 

As of 31.12.20, USD billion

 

 

 

 

 

 

Derivative financial instruments

 

 

 

 

 

 

Interest rate contracts

 

 50.9 

 928 

 43.9 

 880 

 11,292 

Credit derivative contracts

 

 2.4 

 58 

 2.9 

 65 

 0 

Foreign exchange contracts

 

 68.7 

 2,951 

 70.5 

 2,820 

 1 

Equity / index contracts

 

 34.8 

 450 

 41.2 

 581 

 91 

Commodity contracts

 

 2.2 

 58 

 2.0 

 50 

 10 

Loan commitments measured at FVTPL

 

 

 

 0.0 

 10 

 

Unsettled purchases of non-derivative financial instruments3

 

 0.3 

 18 

 0.2 

 10 

 

Unsettled sales of non-derivative financial instruments3

 

 0.2 

 17 

 0.3 

 13 

 

Total derivative financial instruments, based on IFRS netting4

 

 159.6 

 4,479 

 161.1 

 4,430 

 11,394 

Further netting potential not recognized on the balance sheet5

 

 (144.4) 

 

 (141.2) 

 

 

of which: netting of recognized financial liabilities / assets

 

 (117.2) 

 

 (117.2) 

 

 

of which: netting with collateral received / pledged

 

 (27.2) 

 

 (23.9) 

 

 

Total derivative financial instruments, after consideration of further netting potential

 

 15.2 

 

 19.9 

 

 

1 In cases where derivative financial instruments are presented on a net basis on the balance sheet, the respective notional values of the netted derivative financial instruments are still presented on a gross basis. Notional amounts of exchange-traded agency transactions and OTC-cleared transactions entered into on behalf of clients are not disclosed, as they have a significantly different risk profile.    2 Other notional values relate to derivatives that are cleared through either a central counterparty or an exchange. The fair value of these derivatives is presented on the balance sheet net of the corresponding cash margin under Cash collateral receivables on derivative instruments and Cash collateral payables on derivative instruments and was not material for all periods presented.    3 Changes in the fair value of purchased and sold non-derivative financial instruments between trade date and settlement date are recognized as derivative financial instruments.    4 Financial assets and liabilities are presented net on the balance sheet if UBS has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously.    5 Reflects the netting potential in accordance with enforceable master netting and similar arrangements where not all criteria for a net presentation on the balance sheet have been met. Refer to “Note 22 Offsetting financial assets and financial liabilities” in the “Consolidated financial statements” section of the Annual Report 2020 for more information.

 

83 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note Derivative instruments (continued)

b) Cash collateral on derivative instruments

USD billion

 

Receivables

30.9.21

Payables

30.9.21

 

Receivables

30.6.21

Payables

30.6.21

 

Receivables

31.12.20

Payables

31.12.20

Cash collateral on derivative instruments, based on IFRS netting1

 

 31.7 

 33.1 

 

 29.8 

 32.2 

 

 32.7 

 37.3 

Further netting potential not recognized on the balance sheet2

 

 (19.4) 

 (16.9) 

 

 (18.3) 

 (16.9) 

 

 (21.1) 

 (21.6) 

of which: netting of recognized financial liabilities / assets

 

 (15.5) 

 (13.0) 

 

 (15.9) 

 (14.4) 

 

 (19.6) 

 (19.6) 

of which: netting with collateral received / pledged

 

 (3.9) 

 (3.9) 

 

 (2.4) 

 (2.5) 

 

 (1.5) 

 (2.1) 

Cash collateral on derivative instruments, after consideration of further netting potential

 

 12.2 

 16.2 

 

 11.5 

 15.3 

 

 11.6 

 15.7 

1 Financial assets and liabilities are presented net on the balance sheet if UBS has the unconditional and legally enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of UBS or its counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously.    2 Reflects the netting potential in accordance with enforceable master netting and similar arrangements where not all criteria for a net presentation on the balance sheet have been met. Refer to “Note 22 Offsetting financial assets and financial liabilities” in the “Consolidated financial statements” section of the Annual Report 2020 for more information.

 

  

 

Note 10  Other assets and liabilities

a) Other financial assets measured at amortized cost

USD million

30.9.21

30.6.21

31.12.20

Debt securities

 18,267 

 18,484 

 18,801 

of which: government bills / bonds

 9,502 

 9,531 

 9,789 

Loans to financial advisors

 2,499 

 2,415 

 2,569 

Fee- and commission-related receivables

 2,127 

 1,982 

 2,014 

Finance lease receivables

 1,342 

 1,363 

 1,447 

Settlement and clearing accounts

 687 

 1,228 

 614 

Accrued interest income

 518 

 532 

 591 

Other

 1,642 

 1,139 

 1,158 

Total other financial assets measured at amortized cost

 27,082 

 27,143 

 27,194 

 

b) Other non-financial assets

USD million

30.9.21

30.6.21

31.12.20

Precious metals and other physical commodities

 5,027 

 5,470 

 6,264 

Bail deposit1

 1,352 

 1,382 

 1,418 

Prepaid expenses

 1,051 

 1,083 

 1,081 

VAT and other tax receivables

 467 

 435 

 433 

Properties and other non-current assets held for sale

 66 

 68 

 246 

Other

 526 

 545 

 326 

Total other non-financial assets

 8,489 

 8,982 

 9,768 

1 Refer to item 1 in Note 14b for more information.

 

c) Other financial liabilities measured at amortized cost

USD million

30.9.21

30.6.21

31.12.20

Other accrued expenses

 1,768 

 1,758 

 1,696 

Accrued interest expenses

 839 

 1,015 

 1,355 

Settlement and clearing accounts

 1,561 

 2,176 

 1,199 

Lease liabilities

 3,629 

 3,754 

 3,927 

Other

 1,773 

 1,487 

 1,553 

Total other financial liabilities measured at amortized cost

 9,569 

 10,189 

 9,729 

 

84 


 

Note 10  Other assets and liabilities (continued)

d) Other financial liabilities designated at fair value

USD million

30.9.21

30.6.21

31.12.20

Financial liabilities related to unit-linked investment contracts

 21,078 

 22,217 

 20,975 

Securities financing transactions

 7,156 

 6,184 

 7,317 

Over-the-counter debt instruments

 1,911 

 2,142 

 2,060 

Other

 103 

 99 

 35 

Total other financial liabilities designated at fair value

 30,248 

 30,642 

 30,387 

of which: life-to-date own credit (gain) / loss

 (25) 

 (39) 

 (36) 

 

e) Other non-financial liabilities

USD million

30.9.21

30.6.21

31.12.20

Compensation-related liabilities

 6,788 

 5,959 

 7,468 

  of which: Deferred Contingent Capital Plan

 1,570 

 1,500 

 1,858 

  of which: financial advisor compensation plans

 1,423 

 1,314 

 1,500 

  of which: other compensation plans

 2,489 

 1,830 

 2,740 

  of which: net defined benefit liability

 651 

 666 

 722 

  of which: other compensation-related liabilities1

 655 

 650 

 648 

Deferred tax liabilities

 316 

 392 

 564 

Current tax liabilities

 1,273 

 1,250 

 1,009 

VAT and other tax payables

 575 

 597 

 523 

Deferred income

 307 

 262 

 228 

Other

 100 

 116 

 61 

Total other non-financial liabilities

 9,359 

 8,576 

 9,854 

1 Includes liabilities for payroll taxes and untaken vacation.

 

 

  

 

Note 11  Debt issued designated at fair value

USD million

30.9.21

30.6.21

31.12.20

Issued debt instruments

 

 

 

Equity-linked1

 47,170 

 49,157 

 41,069 

Rates-linked

 15,213 

 16,397 

 11,038 

Credit-linked

 1,716 

 1,826 

 1,933 

Fixed-rate

 2,884 

 2,883 

 3,604 

Commodity-linked

 2,029 

 1,961 

 1,497 

Other

 2,886 

 2,841 

 2,101 

of which: debt that contributes to total loss-absorbing capacity

 2,083 

 2,112 

 1,190 

Total debt issued designated at fair value

 71,898 

 75,065 

 61,243 

of which: life-to-date own credit (gain) / loss

 396 

 317 

 418 

1 Includes investment fund unit-linked instruments issued.   

  

85 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

Note 12  Debt issued measured at amortized cost

USD million

30.9.21

30.6.21

31.12.20

Certificates of deposit

 13,548 

 12,193 

 15,680 

Commercial paper

 21,769 

 25,304 

 25,472 

Other short-term debt

 3,170 

 5,219 

 5,515 

Short-term debt1

 38,487 

 42,716 

 46,666 

Senior unsecured debt that contributes to total loss-absorbing capacity (TLAC)

 37,159 

 37,765 

 36,611 

Senior unsecured debt other than TLAC

 28,684 

 28,945 

 21,340 

Covered bonds

 1,413 

 1,449 

 2,796 

Subordinated debt

 18,838 

 20,072 

 22,157 

of which: high-trigger loss-absorbing additional tier 1 capital instruments

 11,149 

 12,330 

 11,837 

of which: low-trigger loss-absorbing additional tier 1 capital instruments

 2,473 

 2,509 

 2,577 

of which: low-trigger loss-absorbing tier 2 capital instruments

2,638

 4,686 

 7,201 

of which: non-Basel III-compliant tier 2 capital instruments

 548 

 547 

 543 

Debt issued through the Swiss central mortgage institutions

 9,081 

 8,963 

 9,660 

Other long-term debt

 0 

 0 

 3 

Long-term debt2

 95,175 

 97,195 

 92,566 

Total debt issued measured at amortized cost3

 133,662 

 139,911 

 139,232 

1 Debt with an original contractual maturity of less than one year.    2 Debt with an original contractual maturity greater than or equal to one year. The classification of debt issued into short-term and long-term does not consider any early redemption features.    3 Net of bifurcated embedded derivatives, the fair value of which was not material for the periods presented.

86 


Note 13   Interest rate benchmark reform

Background

A market-wide reform of major interest rate benchmarks is being undertaken globally, with the Financial Conduct Authority (the FCA) announcing in March 2021 that the publication of London Interbank Offered Rates (LIBORs) will cease for all non-US dollar LIBORs, as well as for one-week and two-month USD LIBOR, after 31 December 2021. Publication of the remaining USD LIBOR tenors will cease immediately after 30 June 2023.

The majority of UBS’s Interbank Offered Rate (IBOR) exposure is to CHF LIBOR and USD LIBOR. The alternative reference rate (the ARR) for CHF LIBOR is the Swiss Average Rate Overnight (SARON). The ARR for USD LIBOR is the Secured Overnight Financing Rate (SOFR); in addition, there are recommended ARRs for GBP LIBOR, JPY LIBOR and EUR LIBOR.

The Euro Interbank Offered Rate (Euribor) was reformed in 2019, with the reform consisting of a change in the underlying calculation method.

The transition to ARRs includes a number of active steps that will also benefit from the support of associated regulatory activities. There will be some contracts, known as “tough legacy contracts,” that cannot be practically transitioned or amended from IBORs to ARRs. UBS is currently assessing post-cessation remediation options, including the adoption of legislative solutions. The UK Financial Services Act 2021 was enacted in April 2021 to amend the UK Benchmarks Regulation, providing the FCA with the authority to publish “synthetic” LIBORs for GBP and JPY after the cessation dates. These synthetic LIBORs will not be available for use in new contracts given that they are non-representative and are instead intended to help reduce disruption where another resolution has not been agreed for certain tough legacy contracts. The FCA continues to consult market participants about the use of synthetic GBP and JPY LIBORs for legacy contracts and prohibiting certain USD LIBOR tenors for new contracts from 1 January 2022 onward. Similarly, the EU Benchmarks Regulation was amended in February 2021 to enable the European Commission to designate a statutory replacement rate for tough legacy LIBOR contracts that are governed by the laws of EU Member States and remain outstanding after LIBOR cessation. On 6 April 2021, the New York State LIBOR legislation was enacted with the intention of minimizing legal uncertainty and adverse economic effects associated with USD LIBOR transition for tough legacy contracts governed by New York law. For USD LIBOR contracts governed by the laws of other US states that have not passed similar legislation, a bill at the federal level, which is intended to eliminate the need to enact LIBOR legislation on a state-by-state basis, has been introduced in Congress.

On 25 January 2021, the IBOR Fallbacks Supplement and IBOR Fallbacks Protocol, which amend the International Swaps and Derivatives Association (ISDA) standard definitions for interest rate derivatives to incorporate fallbacks for derivatives linked to certain IBORs, came into effect. From that date, all newly cleared and non-cleared derivatives between adhering parties that reference ISDA standard definitions now include these fallbacks. UBS adhered to the protocol in November 2020.


UBS is focused on transitioning existing contracts via bi-lateral and multi-lateral agreements, by leveraging industry solutions (e.g., the use of fallback provisions) and through third-party actions (those by clearing houses, agents, etc.). UBS has established a framework to address the transition of contracts that do not contain adequate fallback provisions. Furthermore, in line with regulatory guidance, UBS has implemented a framework to limit entry into new contracts referencing IBORs.

Governance over the transition to alternative benchmark rates

UBS has established a global cross-divisional, cross-functional governance structure and change program to address the scale and complexity of the transition. This global program is sponsored by the Group CFO and led by senior representatives from the business divisions and UBS’s control and support functions. The program includes governance and execution structures within each business division, together with cross-divisional teams from each control and support function. Progress is overseen centrally via a monthly operating committee and a monthly steering committee, as well as quarterly updates to the joint Audit and Risk Committees.

Risks

A core part of UBS’s change program is the identification, management and monitoring of the risks associated with IBOR reform and transition. These risks include, but are not limited to, the following:

      economic risks to UBS and its clients, through the repricing of existing contracts, reduced transparency and / or liquidity of pricing information, market uncertainty or disruption;

      accounting risks, where the transition affects the accounting treatment, including hedge accounting and consequential income statement volatility;

      valuation risks arising from the variation between benchmarks that will cease and ARRs, affecting the risk profile of financial instruments;

      operational risks arising from changes to UBS’s front-to-back processes and systems to accommodate the transition, e.g., data sourcing and processing and bulk migration of contracts; and

      legal and conduct risks relating to UBS’s engagement with clients and market counterparties around new benchmark products and amendments required for existing contracts referencing benchmarks that will cease.

 

Overall, the effort required to transition is affected by multiple factors, including whether negotiations need to take place with multiple stakeholders (as is the case for syndicated loans or certain listed securities), market readiness – such as liquidity in ARR-equivalent products – and a client’s technical readiness to handle ARR market conventions. UBS remains confident that it has the transparency, oversight and operational preparedness to progress with the IBOR transition consistent with market timelines. UBS does not expect changes to its risk management approach and strategy as a result of interest rate benchmark reform.

 

87 


 

Note 13   Interest rate benchmark reform (continued)

Progress with regard to the transition

Non-derivative instruments

UBS’s significant non-derivative IBOR exposures primarily relate to brokerage receivable and payable balances, corporate and private loans, and mortgages, linked to CHF and USD LIBORs. During 2020, UBS transitioned most of its CHF LIBOR-linked deposits to SARON. Furthermore, in 2020 UBS launched SARON-based mortgages and corporate loans based on all major ARRs in the Swiss market, as well as SOFR-based mortgages in the US market. UBS has successfully transitioned its GBP LIBOR- and EUR LIBOR-based private and commercial real estate mortgages in the UK and Monaco to the Sterling Overnight Index Average (SONIA) and Euribor, respectively.

In March 2021, following the FCA announcement regarding the cessation timelines for IBORs, UBS initiated a centralized communication initiative for private mortgages linked to CHF LIBOR, with the objective of transitioning these exposures, either through the activation of existing fallbacks or the amendment of contractual terms where such fallbacks do not exist. During the third quarter of 2021, mortgages that were linked to CHF LIBOR were reduced by approximately USD 2 billion, resulting in a year-to-date transition volume of USD 8 billion. The remaining CHF LIBOR mortgages will automatically transition from January 2022 on their next coupon roll date. US mortgages linked to USD LIBOR are planned to transition to SOFR in 2022–2023. US securities-based lending increased by approximately USD 2 billion in the third quarter of 2021, with transition to SOFR expected from the first quarter of 2022.

UBS is also proactively discussing transition mechanisms with many of its brokerage and corporate clients in order to transition their exposures during 2021 from LIBOR. During the third quarter of 2021, the gross carrying amount of IBOR-indexed non-derivative financial assets and liabilities related to brokerage accounts was reduced by approximately USD 15 billion in aggregate as a result of completed transitions, predominantly for USD and EUR LIBORs. The year-to-date transition volume was approximately USD 30 billion in aggregate, with transition now complete for most brokerage clients.

For certain non-derivative financial assets and financial liabilities, in particular bonds issued by third parties, UBS is dependent on the participation of issuers and the final form of legislative solutions, which, as noted earlier, are still in progress. UBS is monitoring legislative developments and applicable fallback language for these exposures, and is in discussions with relevant parties.

As of 30 September 2021, UBS had approximately USD 2.9 billion equivalent of Japanese yen- and US dollar-denominated publicly issued benchmark bonds that, per current contractual terms, if not called on their respective call dates, would reset based directly on JPY LIBOR and USD LIBOR. These bonds have robust IBOR fallback language and UBS is on track to complete the transition of these instruments to respective ARRs within the required timelines. Similarly, certain benchmark bonds publicly issued by UBS reference rates indirectly derived from IBORs, if they are not called on their respective call dates. UBS is in the process of implementing related changes to the fixed-rate reset terms and aims to transition those bonds on time. These debt instruments have not been included in the table on the following page given their current fixed-rate coupon.

UBS had approximately USD 12 billion of irrevocable commitments as of 30 September 2021 (30 June 2021: USD 16 billion) that can be drawn down in different currencies with IBOR-based interest rates, primarily USD LIBOR and Euribor,1 and that expire after the relevant benchmark cessation dates. Related drawn-down amounts under these commitments were USD 3 billion (30 June 2021: USD 4 billion). The increase in USD LIBOR irrevocable commitments was attributable to US securities-based lending, which is expected to transition to SOFR from the first quarter of 2022. In addition, UBS had approximately USD 3 billion (30 June 2021: USD 10 billion) of committed revocable credit lines outstanding that allow clients to draw down a number of IBOR-linked products. UBS is in discussions with impacted clients, with plans in place to have contracts amended by the relevant cessation dates.

Derivative instruments

UBS holds derivatives for trading and hedging purposes, including those designated in hedge accounting relationships. A significant number of interest rate and cross-currency swaps have floating legs that reference various benchmarks that will cease.

The majority of derivatives are transacted with clearing houses where UBS is dependent upon industry-wide compression activities to reduce exposure and clearing house actions to convert any remaining derivatives nearer the cessation dates. London Clearing House (LCH), which is the clearing house for a significant number of UBS’s interest rate swaps, has confirmed that a standardized transition will be undertaken in December 2021 to transition non-USD IBOR-based derivatives to the respective ARRs. UBS has successfully participated in the preparatory activities for these significant industry-wide events and is confident that it can manage the operational processes that will take place on transition dates. The increase in the number of GBP and USD LIBOR-linked derivatives during the third quarter of 2021 was associated with normal client activity.

For derivatives not transacted with clearing houses, as previously noted, in November 2020 UBS adhered to the ISDA IBOR Fallbacks Protocol, which builds in agreed fallbacks. A significant proportion of UBS’s counterparties have adhered to the protocol. While no significant active switching has been observed, UBS will continue its efforts to switch to ARRs before the relevant cessation dates or bi-laterally compress where feasible.

In order to minimize the operational risk of converting high volumes of transactions at the time of cessation, UBS will begin to bulk convert LIBOR-linked contracts to ARRs after the last rate fixing takes place, which will begin in the fourth quarter of 2021.

 

1 Under these facilities, amounts drawn in a particular currency including Euribor can be repaid and drawn down again in the same or a different currency.

88 


 

Note 13   Interest rate benchmark reform (continued)

Financial instruments yet to transition to alternative benchmarks

The amounts included in the table below relate to financial instrument contracts across UBS’s business divisions where UBS has material exposures subject to IBOR reform that have not yet transitioned to ARRs, and that:

      contractually reference an interest rate benchmark that will transition to an alternative benchmark; and

      have a contractual maturity date (including open-ended contracts) after the agreed cessation dates.

 

Contracts where penalty terms reference IBORs, or where exposure to an IBOR is not the primary purpose of the contract, have not been included, as these contracts do not have a material impact on the transition process.


In line with information provided to management and external parties monitoring UBS’s transition progress, the table below includes the following financial metrics for instruments that are external to the Group, subject to interest rate benchmark reform:

      gross carrying value / exposure for non-derivative financial instruments; and

      total trade count for derivative financial instruments.

 

The exposures included in the table below represent the maximum IBOR exposure, without regard for early termination rights, with the actual exposure being dependent upon client preferences and investment decisions.

 

 

 

 

 

30.9.21

 

 

 

LIBOR benchmark rates

 

Measure

 

CHF

USD

GBP

EUR1

JPY

Multi-currency

Carrying value of non-derivative financial instruments

 

 

 

 

 

 

 

 

Total non-derivative financial assets

USD million

 

 24,9692

 71,3603,4

 1,7744

 2,6934

 2,1284

 3,0395

Total non-derivative financial liabilities

USD million

 

 468 

 6,6494

 4494

 1,3654

 3614

 0 

 

 

 

 

 

 

 

 

 

Trade count of derivative financial instruments

 

 

 

 

 

 

 

 

Total derivative financial instruments

Trade count

 

 6,637 

 45,3866

 13,1406

 6,234 

 3,623 

 2,4367

 

 

 

 

 

 

 

 

 

Off-balance sheet exposures

 

 

 

 

 

 

 

 

Total irrevocable loan commitments

USD million

 

 0 

 5,4478

 0 

 0 

 0 

 12,4099

 

 

 

 

 

 

 

 

 

 

 

 

30.6.21

 

 

 

LIBOR benchmark rates

 

Measure

 

CHF

USD

GBP

EUR1

JPY

Multi-currency

Carrying value of non-derivative financial instruments

 

 

 

 

 

 

 

 

Total non-derivative financial assets

USD million

 

 31,423 

 77,502 

 1,829 

 6,587 

 3,070 

 3,7965

Total non-derivative financial liabilities

USD million

 

 2,029 

 9,834 

 566 

 1,919 

 1,060 

 0 

 

 

 

 

 

 

 

 

 

Trade count of derivative financial instruments

 

 

 

 

 

 

 

 

Total derivative financial instruments

Trade count

 

 9,519 

 42,566 

 12,513 

 9,626 

 4,247 

 5,9487

 

 

 

 

 

 

 

 

 

Off-balance sheet exposures

 

 

 

 

 

 

 

 

Total irrevocable loan commitments

USD million

 

 1 

 4,433 

 0 

 0 

 0 

 15,7679

1 Includes primarily EUR LIBOR positions.    2 Primarily relates to CHF LIBOR mortgages, which were reduced by approximately USD 2 billion during the third quarter of 2021.    3 Primarily relates to US LIBOR securities-based lending, which increased by approximately USD 2 billion in the third quarter of 2021, with a smaller amount related to brokerage accounts.    4 Includes brokerage accounts, which were reduced by approximately USD 15 billion in aggregate during the third quarter of 2021, as a result of completed transitions, predominantly for USD and EUR LIBORs.    5 Includes loans related to revolving multi-currency credit lines.    6 Increase in GBP and USD LIBOR-linked derivatives during the third quarter of 2021 was associated with normal client activity.    7 Includes cross-currency swaps where either leg or both legs are indexed to an IBOR.    8 Includes an approximately USD 1 billion increase in USD LIBOR securities-based lending commitments.    9 Includes loan commitments that can be drawn in different currencies at the client‘s discretion.

 

  

89 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

Note 14  Provisions and contingent liabilities

a) Provisions

The table below presents an overview of total provisions.

USD million

 

30.9.21

30.6.21

31.12.20

Provisions other than provisions for expected credit losses

 

 2,607 

 2,646 

 2,571 

Provisions for expected credit losses1

 

 203 

 209 

 257 

Total provisions

 

 2,810 

 2,855 

 2,828 

1 Refer to Note 7c for more information.   

 

 

The following table presents additional information for provisions other than provisions for expected credit losses.

USD million

Litigation, regulatory and similar matters1

Restructuring2

Other3

Total

Balance as of 31 December 2020

 2,135 

 72 

 363 

 2,571 

Balance as of 30 June 2021

 2,119 

 179 

 348 

 2,646 

Increase in provisions recognized in the income statement

 25 

 72 

 15 

 111 

Release of provisions recognized in the income statement

 (13) 

 (10) 

 (6) 

 (29) 

Provisions used in conformity with designated purpose

 (27) 

 (67) 

 (14) 

 (108) 

Capitalized reinstatement costs

 0 

 0 

 13 

 13 

Foreign currency translation / unwind of discount

 (20) 

 (2) 

 (4) 

 (26) 

Balance as of 30 September 2021

 2,084 

 170 

 352 

 2,607 

1 Comprises provisions for losses resulting from legal, liability and compliance risks.    2 Includes personnel-related restructuring provisions of USD 122 million as of 30 September 2021 (30 June 2021: USD 135 million; 31 December 2020: USD 18 million) and provisions for onerous contracts of USD 48 million as of 30 September 2021 (30 June 2021: USD 40 million; 31 December 2020: USD 49 million).    3 Mainly includes provisions related to real estate, employee benefits and operational risks.

 

 

Restructuring provisions primarily relate to personnel-related provisions and onerous contracts. Personnel-related restructuring provisions are used within a short period of time but potential changes in amount may be triggered when natural staff attrition reduces the number of people affected by a restructuring event and therefore the estimated costs. Onerous contracts for property are recognized when UBS is committed to pay for non‑lease components, such as utilities, service charges, taxes and maintenance, when a property is vacated or not fully recovered from sub-tenants.

Information about provisions and contingent liabilities in respect of litigation, regulatory and similar matters, as a class, is included in Note 14b. There are no material contingent liabilities associated with the other classes of provisions.

b) Litigation, regulatory and similar matters

The Group operates in a legal and regulatory environment that exposes it to significant litigation and similar risks arising from disputes and regulatory proceedings. As a result, UBS (which for purposes of this Note may refer to UBS Group AG and/or one or more of its subsidiaries, as applicable) is involved in various disputes and legal proceedings, including litigation, arbitration, and regulatory and criminal investigations.

Such matters are subject to many uncertainties, and the outcome and the timing of resolution are often difficult to predict, particularly in the earlier stages of a case. There are also situations where the Group may enter into a settlement agreement. This may occur in order to avoid the expense, management distraction or reputational implications of continuing to contest liability, even for those matters for which the Group believes it should be exonerated. The uncertainties inherent in all such matters affect the amount and timing of any potential outflows for both matters with respect to which provisions have been established and other contingent liabilities. The Group makes provisions for such matters brought against it when, in the opinion of management after seeking legal advice, it is more likely than not that the Group has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required, and the amount can be reliably estimated. Where these factors are otherwise satisfied, a provision may be established for claims that have not yet been asserted against the Group, but are nevertheless expected to be, based on the Group’s experience with similar asserted claims. If any of those conditions is not met, such matters result in contingent liabilities. If the amount of an obligation cannot be reliably estimated, a liability exists that is not recognized even if an outflow of resources is probable. Accordingly, no provision is established even if the potential outflow of resources with respect to such matters could be significant. Developments relating to a matter that occur after the relevant reporting period, but prior to the issuance of financial statements, which affect management’s assessment of the provision for such matter (because, for example, the developments provide evidence of conditions that existed at the end of the reporting period), are adjusting events after the reporting period under IAS 10 and must be recognized in the financial statements for the reporting period.

 

90 


 

 

Note 14  Provisions and contingent liabilities (continued)

Specific litigation, regulatory and other matters are described below, including all such matters that management considers to be material and others that management believes to be of significance due to potential financial, reputational and other effects. The amount of damages claimed, the size of a transaction or other information is provided where available and appropriate in order to assist users in considering the magnitude of potential exposures.

In the case of certain matters below, we state that we have established a provision, and for the other matters, we make no such statement. When we make this statement and we expect disclosure of the amount of a provision to prejudice seriously our position with other parties in the matter because it would reveal what UBS believes to be the probable and reliably estimable outflow, we do not disclose that amount. In some cases we are subject to confidentiality obligations that preclude such disclosure. With respect to the matters for which we do not state whether we have established a provision, either: (a) we have not established a provision, in which case the matter is treated as a contingent liability under the applicable accounting standard; or (b) we have established a provision but expect disclosure of that fact to prejudice seriously our position with other parties in the matter because it would reveal the fact that UBS believes an outflow of resources to be probable and reliably estimable.

With respect to certain litigation, regulatory and similar matters for which we have established provisions, we are able to estimate the expected timing of outflows. However, the aggregate amount of the expected outflows for those matters for which we are able to estimate expected timing is immaterial relative to our current and expected levels of liquidity over the relevant time periods.

The aggregate amount provisioned for litigation, regulatory and similar matters as a class is disclosed in the “Provisions” table in Note 14a above. It is not practicable to provide an aggregate estimate of liability for our litigation, regulatory and similar matters as a class of contingent liabilities. Doing so would require UBS to provide speculative legal assessments as to claims and proceedings that involve unique fact patterns or novel legal theories, that have not yet been initiated or are at early stages of adjudication, or as to which alleged damages have not been quantified by the claimants. Although UBS therefore cannot provide a numerical estimate of the future losses that could arise from litigation, regulatory and similar matters, UBS believes that the aggregate amount of possible future losses from this class that are more than remote substantially exceeds the level of current provisions.

Litigation, regulatory and similar matters may also result in non-monetary penalties and consequences. For example, the non-prosecution agreement UBS entered into with the US Department of Justice (DOJ), Criminal Division, Fraud Section in connection with submissions of benchmark interest rates, including, among others, the British Bankers’ Association London Interbank Offered Rate (LIBOR), was terminated by the DOJ based on its determination that UBS had committed a US crime in relation to foreign exchange matters. As a consequence, UBS AG pleaded guilty to one count of wire fraud for conduct in the LIBOR matter, paid a fine and was subject to probation, which ended in January 2020.

A guilty plea to, or conviction of, a crime could have material consequences for UBS. Resolution of regulatory proceedings may require UBS to obtain waivers of regulatory disqualifications to maintain certain operations, may entitle regulatory authorities to limit, suspend or terminate licenses and regulatory authorizations, and may permit financial market utilities to limit, suspend or terminate UBS’s participation in such utilities. Failure to obtain such waivers, or any limitation, suspension or termination of licenses, authorizations or participations, could have material consequences for UBS.

The risk of loss associated with litigation, regulatory and similar matters is a component of operational risk for purposes of determining capital requirements. Information concerning our capital requirements and the calculation of operational risk for this purpose is included in the “Capital management” section of this report.

 

Provisions for litigation, regulatory and similar matters by business division and in Group Functions1

USD million

Global Wealth

Manage-

ment

Personal & Corporate Banking

Asset

Manage-

ment

Investment Bank

Group Functions

Total

Balance as of 31 December 2020

 861 

 115 

 0 

 227 

 932 

 2,135 

Balance as of 30 June 2021

 800 

 100 

 1 

 282 

 936 

 2,119 

Increase in provisions recognized in the income statement

 13 

 0 

 8 

 2 

 2 

 25 

Release of provisions recognized in the income statement

 (12) 

 0 

 0 

 (1) 

 0 

 (13) 

Provisions used in conformity with designated purpose

 (23) 

 0 

 (1) 

 (4) 

 0 

 (27) 

Foreign currency translation / unwind of discount

 (14) 

 (2) 

 0 

 (4) 

 0 

 (20) 

Balance as of 30 September 2021

 765 

 98 

 8 

 275 

 938 

 2,084 

1 Provisions, if any, for matters described in this Note are recorded in Global Wealth Management (item 3 and item 4) and Group Functions (item 2). Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and Personal & Corporate Banking, and provisions, if any, for the matters described in this Note in item 5 are allocated between the Investment Bank and Group Functions.

 

91 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note 14  Provisions and contingent liabilities (continued)

1. Inquiries regarding cross-border wealth management businesses

Tax and regulatory authorities in a number of countries have made inquiries, served requests for information or examined employees located in their respective jurisdictions relating to the cross-border wealth management services provided by UBS and other financial institutions. It is possible that the implementation of automatic tax information exchange and other measures relating to cross-border provision of financial services could give rise to further inquiries in the future. UBS has received disclosure orders from the Swiss Federal Tax Administration (FTA) to transfer information based on requests for international administrative assistance in tax matters. The requests concern a number of UBS account numbers pertaining to current and former clients and are based on data from 2006 and 2008. UBS has taken steps to inform affected clients about the administrative assistance proceedings and their procedural rights, including the right to appeal. The requests are based on data received from the German authorities, who seized certain data related to UBS clients booked in Switzerland during their investigations and have apparently shared this data with other European countries. UBS expects additional countries to file similar requests.

Since 2013, UBS (France) S.A., UBS AG and certain former employees have been under investigation in France for alleged complicity in unlawful solicitation of clients on French territory, regarding the laundering of proceeds of tax fraud, and banking and financial solicitation by unauthorized persons. In connection with this investigation, the investigating judges ordered UBS AG to provide bail (“caution”) of EUR 1.1 billion and UBS (France) S.A. to post bail of EUR 40 million, which was reduced on appeal to EUR 10 million.

A trial in the court of first instance took place from 8 October 2018 until 15 November 2018. On 20 February 2019, the court announced a verdict finding UBS AG guilty of unlawful solicitation of clients on French territory and aggravated laundering of the proceeds of tax fraud, and UBS (France) S.A. guilty of aiding and abetting unlawful solicitation and laundering the proceeds of tax fraud. The court imposed fines aggregating EUR 3.7 billion on UBS AG and UBS (France) S.A. and awarded EUR 800 million of civil damages to the French state. UBS has appealed the decision. Under French law, the judgment is suspended while the appeal is pending. The trial in the Court of Appeal took place between 8-24 March 2021. At the conclusion of the trial, the prosecutor asserted that the maximum penalty was EUR 2.2 billion and requested the court to award a penalty of at least EUR 2 billion. The French state asked for civil damages of EUR 1 billion. The deliberations of the Court of Appeal on the merits of the case have been extended and the decision is currently set to be rendered on 13 December 2021. A subsequent appeal to the Cour de Cassation, France’s highest court, is possible with respect to questions of law.

UBS believes that based on both the law and the facts the judgment of the court of first instance should be reversed. UBS believes it followed its obligations under Swiss and French law as well as the European Savings Tax Directive. Even assuming liability, which it contests, UBS believes the penalties and damage amounts awarded greatly exceed the amounts that could be supported by the law and the facts. In particular, UBS believes the court incorrectly based the penalty on the total regularized assets rather than on any unpaid taxes on those assets for which a fraud has been characterized and further incorrectly awarded damages based on costs that were not proven by the civil party. Notwithstanding that UBS believes it should be acquitted, our balance sheet at 30 September 2021 reflected provisions with respect to this matter in an amount of EUR 450 million (USD 521 million at 30 September 2021). The wide range of possible outcomes in this case contributes to a high degree of estimation uncertainty. The provision reflected on our balance sheet at 30 September 2021 reflects our best estimate of possible financial implications, although it is reasonably possible that actual penalties and civil damages could exceed the provision amount.

In 2016, UBS was notified by the Belgian investigating judge that it is under formal investigation (“inculpé”) regarding the laundering of proceeds of tax fraud, of banking and financial solicitation by unauthorized persons, and of serious tax fraud.

Our balance sheet at 30 September 2021 reflected provisions with respect to matters described in this item 1 in an amount that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

 

92 


 

Note 14  Provisions and contingent liabilities (continued)

2. Claims related to sales of residential mortgage-backed securities and mortgages

From 2002 through 2007, prior to the crisis in the US residential loan market, UBS was a substantial issuer and underwriter of US residential mortgage-backed securities (RMBS) and was a purchaser and seller of US residential mortgages.

In November 2018, the DOJ filed a civil complaint in the District Court for the Eastern District of New York. The complaint seeks unspecified civil monetary penalties under the Financial Institutions Reform, Recovery and Enforcement Act of 1989 related to UBS’s issuance, underwriting and sale of 40 RMBS transactions in 2006 and 2007. UBS moved to dismiss the civil complaint on 6 February 2019. On 10 December 2019, the district court denied UBS’s motion to dismiss.

Our balance sheet at 30 September 2021 reflected a provision with respect to matters described in this item 2 in an amount that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of this matter cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

3. Madoff

In relation to the Bernard L. Madoff Investment Securities LLC (BMIS) investment fraud, UBS AG, UBS (Luxembourg) S.A. (now UBS Europe SE, Luxembourg branch) and certain other UBS subsidiaries have been subject to inquiries by a number of regulators, including the Swiss Financial Market Supervisory Authority (FINMA) and the Luxembourg Commission de Surveillance du Secteur Financier. Those inquiries concerned two third-party funds established under Luxembourg law, substantially all assets of which were with BMIS, as well as certain funds established in offshore jurisdictions with either direct or indirect exposure to BMIS. These funds faced severe losses, and the Luxembourg funds are in liquidation. The documentation establishing both funds identifies UBS entities in various roles, including custodian, administrator, manager, distributor and promoter, and indicates that UBS employees serve as board members.

In 2009 and 2010, the liquidators of the two Luxembourg funds filed claims against UBS entities, non-UBS entities and certain individuals, including current and former UBS employees, seeking amounts totaling approximately EUR 2.1 billion, which includes amounts that the funds may be held liable to pay the trustee for the liquidation of BMIS (BMIS Trustee).

A large number of alleged beneficiaries have filed claims against UBS entities (and non-UBS entities) for purported losses relating to the Madoff fraud. The majority of these cases have been filed in Luxembourg, where decisions that the claims in eight test cases were inadmissible have been affirmed by the Luxembourg Court of Appeal, and the Luxembourg Supreme Court has dismissed a further appeal in one of the test cases.


In the US, the BMIS Trustee filed claims against UBS entities, among others, in relation to the two Luxembourg funds and one of the offshore funds. The total amount claimed against all defendants in these actions was not less than USD 2 billion. In 2014, the US Supreme Court rejected the BMIS Trustee’s motion for leave to appeal decisions dismissing all claims except those for the recovery of approximately USD 125 million of payments alleged to be fraudulent conveyances and preference payments. In 2016, the bankruptcy court dismissed these claims against the UBS entities. In February 2019, the Court of Appeals reversed the dismissal of the BMIS Trustee’s remaining claims, and the US Supreme Court subsequently denied a petition seeking review of the Court of Appeals’ decision. The case has been remanded to the Bankruptcy Court for further proceedings.

4. Puerto Rico

Declines since 2013 in the market prices of Puerto Rico municipal bonds and of closed-end funds (funds) that are sole-managed and co-managed by UBS Trust Company of Puerto Rico and distributed by UBS Financial Services Incorporated of Puerto Rico (UBS PR) led to multiple regulatory inquiries, which in 2014 and 2015, led to settlements with the Office of the Commissioner of Financial Institutions for the Commonwealth of Puerto Rico, the US Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority.

Since then, UBS clients in Puerto Rico who own the funds or Puerto Rico municipal bonds and/or who used their UBS account assets as collateral for UBS non-purpose loans filed customer complaints and arbitration demands seeking aggregate damages of USD 3.4 billion, of which USD 3.0 billion have been resolved through settlements, arbitration or withdrawal of claims. Allegations include fraud, misrepresentation and unsuitability of the funds and of the loans.

A shareholder derivative action was filed in 2014 against various UBS entities and current and certain former directors of the funds, alleging hundreds of millions of US dollars in losses in the funds. In 2015, defendants’ motion to dismiss was denied.

In 2011, a purported derivative action was filed on behalf of the Employee Retirement System of the Commonwealth of Puerto Rico (System) against over 40 defendants, including UBS PR, which was named in connection with its underwriting and consulting services. Plaintiffs alleged that defendants violated their purported fiduciary duties and contractual obligations in connection with the issuance and underwriting of USD 3 billion of bonds by the System in 2008 and sought damages of over USD 800 million. In 2016, the court granted the System’s request to join the action as a plaintiff. In 2017, the court denied defendants’ motion to dismiss the complaint. In 2020, the court denied plaintiffs’ motion for summary judgment.

 

 

93 


 

Note 14  Provisions and contingent liabilities (continued)

Beginning in 2015, certain agencies and public corporations of the Commonwealth of Puerto Rico (Commonwealth) defaulted on certain interest payments on Puerto Rico bonds. In 2016, US federal legislation created an oversight board with power to oversee Puerto Rico’s finances and to restructure its debt. The oversight board has imposed a stay on the exercise of certain creditors’ rights. In 2017, the oversight board placed certain of the bonds into a bankruptcy-like proceeding under the supervision of a Federal District Judge.

In May 2019, the oversight board filed complaints in Puerto Rico federal district court bringing claims against financial, legal and accounting firms that had participated in Puerto Rico municipal bond offerings, including UBS, seeking a return of underwriting and swap fees paid in connection with those offerings. UBS estimates that it received approximately USD 125 million in fees in the relevant offerings.

In August 2019, and February and November 2020, four US insurance companies that insured issues of Puerto Rico municipal bonds sued UBS and several other underwriters of Puerto Rico municipal bonds in three separate cases. The actions collectively seek recovery of an aggregate of USD 955 million in damages from the defendants. The plaintiffs in these cases claim that defendants failed to reasonably investigate financial statements in the offering materials for the insured Puerto Rico bonds issued between 2002 and 2007, which plaintiffs argue they relied upon in agreeing to insure the bonds notwithstanding that they had no contractual relationship with the underwriters. In June 2021 the court in the first of the three cases denied defendants’ motion to dismiss; defendants are seeking leave to appeal that decision. In July 2021, the court in another of these cases granted defendants’ motion to dismiss. A motion to dismiss is pending in the remaining case.

Our balance sheet at 30 September 2021 reflected provisions with respect to matters described in this item 4 in amounts that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provisions that we have recognized.

5. Foreign exchange, LIBOR and benchmark rates, and other trading practices

Foreign exchange-related regulatory matters: Beginning in 2013, numerous authorities commenced investigations concerning possible manipulation of foreign exchange markets and precious metals prices. As a result of these investigations, UBS entered into resolutions with Swiss, US and United Kingdom regulators and the European Commission. UBS was granted conditional immunity by the Antitrust Division of the DOJ and by authorities in other jurisdictions in connection with potential competition law violations relating to foreign exchange and precious metals businesses.


Foreign exchange-related civil litigation: Putative class actions have been filed since 2013 in US federal courts and in other jurisdictions against UBS and other banks on behalf of putative classes of persons who engaged in foreign currency transactions with any of the defendant banks. UBS has resolved US federal court class actions relating to foreign currency transactions with the defendant banks and persons who transacted in foreign exchange futures contracts and options on such futures under a settlement agreement that provides for UBS to pay an aggregate of USD 141 million and provide cooperation to the settlement classes. Certain class members have excluded themselves from that settlement and have filed individual actions in US and English courts against UBS and other banks, alleging violations of US and European competition laws and unjust enrichment.

In 2015, a putative class action was filed in federal court against UBS and numerous other banks on behalf of persons and businesses in the US who directly purchased foreign currency from the defendants and alleged co-conspirators for their own end use. In March 2017, the court granted UBS’s (and the other banks’) motions to dismiss the complaint. The plaintiffs filed an amended complaint in August 2017. In March 2018, the court denied the defendants’ motions to dismiss the amended complaint.

LIBOR and other benchmark-related regulatory matters: Numerous government agencies conducted investigations regarding potential improper attempts by UBS, among others, to manipulate LIBOR and other benchmark rates at certain times. UBS reached settlements or otherwise concluded investigations relating to benchmark interest rates with the investigating authorities. UBS was granted conditional leniency or conditional immunity from authorities in certain jurisdictions, including the Antitrust Division of the DOJ and the Swiss Competition Commission (WEKO), in connection with potential antitrust or competition law violations related to certain rates. However, UBS has not reached a final settlement with WEKO, as the Secretariat of WEKO has asserted that UBS does not qualify for full immunity.

LIBOR and other benchmark-related civil litigation: A number of putative class actions and other actions are pending in the federal courts in New York against UBS and numerous other banks on behalf of parties who transacted in certain interest rate benchmark-based derivatives. Also pending in the US and in other jurisdictions are a number of other actions asserting losses related to various products whose interest rates were linked to LIBOR and other benchmarks, including adjustable rate mortgages, preferred and debt securities, bonds pledged as collateral, loans, depository accounts, investments and other interest-bearing instruments. The complaints allege manipulation, through various means, of certain benchmark interest rates, including USD LIBOR, Euroyen TIBOR, Yen LIBOR, EURIBOR, CHF LIBOR, GBP LIBOR, SGD SIBOR and SOR and Australian BBSW, and seek unspecified compensatory and other damages under varying legal theories.

 

 

94 


 

 

Note 14  Provisions and contingent liabilities (continued)

USD LIBOR class and individual actions in the US: In 2013 and 2015, the district court in the USD LIBOR actions dismissed, in whole or in part, certain plaintiffs’ antitrust claims, federal racketeering claims, CEA claims, and state common law claims. Although the Second Circuit vacated the district court’s judgment dismissing antitrust claims, the district court again dismissed antitrust claims against UBS in 2016. Certain plaintiffs have appealed that decision to the Second Circuit. Separately, in 2018, the Second Circuit reversed in part the district court’s 2015 decision dismissing certain individual plaintiffs’ claims and certain of these actions are now proceeding. UBS entered into an agreement in 2016 with representatives of a class of bondholders to settle their USD LIBOR class action. The agreement has received final court approval. In 2018, the district court denied plaintiffs’ motions for class certification in the USD class actions for claims pending against UBS, and plaintiffs sought permission to appeal that ruling to the Second Circuit. In July 2018, the Second Circuit denied the petition to appeal of the class of USD lenders and in November 2018 denied the petition of the USD exchange class. In December 2019, UBS entered into an agreement with representatives of the class of USD lenders to settle their USD LIBOR class action. The agreement has received final court approval. In January 2019, a putative class action was filed in the District Court for the Southern District of New York against UBS and numerous other banks on behalf of US residents who, since 1 February 2014, directly transacted with a defendant bank in USD LIBOR instruments. The complaint asserts antitrust claims. The defendants moved to dismiss the complaint in August 2019. On 26 March 2020 the court granted defendants’ motion to dismiss the complaint in its entirety. Plaintiffs have appealed the dismissal. In August 2020, an individual action was filed in the Northern District of California against UBS and numerous other banks alleging that the defendants conspired to fix the interest rate used as the basis for loans to consumers by jointly setting the USD LIBOR rate and monopolized the market for LIBOR-based consumer loans and credit cards. Defendants moved to dismiss the complaint on 30 September 2021.

Other benchmark class actions in the US: In 2014, 2015 and 2017, the court in one of the Euroyen TIBOR lawsuits dismissed certain of the plaintiffs’ claims, including plaintiffs’ federal antitrust and racketeering claims. In August 2020, the court granted defendants’ motion for judgment on the pleadings and dismissed the lone remaining claim in the action as impermissibly extraterritorial. Plaintiffs have appealed. In 2017, the court dismissed the other Yen LIBOR / Euroyen TIBOR action in its entirety on standing grounds. In April 2020, the appeals court reversed the dismissal and in August 2020 plaintiffs in that action filed an amended complaint. The court granted in part and denied in part defendants’ motion to dismiss the amended complaint in September 2021. In 2017, the court dismissed the CHF LIBOR action on standing grounds and failure to state a claim. Plaintiffs filed an amended complaint following the dismissal, and the court granted a renewed motion to dismiss in September 2019. Plaintiffs appealed. In September 2021, the Second Circuit granted the parties’ joint motion to vacate the dismissal and remand the case for further proceedings. Also in 2017, the court in the EURIBOR lawsuit dismissed the case as to UBS and certain other foreign defendants for lack of personal jurisdiction. Plaintiffs have appealed. In October 2018, the court in the SIBOR / SOR action dismissed all but one of plaintiffs’ claims against UBS. Plaintiffs filed an amended complaint following the dismissal, and the court granted a renewed motion to dismiss in July 2019. Plaintiffs appealed. In March 2021, the Second Circuit reversed the dismissal. In November 2018, the court in the BBSW lawsuit dismissed the case as to UBS and certain other foreign defendants for lack of personal jurisdiction. Following that dismissal, plaintiffs filed an amended complaint in April 2019, which UBS and other defendants named in the amended complaint moved to dismiss. In February 2020, the court in the BBSW action granted in part and denied in part defendants’ motions to dismiss the amended complaint. In August 2020, UBS and other BBSW defendants joined a motion for judgment on the pleadings, which the court denied in May 2021. The court dismissed the GBP LIBOR action in August 2019. Plaintiffs have appealed.

Government bonds: Putative class actions have been filed since 2015 in US federal courts against UBS and other banks on behalf of persons who participated in markets for US Treasury securities since 2007. A consolidated complaint was filed in 2017 in the US District Court for the Southern District of New York alleging that the banks colluded with respect to, and manipulated prices of, US Treasury securities sold at auction and in the secondary market and asserting claims under the antitrust laws and for unjust enrichment. Defendants’ motions to dismiss the consolidated complaint was granted in March 2021. Plaintiffs filed an amended complaint, which defendants moved to dismiss in June 2021. Similar class actions have been filed concerning European government bonds and other government bonds.

In May 2021, the European Commission issued a decision finding that UBS and six other banks breached European Union antitrust rules in 2007-2011 relating to European government bonds. The European Commission fined UBS EUR 172 million. UBS is appealing the amount of the fine

With respect to additional matters and jurisdictions not encompassed by the settlements and orders referred to above, our balance sheet at 30 September 2021 reflected a provision in an amount that UBS believes to be appropriate under the applicable accounting standard. As in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

 

95 


Notes to the UBS Group AG interim consolidated financial statements (unaudited) 

 

Note 14  Provisions and contingent liabilities (continued)

6. Swiss retrocessions

The Federal Supreme Court of Switzerland ruled in 2012, in a test case against UBS, that distribution fees paid to a firm for distributing third-party and intra-group investment funds and structured products must be disclosed and surrendered to clients who have entered into a discretionary mandate agreement with the firm, absent a valid waiver. FINMA issued a supervisory note to all Swiss banks in response to the Supreme Court decision. UBS has met the FINMA requirements and has notified all potentially affected clients.

The Supreme Court decision has resulted, and may continue to result, in a number of client requests for UBS to disclose and potentially surrender retrocessions. Client requests are assessed on a case-by-case basis. Considerations taken into account when assessing these cases include, among other things, the existence of a discretionary mandate and whether or not the client documentation contained a valid waiver with respect to distribution fees.

Our balance sheet at 30 September 2021 reflected a provision with respect to matters described in this item 6 in an amount that UBS believes to be appropriate under the applicable accounting standard. The ultimate exposure will depend on client requests and the resolution thereof, factors that are difficult to predict and assess. Hence, as in the case of other matters for which we have established provisions, the future outflow of resources in respect of such matters cannot be determined with certainty based on currently available information and accordingly may ultimately prove to be substantially greater (or may be less) than the provision that we have recognized.

 

  

 

Note 15   Currency translation rates

The following table shows the rates of the main currencies used to translate the financial information of UBS’s operations with a functional currency other than the US dollar into US dollars.

 

 

 

Closing exchange rate

 

Average rate1

 

 

As of

 

For the quarter ended

 

Year-to-date

 

 

30.9.21

30.6.21

31.12.20

30.9.20

 

30.9.21

30.6.21

30.9.20

 

30.9.21

30.9.20

1 CHF

 

 1.07 

 1.08 

 1.13 

 1.09 

 

 1.09 

 1.10 

 1.10 

 

 1.09 

 1.06 

1 EUR

 

 1.16 

 1.19 

 1.22 

 1.17 

 

 1.17 

 1.20 

 1.18 

 

 1.19 

 1.13 

1 GBP

 

 1.35 

 1.38 

 1.37 

 1.29 

 

 1.37 

 1.39 

 1.31 

 

 1.38 

 1.28 

100 JPY

 

 0.90 

 0.90 

 0.97 

 0.95 

 

 0.90 

 0.91 

 0.95 

 

 0.91 

 0.93 

1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a quarter represent an average of three month-end rates, weighted according to the income and expense volumes of all operations of the Group with the same functional currency for each month. Weighted average rates for individual business divisions may deviate from the weighted average rates for the Group.

  

96 


 

UBS AG interim consolidated financial
information (unaudited)

This section contains a comparison of selected financial and capital information between UBS Group AG consolidated and UBS AG consolidated. Refer to the UBS AG third quarter 2021 report, which will be available as of 29 October 2021 under “Quarterly reporting” at ubs.com/investors, for the interim consolidated financial statements of UBS AG.

Comparison between UBS Group AG consolidated and UBS AG consolidated

The accounting policies applied under International Financial Reporting Standards (IFRS) to both the UBS Group AG and the UBS AG consolidated financial statements are identical. However, there are certain scope and presentation differences as noted below.

      Assets, liabilities, operating income, operating expenses and operating profit before tax relating to UBS Group AG and its directly held subsidiaries, including UBS Business Solutions AG, are reflected in the consolidated financial statements of UBS Group AG but not in those of UBS AG. UBS AG’s assets, liabilities, operating income and operating expenses related to transactions with UBS Group AG and its directly held subsidiaries, including UBS Business Solutions AG and other shared services subsidiaries, are not subject to elimination in the consolidated financial statements of UBS AG, but are eliminated in the consolidated financial statements of UBS Group AG. UBS Business Solutions AG and other shared services subsidiaries of UBS Group AG charge other legal entities within the UBS AG consolidation scope for services provided, including a markup on costs incurred.

      The equity of UBS Group AG consolidated was USD 3.1 billion higher than the equity of UBS AG consolidated as of 30 September 2021. This difference was mainly driven by higher dividends paid by UBS AG to UBS Group AG compared with the dividend distributions of UBS Group AG, as well as higher retained earnings in the consolidated financial statements of UBS Group AG, largely related to the aforementioned markup charged by shared services subsidiaries of UBS Group AG to other legal entities in the UBS AG scope of consolidation. In addition, UBS Group AG is the grantor of the majority of the compensation plans of the Group and recognizes share premium for equity-settled awards granted. These effects were partly offset by treasury shares acquired and canceled as part of our share repurchase programs and those held to hedge share delivery obligations associated with Group compensation plans, as well as additional share premium recognized at the UBS AG consolidated level related to the establishment of UBS Group AG and UBS Business Solutions AG, a wholly owned subsidiary of UBS Group AG.

      The going concern capital of UBS Group AG consolidated was USD 5.0 billion higher than the going concern capital of UBS AG consolidated as of 30 September 2021, reflecting higher common equity tier 1 (CET1) capital of USD 3.7 billion and going concern loss-absorbing additional tier 1 (AT1) capital of USD 1.4 billion.

      The CET1 capital of UBS Group AG consolidated was USD 3.7 billion higher than that of UBS AG consolidated as of 30 September 2021. The higher CET1 capital of UBS Group AG consolidated was primarily due to higher UBS Group AG consolidated IFRS equity of USD 3.1 billion, as described above, and lower UBS Group AG accruals for future capital returns to shareholders, partly offset by compensation-related regulatory capital accruals at the UBS Group AG level.

      The going concern loss-absorbing AT1 capital of UBS Group AG consolidated was USD 1.4 billion higher than that of UBS AG consolidated as of 30 September 2021, mainly reflecting deferred contingent capital plan awards granted at the Group level to eligible employees for the performance years 2016 to 2020, partly offset by two loss-absorbing AT1 capital instruments on-lent by UBS Group AG to UBS AG.

 

 

 

 

97 


Comparison between UBS Group AG consolidated and UBS AG consolidated

 

 

As of or for the quarter ended 30.9.21

USD million, except where indicated

 

UBS Group AG

consolidated

UBS AG

consolidated

Difference

(absolute)

 

 

 

 

 

Income statement

 

 

 

 

Operating income

 

 9,128 

 9,224 

 (95) 

Operating expenses

 

 6,264 

 6,512 

 (248) 

Operating profit / (loss) before tax

 

 2,865 

 2,712 

 152 

of which: Global Wealth Management

 

 1,516 

 1,500 

 16 

of which: Personal & Corporate Banking

 

 478 

 479 

 (1) 

of which: Asset Management

 

 214 

 214 

 0 

of which: Investment Bank

 

 837 

 833 

 4 

of which: Group Functions

 

 (180) 

 (314) 

 134 

Net profit / (loss)

 

 2,289 

 2,163 

 125 

of which: net profit / (loss) attributable to shareholders

 

 2,279 

 2,154 

 125 

of which: net profit / (loss) attributable to non-controlling interests

 

 9 

 9 

 0 

 

 

 

 

 

Statement of comprehensive income

 

 

 

 

Other comprehensive income

 

(610)

(598)

(12)

of which: attributable to shareholders

 

(596)

(584)

(12)

of which: attributable to non-controlling interests

 

(14)

(14)

0

Total comprehensive income

 

1,678

1,565

113

of which: attributable to shareholders

 

1,683

1,570

113

of which: attributable to non-controlling interests

 

(5)

(5)

0

 

 

 

 

 

Balance sheet

 

 

 

 

Total assets

 

1,088,773

1,088,246

528

Total liabilities

 

1,028,221

1,030,828

(2,607)

Total equity

 

60,552

57,418

3,134

of which: equity attributable to shareholders

 

60,219

57,085

3,134

of which: equity attributable to non-controlling interests

 

333

333

0

 

 

 

 

 

Capital information

 

 

 

 

Common equity tier 1 capital

 

 45,022 

 41,356 

 3,665 

Going concern capital

 

 60,369 

 55,334 

 5,035 

Risk-weighted assets

 

 302,426 

 299,612 

 2,814 

Common equity tier 1 capital ratio (%)

 

 14.9 

 13.8 

 1.1 

Going concern capital ratio (%)

 

 20.0 

 18.5 

 1.5 

Total loss-absorbing capacity ratio (%)

 

 34.0 

 32.6 

 1.4 

Leverage ratio denominator1

 

 1,044,916 

 1,044,438 

 479 

Common equity tier 1 leverage ratio (%)1

 

 4.31 

 3.96 

 0.35 

Going concern leverage ratio (%)1

 

 5.8 

 5.3 

 0.5 

Total loss-absorbing capacity leverage ratio (%)

 

 9.8 

 9.4 

 0.5 

1 Leverage ratio denominators and leverage ratios for 31 December 2020 do not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.

 

 

98 


 

 

 

 

 

 

 

 

 

As of or for the quarter ended 30.6.21

 

As of or for the quarter ended 31.12.20

UBS Group AG

consolidated

UBS AG

consolidated

Difference

(absolute)

 

UBS Group AG

consolidated

UBS AG

consolidated

Difference

(absolute)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 8,976 

 9,071 

 (94) 

 

 8,117 

 8,220 

 (103) 

 6,384 

 6,589 

 (206) 

 

 6,132 

 6,324 

 (192) 

 2,593 

 2,481 

 111 

 

 1,985 

 1,896 

 89 

 1,294 

 1,273 

 21 

 

 864 

 855 

 9 

 498 

 496 

 2 

 

 353 

 353 

 (1) 

 255 

 254 

 1 

 

 401 

 401 

 0 

 668 

 655 

 14 

 

 529 

 528 

 1 

 (124) 

 (197) 

 73 

 

 (161) 

 (241) 

 79 

 2,012 

 1,919 

 93 

 

 1,645 

 1,572 

 73 

 2,006 

 1,913 

 93 

 

 1,636 

 1,563 

 73 

 6 

 6 

 0 

 

 9 

 9 

 0 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

591

592

(1)

 

 83 

 54 

29

576

578

 (1) 

 

 65 

 36 

29

14

14

0

 

 18 

 18 

0

2,602

2,510

92

 

 1,728 

 1,626 

102

2,582

2,491

 92 

 

 1,701 

 1,599 

102

20

20

0

 

 27 

 27 

0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,086,519

1,085,861

658

 

 1,125,765 

 1,125,327 

 438 

1,027,469

1,030,216

 (2,746) 

 

 1,066,000 

 1,067,254 

 (1,254) 

59,050

55,645

3,405

 

 59,765 

 58,073 

 1,691 

58,765

55,361

 3,405 

 

 59,445 

 57,754 

 1,691 

284

284

0

 

 319 

 319 

 0 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 42,583 

 40,190 

 2,393 

 

 39,890 

 38,181 

 1,709 

 59,188 

 55,398 

 3,790 

 

 56,178 

 52,610 

 3,567 

 293,277 

 290,470 

 2,807 

 

 289,101 

 286,743 

 2,358 

 14.5 

 13.8 

 0.7 

 

 13.8 

 13.3 

 0.5 

 20.2 

 19.1 

 1.1 

 

 19.4 

 18.3 

 1.1 

 35.6 

 34.6 

 1.0 

 

 35.2 

 34.2 

 1.0 

 1,039,939 

 1,039,375 

 564 

 

 1,037,150 

 1,036,771 

 379 

 4.09 

 3.87 

 0.23 

 

 3.85 

 3.68 

 0.16 

 5.7 

 5.3 

 0.4 

 

 5.4 

 5.1 

 0.3 

 10.0 

 9.7 

 0.4 

 

 9.8 

 9.5 

 0.3 

 

 

 

 

 

 

 

  

99 


 

 


Significant regulated subsidiary and sub-group information

Unaudited

 


Significant regulated subsidiary and sub-group information 

Financial and regulatory key figures for our significant regulated subsidiaries and sub-groups

 

 

UBS AG

(standalone)

 

UBS Switzerland AG

(standalone)

 

UBS Europe SE

(consolidated)

 

UBS Americas Holding LLC

(consolidated)

All values in millions, except where indicated

 

USD

 

CHF

 

EUR

 

USD

Financial and regulatory requirements

 

Swiss GAAP

Swiss SRB rules

 

Swiss GAAP

Swiss SRB rules

 

IFRS

EU regulatory rules

 

US GAAP

US Basel III rules

As of or for the quarter ended

 

30.9.21

30.6.21

 

30.9.21

30.6.21

 

30.9.21

30.6.211

 

30.9.21

30.6.21

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial information2

 

 

 

 

 

 

 

 

 

 

 

 

Income statement

 

 

 

 

 

 

 

 

 

 

 

 

Total operating income

 

3,196

4,473

 

2,132

2,135

 

349

277

 

3,616

3,423

Total operating expenses

 

2,003

2,030

 

1,298

1,352

 

179

205

 

2,967

2,930

Operating profit / (loss) before tax

 

1,193

2,443

 

834

783

 

170

72

 

649

493

Net profit / (loss)

 

1,311

2,479

 

678

636

 

129

50

 

406

299

Balance sheet

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

508,794

511,973

 

319,163

323,291

 

47,436

47,426

 

188,404

183,777

Total liabilities

 

456,581

461,071

 

305,080

309,886

 

42,559

42,675

 

160,599

155,939

Total equity

 

52,213

50,902

 

14,083

13,405

 

4,877

4,751

 

27,806

27,838

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital3

 

 

 

 

 

 

 

 

 

 

 

 

Common equity tier 1 capital

 

 51,233 

 51,279 

 

 12,199 

 12,312 

 

3,930

3,927

 

14,831

14,477

Additional tier 1 capital

 

 13,978 

 15,208 

 

 5,396 

 5,393 

 

290

290

 

3,047

3,047

Total going concern capital / Tier 1 capital

 

 65,211 

 66,487 

 

 17,596 

 17,705 

 

4,220

4,217

 

17,877

17,523

Tier 2 capital

 

 3,170 

 5,214 

 

 

 

 

 

 

 

607

620

Total capital

 

 

 

 

 

 

 

4,220

4,217

 

18,485

18,143

Total gone concern loss-absorbing capacity

 

 42,412 

 45,091 

 

 10,876 

 10,868 

 

2,1504

2,1504

 

6,5005

6,3005

Total loss-absorbing capacity

 

 107,623 

 111,578 

 

 28,472 

 28,572 

 

6,370

6,367

 

24,377

23,823

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk-weighted assets and leverage ratio denominator3

 

 

 

 

 

 

 

 

 

 

 

 

Risk-weighted assets

 

 318,755 

 319,195 

 

 109,941 

 109,602 

 

13,455

13,119

 

71,571

69,139

Leverage ratio denominator

 

 597,542 

 606,536 

 

 338,636 

 341,991 

 

47,237

47,0946

 

175,486

170,985

Supplementary leverage ratio denominator

 

 

 

 

 

 

 

 

 

 

199,073

195,617

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital and leverage ratios (%)3

 

 

 

 

 

 

 

 

 

 

 

 

Common equity tier 1 capital ratio

 

 16.1 

 16.1 

 

 11.1 

 11.2 

 

 29.2 

 29.9 

 

 20.7 

 20.9 

Going concern capital ratio / Tier 1 capital ratio

 

 20.5 

 20.8 

 

 16.0 

 16.2 

 

 31.4 

 32.1 

 

 25.0 

 25.3 

Total capital ratio

 

 

 

 

 

 

 

 31.4 

 32.1 

 

 25.8 

 26.2 

Total loss-absorbing capacity ratio

 

 

 

 

 25.9 

 26.1 

 

 47.3 

 48.5 

 

 34.1 

 34.5 

Tier 1 leverage ratio

 

 

 

 

 

 

 

 8.9 

 9.06

 

 10.2 

 10.2 

Supplementary tier 1 leverage ratio

 

 

 

 

 

 

 

 

 

 

 9.0 

 9.0 

Going concern leverage ratio

 

 10.9 

 11.0 

 

 5.2 

 5.2 

 

 

 

 

 

 

Total loss-absorbing capacity leverage ratio

 

 

 

 

 8.4 

 8.4 

 

 13.5 

 13.5 

 

 13.9 

 13.9 

Gone concern capital coverage ratio

 

 110.2 

 120.6 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liquidity coverage ratio3

 

 

 

 

 

 

 

 

 

 

 

 

High-quality liquid assets (billion)

 

92

89

 

92

98

 

17

17

 

30

29

Net cash outflows (billion)

 

51

51

 

64

65

 

10

11

 

20

18

Liquidity coverage ratio (%)7,8

 

183

176

 

143

150

 

165

161

 

154

166

 

 

 

 

 

 

 

 

 

 

 

 

 

Net stable funding ratio3

 

 

 

 

 

 

 

 

 

 

 

 

Total available stable funding

 

251,277

 

 

229,666

 

 

15,472

15,816

 

 

 

Total required stable funding

 

283,682

 

 

156,849

 

 

9,160

9,631

 

 

 

Net stable funding ratio (%)

 

899

 

 

1469

 

 

169

164

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

Joint and several liability between UBS AG and UBS Switzerland AG (billion)10

 

 

 

 

5

7

 

 

 

 

 

 

1 Comparative figures have been restated to align with the regulatory reports as submitted to the European Central Bank (the ECB).    2 The financial information disclosed does not represent interim financial statements under the respective GAAP / IFRS.    3 Refer to the 30 September 2021 Pillar 3 report, available under “Pillar 3 disclosures” at ubs.com/investors, for more information.    4 Consists of positions that meet the conditions laid down in Art. 72a–b of the Capital Requirements Regulation (CRR) II with regard to contractual, structural or legal subordination.    5 Consists of eligible long-term debt that meets the conditions specified in 12 CFR 252.162 of the final TLAC rules. Total loss-absorbing capacity is the sum of tier 1 capital and eligible long-term debt.    6 Comparative figures have been adjusted following the initial CRR II go-live to align with the regulatory reports as submitted to the ECB.    7 In the third quarter of 2021, the UBS AG liquidity coverage ratio (LCR) was 183%, remaining above the prudential requirements communicated by FINMA.    8 In the third quarter of 2021, the LCR of UBS Switzerland AG, which is a Swiss SRB, was 143%, remaining above the prudential requirement communicated by FINMA in connection with the Swiss Emergency Plan.    9 In accordance with Art. 17h para. 3 and 4 of the Liquidity Ordinance, UBS AG standalone is required to maintain a minimum NSFR of at least 80% without taking into account excess funding of UBS Switzerland AG and 100% after taking into account such excess funding.    10 Refer to the “Capital, liquidity and funding, and balance sheet” section of our Annual Report 2020 for more information about the joint and several liability. Under certain circumstances, the Swiss Banking Act and FINMA’s Banking Insolvency Ordinance authorize FINMA to modify, extinguish or convert to common equity liabilities of a bank in connection with a resolution or insolvency of such bank.   

    

102 


 

UBS Group AG is a holding company and conducts substantially all of its operations through UBS AG and subsidiaries thereof. UBS Group AG and UBS AG have contributed a significant portion of their respective capital to, and provide substantial liquidity to, such subsidiaries. Many of these subsidiaries are subject to regulations requiring compliance with minimum capital, liquidity and similar requirements. The tables in this section summarize the regulatory capital components and capital ratios of our significant regulated subsidiaries and sub-groups determined under the regulatory framework of each subsidiary’s or sub-group’s home jurisdiction.

Supervisory authorities generally have discretion to impose higher requirements or to otherwise limit the activities of subsidiaries. Supervisory authorities also may require entities to measure capital and leverage ratios on a stressed basis and may limit the ability of an entity to engage in new activities or take capital actions based on the results of those tests.


Following the completion of the annual Dodd–Frank Act Stress Testing (DFAST) and the Comprehensive Capital Analysis and Review (CCAR), UBS Americas Holding LLC was assigned a stress capital buffer (SCB) of 7.1% (previously 6.7%) under the SCB rule as of 1 October 2021, resulting in a total common equity tier 1 (CET1) capital requirement of 11.6%. As of 30 September 2021, the CET1 ratio of UBS Americas Holding LLC was 20.7%.

Standalone regulatory information for UBS AG and UBS Switzerland AG, as well as consolidated regulatory information for UBS Europe SE and UBS Americas Holding LLC, is provided in the 30 September 2021 Pillar 3 report, which is available under “Pillar 3 disclosures” at ubs.com/investors

Selected financial and regulatory information for UBS AG consolidated is included in the key figures table below. Refer also to the UBS AG third quarter 2021 report, which will be available as of 29 October 2021 under “Quarterly reporting” at ubs.com/investors

 

UBS AG consolidated key figures

 

 

 

 

 

 

 

 

 

 

As of or for the quarter ended

 

As of or year-to-date

USD million, except where indicated

 

30.9.21

30.6.21

31.12.20

30.9.20

 

30.9.21

30.9.20

Results

 

 

 

 

 

 

 

 

Operating income

 

 9,224 

 9,071 

 8,220 

 9,038 

 

 27,130 

 24,559 

Operating expenses

 

 6,512 

 6,589 

 6,324 

 6,560 

 

 19,785 

 18,757 

Operating profit / (loss) before tax

 

 2,712 

 2,481 

 1,896 

 2,478 

 

 7,345 

 5,802 

Net profit / (loss) attributable to shareholders

 

 2,154 

 1,913 

 1,563 

 2,018 

 

 5,777 

 4,632 

Profitability and growth

 

 

 

 

 

 

 

 

Return on equity (%)

 

 15.3 

 13.6 

 10.9 

 14.3 

 

 13.6 

 11.0 

Return on tangible equity (%)

 

 17.3 

 15.3 

 12.2 

 16.1 

 

 15.3 

 12.4 

Return on common equity tier 1 capital (%)

 

 21.1 

 19.4 

 16.3 

 21.2 

 

 19.5 

 16.8 

Return on risk-weighted assets, gross (%)

 

 12.5 

 12.5 

 11.7 

 12.9 

 

 12.4 

 12.0 

Return on leverage ratio denominator, gross (%)1

 

 3.5 

 3.5 

 3.3 

 3.7 

 

 3.5 

 3.5 

Cost / income ratio (%)

 

 70.7 

 73.3 

 76.3 

 71.9 

 

 73.3 

 74.5 

Net profit growth (%)

 

 6.8 

 60.3 

 151.3 

 108.5 

 

 24.7 

 38.6 

Resources

 

 

 

 

 

 

 

 

Total assets

 

 1,088,246 

 1,085,861 

 1,125,327 

 1,064,621 

 

 1,088,246 

 1,064,621 

Equity attributable to shareholders

 

 57,085 

 55,361 

 57,754 

 57,461 

 

 57,085 

 57,461 

Common equity tier 1 capital2

 

 41,356 

 40,190 

 38,181 

 38,652 

 

 41,356 

 38,652 

Risk-weighted assets2

 

 299,612 

 290,470 

 286,743 

 281,442 

 

 299,612 

 281,442 

Common equity tier 1 capital ratio (%)2

 

 13.8 

 13.8 

 13.3 

 13.7 

 

 13.8 

 13.7 

Going concern capital ratio (%)2

 

 18.5 

 19.1 

 18.3 

 18.8 

 

 18.5 

 18.8 

Total loss-absorbing capacity ratio (%)2

 

 32.6 

 34.6 

 34.2 

 34.2 

 

 32.6 

 34.2 

Leverage ratio denominator1,2

 

 1,044,438 

 1,039,375 

 1,036,771 

 994,015 

 

 1,044,438 

 994,015 

Common equity tier 1 leverage ratio (%)1,2

 

 3.96 

 3.87 

 3.68 

 3.89 

 

 3.96 

 3.89 

Going concern leverage ratio (%)1,2

 

 5.3 

 5.3 

 5.1 

 5.3 

 

 5.3 

 5.3 

Total loss-absorbing capacity leverage ratio (%)2

 

 9.4 

 9.7 

 9.5 

 9.7 

 

 9.4 

 9.7 

Other

 

 

 

 

 

 

 

 

Invested assets (USD billion)3

 

 4,432 

 4,485 

 4,187 

 3,807 

 

 4,432 

 3,807 

Personnel (full-time equivalents)

 

 47,293 

 47,227 

 47,546 

 47,584 

 

 47,293 

 47,584 

1 Leverage ratio denominators and leverage ratios for the respective periods in 2020 do not reflect the effects of the temporary exemption that applied from 25 March 2020 until 1 January 2021 and was granted by FINMA in connection with COVID-19. Refer to the “Regulatory and legal developments” section of our Annual Report 2020 for more information.    2 Based on the Swiss systemically relevant bank framework as of 1 January 2020. Refer to the “Capital management” section of this report for more information.    3 Consists of invested assets for Global Wealth Management, Asset Management and Personal & Corporate Banking. Refer to “Note 32 Invested assets and net new money” in the “Consolidated financial statements” section of our Annual Report 2020 for more information.   

  

103 


 

104 


 

Appendix

105 


Appendix 

Alternative performance measures

 

Alternative performance measures

An alternative performance measure (an APM) is a financial measure of historical or future financial performance, financial position or cash flows other than a financial measure defined or specified in the applicable recognized accounting standards or in other applicable regulations. We report a number of APMs in the discussion of the financial and operating performance of the Group, our business divisions and our Group Functions. We use APMs to provide a more complete picture of our operating performance and to reflect management’s view of the fundamental drivers of our business results. A definition of each APM, the method used to calculate it and the information content are presented in the table below. Our APMs may qualify as non-GAAP measures as defined by US Securities and Exchange Commission (SEC) regulations.

 

APM label

Calculation

Information content

 

Invested assets (USD and CHF)

– GWM, P&C, AM

Calculated as the sum of managed fund assets, managed institutional assets, discretionary and advisory wealth management portfolios, fiduciary deposits, time deposits, savings accounts, and wealth management securities or brokerage accounts.

This measure provides information about the volume of client assets managed by or deposited with UBS for investment purposes.

Client assets (USD and CHF)

– GWM, P&C

Calculated as the sum of invested assets and other assets held purely for transactional purposes or custody only.

This measure provides information about the volume of client assets managed by or deposited with UBS for investment purposes, including other assets held purely for transactional purposes or custody only.

Recurring net fee income

(USD and CHF)

– GWM, P&C

Calculated as the total of fees for services provided on an ongoing basis, such as portfolio management fees, asset-based investment fund fees and custody fees, which are generated on client assets, and administrative fees for accounts.

This measure provides information about the amount of recurring net fee income.

Transaction-based income

(USD and CHF)

– GWM, P&C

Calculated as the total of the non-recurring portion of net fee and commission income, mainly composed of brokerage and transaction-based investment fund fees, and credit card fees, as well as fees for payment and foreign exchange transactions, together with other net income from financial instruments measured at fair value through profit or loss.

This measure provides information about the amount of the non-recurring portion of net fee and commission income.

Cost / income ratio (%)

Calculated as operating expenses divided by operating income before credit loss expense or release (annualized as applicable).

This measure provides information about the efficiency of the business by comparing operating expenses with gross income.

Gross margin on invested assets (bps)

– AM

Calculated as operating income before credit loss expense or release (annualized as applicable) divided by average invested assets.

This measure provides information about the operating income before credit loss expense or release of the business in relation to invested assets.

Net interest margin (bps)

– P&C

Calculated as net interest income (annualized as applicable) divided by average loans.

This measure provides information about the profitability of the business by calculating the difference between the price charged for lending and the cost of funding, relative to loan value.

Net margin on invested assets (bps)

– AM

Calculated as operating profit before tax (annualized as applicable) divided by average invested assets.

This measure provides information about the operating profit before tax of the business in relation to invested assets.

Business volume for Personal
Banking (CHF and USD)

– P&C

Calculated as the sum of client assets and loans.

This measure provides information about the volume of client assets and loans.

Net new business volume for Personal Banking (CHF and USD)

– P&C

Calculated as the sum of net inflows and outflows of client assets and loans during a specific period (annualized as applicable).

This measure provides information about the business volume as a result of net new business volume flows during a specific period.

Net new business volume growth for Personal Banking (%)

– P&C

Calculated as the sum of net inflows and outflows of client assets and loans during a specific period (annualized as applicable) divided by total business volume / client assets at the beginning of the period.

This measure provides information about the growth of business volume as a result of net new business volume flows during a specific period.

 

106  


 

APM label

Calculation

Information content

 

Net profit growth (%)

Calculated as the change in net profit attributable to shareholders from continuing operations between current and comparison periods divided by net profit attributable to shareholders from continuing operations of the comparison period.

This measure provides information about profit growth in comparison with the prior period.

Pre-tax profit growth (%)

Calculated as the change in net profit before tax attributable to shareholders from continuing operations between current and comparison periods divided by net profit before tax attributable to shareholders from continuing operations of the comparison period.

This measure provides information about pre-tax profit growth in comparison with the prior period.

Return on common equity tier 1
capital (%)

Calculated as annualized net profit attributable to shareholders divided by average common equity tier 1 capital.

This measure provides information about the profitability of the business in relation to common equity tier 1 capital.

Return on equity (%)

Calculated as annualized net profit attributable to shareholders divided by average equity attributable to shareholders.

This measure provides information about the profitability of the business in relation to equity.

Return on attributed equity (%)

Calculated as annualized business division operating profit before tax divided by average attributed equity.

This measure provides information about the profitability of the business divisions in relation to attributed equity.

Return on leverage ratio denominator, gross (%)

Calculated as annualized operating income before credit loss expense or release divided by average leverage ratio denominator.

This measure provides information about the revenues of the business in relation to leverage ratio denominator.

Return on risk-weighted
assets, gross (%)

Calculated as annualized operating income before credit loss expense or release divided by average risk-weighted assets.

This measure provides information about the revenues of the business in relation to risk-weighted assets.

Return on tangible equity (%)

Calculated as annualized net profit attributable to shareholders divided by average equity attributable to shareholders less average goodwill and intangible assets.

This measure provides information about the profitability of the business in relation to tangible equity.

Total book value per share

(USD and CHF1)

Calculated as equity attributable to shareholders divided by the number of shares outstanding.

This measure provides information about net assets on a per-share basis.

Tangible book value per share

(USD and CHF1)

Calculated as equity attributable to shareholders less goodwill and intangible assets divided by the number of shares outstanding.

This measure provides information about tangible net assets on a per-share basis.

Loan penetration (%)

– GWM

Calculated as loans divided by invested assets.

This measure provides information about loan volume in relation to invested assets.

Net new money (USD)

– AM

Calculated as the sum of the net amount of inflows and outflows of invested assets (as defined in UBS policy) recorded during a specific period.

This measure provides information about the development of invested assets during a specific period as a result of net new money flows and excludes movements due to market performance, foreign exchange translation, dividends, interest and fees.

Impaired loan portfolio as a percentage of total loan portfolio, gross (%)

– GWM, P&C

Calculated as impaired loan portfolio divided by total gross loan portfolio.

This measure provides information about the proportion of impaired loan portfolio in the total gross loan portfolio.

Secured loan portfolio as a percentage of total loan portfolio, gross (%)

– P&C

Calculated as secured loan portfolio divided by total gross loan portfolio.

This measure provides information about the proportion of the secured loan portfolio in the total gross loan portfolio.

Active Digital Banking clients in Personal Banking (%)

– P&C

Calculated as the average number of active clients for each month in the relevant period divided by the average number of total clients. “Clients” refers to the number of unique business relationships operated by Personal Banking, excluding persons under the age of 15, clients who do not have a private account, clients domiciled outside Switzerland, and clients who have defaulted on loans or credit facilities. At the end of each month, any client that has logged on at least once in that month is determined to be “active.”

This measure provides information about the proportion of active Digital Banking clients in the total number of UBS clients (within the aforementioned meaning) who are serviced by Personal Banking.

 

 

  107 


Appendix 

APM label

Calculation

Information content

 

Active Digital Banking clients in Corporate & Institutional Clients (%)

– P&C

Calculated as the average number of active clients for each month in the relevant period divided by the average number of total clients. “Clients” refers to the number of unique business relationships or legal entities operated by Corporate & Institutional Clients, excluding clients that do not have an account, mono-product clients and clients that have defaulted on loans or credit facilities. At the end of each month, any client that has logged on at least once in that month is determined to be “active.”

This measure provides information about the proportion of active Digital Banking clients in the total number of UBS clients (within the aforementioned meaning) which are serviced by Corporate & Institutional Clients.

Mobile Banking log-in share in Personal Banking (%)

– P&C

Calculated as the number of Mobile Banking app
log-ins divided by total log-ins via E-Banking and the Mobile Banking app in Personal Banking.

This measure provides information about the proportion of Mobile Banking app log-ins in the total number of log-ins via E-Banking and the Mobile Banking app in Personal Banking.

Fee-generating assets (USD)

– GWM

Calculated as the sum of discretionary and non-discretionary wealth management portfolios (mandate volume) and assets where generated revenues are predominantly of a recurring nature, i.e., mainly investment and mutual funds, including hedge funds and private markets, where we have a distribution agreement.

This measure provides information about the volume of invested assets that create a revenue stream, whether as a result of the nature of the contractual relationship with clients or through the fee structure of the asset. An increase in the level of fee-generating assets results in an increase in the associated revenue stream.

Net new fee-generating assets (USD)

– GWM

Calculated as the sum of the net amount of fee-generating assets inflows and outflows, including dividend and interest inflows into mandates and outflows from mandate fees paid by clients, during a specific period.

This measure provides information about the development of fee-generating assets during a specific period as a result of net flows and excludes movements due to market performance and foreign exchange translation.

Fee-generating asset margin (bps)

– GWM

Calculated as revenues from fee-generating assets (a portion of which is included in recurring fee income and a portion of which is included in transaction-based income, annualized as applicable) divided by average fee-generating assets for the relevant mandate fee billing period.

This measure provides information about the revenues from fee-generating assets in relation to their average volume during the relevant mandate fee billing period

1  Total book value per share and tangible book value per share in Swiss francs are calculated based on a translation of equity under our US dollar presentation currency.

 

108  


 

Abbreviations frequently used in our financial reports

 

A

ABS                asset-backed securities

AEI                 automatic exchange of information

AGM              Annual General Meeting of shareholders

A-IRB              advanced internal
ratings-based

AIV                 alternative investment vehicle

ALCO             Asset and Liability Committee

AMA              advanced measurement approach

AML               anti-money laundering

AoA                Articles of Association

APAC             Asia Pacific

APM               alternative performance measure

ARR                alternative reference rate

ARS                auction rate securities

ASF                 available stable funding

AT1                additional tier 1

AuM               assets under management

 

B

BCBS              Basel Committee on
Banking Supervision

BEAT              base erosion and anti-abuse tax

BIS                  Bank for International Settlements

BoD                Board of Directors

BVG                Swiss occupational
pension plan

 

C

CAO               Capital Adequacy Ordinance

CCAR             Comprehensive Capital Analysis and Review

CCF                credit conversion factor

CCP                central counterparty

CCR                counterparty credit risk

CCRC             Corporate Culture and Responsibility Committee

CCyB              countercyclical capital buffer

CDO               collateralized debt
obligation

CDS                credit default swap

CEA                Commodity Exchange Act

 


CEM               current exposure method

CEO               Chief Executive Officer

CET1              common equity tier 1

CFO                Chief Financial Officer

CFTC              US Commodity Futures Trading Commission

CHF                Swiss franc

CIC                 Corporate & Institutional Clients

CIO                 Chief Investment Office

CLS                 Continuous Linked Settlement

CMBS             commercial mortgage-backed security

C&ORC          Compliance & Operational Risk Control

CRD IV           EU Capital Requirements Directive of 2013

CRM               credit risk mitigation (credit risk) or comprehensive risk measure (market risk)

CRR                Capital Requirements Regulation

CST                combined stress test

CVA               credit valuation adjustment

 

D

DBO               defined benefit obligation

DCCP             Deferred Contingent Capital Plan

DJSI                Dow Jones Sustainability Indices

DM                 discount margin

DOJ                US Department of Justice

D-SIB              domestic systemically important bank

DTA                deferred tax asset

DVA               debit valuation adjustment

 

E

EAD                exposure at default

EB                   Executive Board

EBA                European Banking Authority

EC                  European Commission

ECB                European Central Bank

ECL                expected credit loss

EIR                  effective interest rate

EL                   expected loss

EMEA             Europe, Middle East and Africa

EOP                Equity Ownership Plan

EPE                 expected positive exposure


EPS                 earnings per share

ESG                environmental, social and governance

ETD                exchange-traded derivatives

ETF                 exchange-traded fund

EU                  European Union

EUR                euro

Euribor           Euro Interbank Offered Rate

EVE                economic value of equity

EY                  Ernst & Young (Ltd)

 

F

FA                  financial advisor

FCA                UK Financial Conduct
Authority

FCT                foreign currency translation

FINMA            Swiss Financial Market Supervisory Authority

FMIA              Swiss Financial Market Infrastructure Act

FSB                 Financial Stability Board

FTA                Swiss Federal Tax Administration

FVA                funding valuation adjustment

FVOCI             fair value through other comprehensive income

FVTPL             fair value through profit or loss

FX                   foreign exchange

 

G

GAAP             generally accepted
accounting principles

GBP                pound sterling

GDP               gross domestic product

GEB                Group Executive Board

GIA                 Group Internal Audit

GIIPS              Greece, Italy, Ireland,
Portugal and Spain

GMD              Group Managing Director

GRI                 Global Reporting Initiative

GSE                government-sponsored entities

G-SIB              global systemically important bank

 

H

HQLA             high-quality liquid assets

HR                  human resources

 

 

  109 


Appendix 

 

Abbreviations frequently used in our financial reports (continued)

 

I

IAA                 internal assessment approach

IAS                 International Accounting Standards

IASB               International Accounting Standards Board

IBOR               Interbank Offered Rate

IFRIC               International Financial Reporting Interpretations Committee

IFRS                International Financial Reporting Standards

IHC                 intermediate holding company

IMA                internal models approach

IMM               internal model method

IRB                  internal ratings-based

IRC                 incremental risk charge

IRRBB              interest rate risk in the banking book

ISDA               International Swaps and Derivatives Association

 

K

KRT                Key Risk Taker

 

L

LAS                liquidity-adjusted stress

LCR                liquidity coverage ratio

LGD                loss given default

LIBOR             London Interbank Offered Rate

LLC                 limited liability company

LRD                leverage ratio denominator

LTIP                Long-Term Incentive Plan

LTV                 loan-to-value

 

M

M&A              mergers and acquisitions

MiFID II           Markets in Financial Instruments Directive II

MRT               Material Risk Taker

 

N

NAV               net asset value

NCL                Non-core and Legacy Portfolio

 


NII                   net interest income

NRV                negative replacement value

NSFR              net stable funding ratio

NYSE              New York Stock Exchange

 

O

OCA               own credit adjustment

OCI                 other comprehensive income

OTC               over-the-counter

 

P

PD                  probability of default   

PFE                 potential future exposure

PIT                  point in time

P&L                profit or loss

POCI               purchased or originated credit-impaired

PRA                UK Prudential Regulation Authority

PRV                positive replacement value

 

Q

QCCP             qualifying central counterparty

QRRE              qualifying revolving retail exposures

 

R

RBA                role-based allowances

RBC                risk-based capital

RbM               risk-based monitoring

RMBS             residential mortgage-backed securities

RniV                risks not in VaR

RoAE              return on attributed equity

RoCET1          return on CET1 capital

RoTE               return on tangible equity

RoU                right-of-use

RV                  replacement value

RW                 risk weight

RWA               risk-weighted assets

 

S

SA                  standardized approach

SA-CCR          standardized approach for counterparty credit risk


SBC                Swiss Bank Corporation

SDG               Sustainable Development Goal

SE                   structured entity

SEC                US Securities and Exchange Commission

SEEOP            Senior Executive Equity Ownership Plan

SFT                 securities financing transaction

SI                    sustainable investing

SICR               significant increase in credit risk

SIX                  SIX Swiss Exchange

SME               small and medium-sized entity

SMF                Senior Management Function

SNB                Swiss National Bank

SPPI                solely payments of principal and interest

SRB                 systemically relevant bank

SRM               specific risk measure

SVaR              stressed value-at-risk

 

T

TBTF               too big to fail

TCJA              US Tax Cuts and Jobs Act

TLAC              total loss-absorbing capacity

TTC                through-the-cycle

 

U

UBS RESI        UBS Real Estate Securities Inc.

UoM               units of measure

USD                US dollar

 

V

VaR                value-at-risk

VAT                value added tax

 

W

WEKO            Swiss Competition Commission

 

 

This is a general list of the abbreviations frequently used in our financial reporting. Not all of the listed abbreviations may appear in this particular report.

110  


 

Information sources

Reporting publications

Annual publications

Annual Report (SAP No. 80531): Published in English, this single-volume report provides descriptions of: our Group strategy and performance; the strategy and performance of the business divisions and Group Functions; risk, treasury and capital management; corporate governance, corporate responsibility and our compensation framework, including information about compensation for the Board of Directors and the Group Executive Board members; and financial information, including the financial statements.

Geschäftsbericht (SAP No. 80531): This publication provides a German translation of selected sections of our Annual Report.

Annual Review (SAP No. 80530): This booklet contains key information about our strategy and performance, with a focus on corporate responsibility at UBS. It is published in English, German, French and Italian.

Compensation Report (SAP No. 82307): This report discusses our compensation framework and provides information about compensation for the Board of Directors and the Group Executive Board members. It is available in English and German.

 

Quarterly publications  

The quarterly financial report provides an update on our strategy and performance for the respective quarter. It is available in English.

 

How to order publications

The annual and quarterly publications are available in .pdf format at ubs.com/investors, under “Financial information,” and printed copies can be requested from UBS free of charge. For annual publications, refer to the “Investor services” section at ubs.com/investors. Alternatively, they can be ordered by quoting the SAP number and the language preference, where applicable, from UBS AG, F4UK–AUL, P.O. Box, CH-8098 Zurich, Switzerland.

 


Other information

Website

The “Investor Relations” website at ubs.com/investors  provides the following information about UBS: news releases; financial information, including results-related filings with the US Securities and Exchange Commission; information for shareholders, including UBS share price charts, as well as data and dividend information, and for bondholders; the UBS corporate calendar; and presentations by management for investors and financial analysts. Information is available online in English, with some information also available in German.

 

Results presentations

Our quarterly results presentations are webcast live. Recordings of most presentations can be downloaded from ubs.com/presentations

 

Messaging service

Email alerts to news about UBS can be subscribed for under UBS News Alert” at ubs.com/global/en/investor-relations/contact/
investor-services.html
. Messages are sent in English, German, French or Italian, with an option to select theme preferences for such alerts.

 

Form 20-F and other submissions to the US Securities and Exchange Commission

We file periodic reports and submit other information about UBS to the US Securities and Exchange Commission (the SEC). Principal among these filings is the annual report on Form 20-F, filed pursuant to the US Securities Exchange Act of 1934. The filing of Form 20-F is structured as a wrap-around document. Most sections of the filing can be satisfied by referring to the combined UBS Group AG and UBS AG annual report. However, there is a small amount of additional information in Form 20-F that is not presented elsewhere and is particularly targeted at readers in the US. Readers are encouraged to refer to this additional disclosure. Any document that we file with the SEC is available on the SEC’s website: sec.gov. Refer to ubs.com/investors  for more information.

  

 

  111 


Appendix 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cautionary Statement Regarding Forward-Looking Statements | This report contains statements that constitute “forward-looking statements,” including but not limited to management’s outlook for UBS’s financial performance, statements relating to the anticipated effect of transactions and strategic initiatives on UBS’s business and future development and goals or intentions to achieve climate, sustainability and other social objectives. While these forward-looking statements represent UBS’s judgments, expectations and objectives concerning the matters described, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS’s expectations. The outbreak of COVID-19 and the measures taken in response to the pandemic have had and may continue to have a significant adverse effect on global economic activity, including disruptions to global supply chains, and an adverse effect on the credit profile of some of our clients and other market participants, which has resulted in and may continue to increase credit loss expense and credit impairments. In addition, we face heightened operational risks due to remote working arrangements, including risks to supervisory and surveillance controls, as well as increased fraud and data security risks. The unprecedented scale of the measures taken to respond to the pandemic, as well as the uncertainty surrounding vaccine supply, distribution, and efficacy against mutated virus strains create significantly greater uncertainty about forward-looking statements. Factors that may affect our performance and ability to achieve our plans, outlook and other objectives also include, but are not limited to: (i) the degree to which UBS is successful in the ongoing execution of its strategic plans, including its cost reduction and efficiency initiatives and its ability to manage its levels of risk-weighted assets (RWA) and leverage ratio denominator (LRD), liquidity coverage ratio and other financial resources, including changes in RWA assets and liabilities arising from higher market volatility; (ii) the degree to which UBS is successful in implementing changes to its businesses to meet changing market, regulatory and other conditions; (iii) the continuing low or negative interest rate environment in Switzerland and other jurisdictions; (iv) developments (including as a result of the COVID-19 pandemic) in the macroeconomic climate and in the markets in which UBS operates or to which it is exposed, including movements in securities prices or liquidity, credit spreads, and currency exchange rates, and the effects of economic conditions, market developments, and increasing geopolitical tensions, and changes to national trade policies on the financial position or creditworthiness of UBS’s clients and counterparties, as well as on client sentiment and levels of activity; (v) changes in the availability of capital and funding, including any changes in UBS’s credit spreads and ratings, as well as availability and cost of funding to meet requirements for debt eligible for total loss-absorbing capacity (TLAC); (vi) changes in central bank policies or the implementation of financial legislation and regulation in Switzerland, the US, the UK, the European Union and other financial centers that have imposed, or resulted in, or may do so in the future, more stringent or entity-specific capital, TLAC, leverage ratio, net stable funding ratio, liquidity and funding requirements, heightened operational resilience requirements, incremental tax requirements, additional levies, limitations on permitted activities, constraints on remuneration, constraints on transfers of capital and liquidity and sharing of operational costs across the Group or other measures, and the effect these will or would have on UBS’s business activities; (vii) UBS’s ability to successfully implement resolvability and related regulatory requirements and the potential need to make further changes to the legal structure or booking model of UBS Group in response to legal and regulatory requirements, or other external developments; (viii) UBS’s ability to maintain and improve its systems and controls for the detection and prevention of money laundering and compliance with sanctions to meet evolving regulatory requirements and expectations, in particular in the US; (ix) the uncertainty arising from domestic stresses in certain major economies; (x) changes in UBS’s competitive position, including whether differences in regulatory capital and other requirements among the major financial centers will adversely affect UBS’s ability to compete in certain lines of business; (xi) changes in the standards of conduct applicable to our businesses that may result from new regulations or new enforcement of existing standards, including measures to impose new and enhanced duties when interacting with customers and in the execution and handling of customer transactions; (xii) the liability to which UBS may be exposed, or possible constraints or sanctions that regulatory authorities might impose on UBS, due to litigation, contractual claims and regulatory investigations, including the potential for disqualification from certain businesses, potentially large fines or monetary penalties, or the loss of licenses or privileges as a result of regulatory or other governmental sanctions, as well as the effect that litigation, regulatory and similar matters have on the operational risk component of our RWA, as well as the amount of capital available for return to shareholders; (xiii) the effects on UBS’s cross-border banking business of tax or regulatory developments and of possible changes in UBS’s policies and practices relating to this business; (xiv) UBS’s ability to retain and attract the employees necessary to generate revenues and to manage, support and control its businesses, which may be affected by competitive factors; (xv) changes in accounting or tax standards or policies, and determinations or interpretations affecting the recognition of gain or loss, the valuation of goodwill, the recognition of deferred tax assets and other matters; (xvi) UBS’s ability to implement new technologies and business methods, including digital services and technologies, and ability to successfully compete with both existing and new financial service providers, some of which may not be regulated to the same extent; (xvii) limitations on the effectiveness of UBS’s internal processes for risk management, risk control, measurement and modeling, and of financial models generally; (xviii) the occurrence of operational failures, such as fraud, misconduct, unauthorized trading, financial crime, cyberattacks, data leakage and systems failures, the risk of which is increased while COVID-19 control measures require large portions of the staff of both UBS and its service providers to work remotely; (xix) restrictions on the ability of UBS Group AG to make payments or distributions, including due to restrictions on the ability of its subsidiaries to make loans or distributions, directly or indirectly, or, in the case of financial difficulties, due to the exercise by FINMA or the regulators of UBS’s operations in other countries of their broad statutory powers in relation to protective measures, restructuring and liquidation proceedings; (xx) the degree to which changes in regulation, capital or legal structure, financial results or other factors may affect UBS’s ability to maintain its stated capital return objective; (xxi) uncertainty over the scope of actions that may be required by UBS, governments and others to achieve goals relating to climate, environmental and social matters, as well as the evolving nature of underlying science and industry and governmental standards; and (xxii) the effect that these or other factors or unanticipated events may have on our reputation and the additional consequences that this may have on our business and performance. The sequence in which the factors above are presented is not indicative of their likelihood of occurrence or the potential magnitude of their consequences. Our business and financial performance could be affected by other factors identified in our past and future filings and reports, including those filed with the SEC. More detailed information about those factors is set forth in documents furnished by UBS and filings made by UBS with the SEC, including UBS’s Annual Report on Form 20-F for the year ended 31 December 2020 and UBS’s First Quarter 2021 Report on Form 6K. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.

Rounding | Numbers presented throughout this report may not add up precisely to the totals provided in the tables and text. Percentages and percent changes disclosed in text and tables are calculated on the basis of unrounded figures. Absolute changes between reporting periods disclosed in the text, which can be derived from numbers presented in related tables, are calculated on a rounded basis.

Tables | Within tables, blank fields generally indicate non-applicability or that presentation of any content would not be meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Values that are zero on a rounded basis can be either negative or positive on an actual basis.

112  



 

UBS Group AG

P.O. Box

CH-8098 Zurich 

 

ubs.com

 

 

 

 

 


This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-253432), and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; 333-200665; 333-215254; 333-215255; 333-228653; 333-230312; and 333-249143), and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Forms 6-K of UBS AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333-111572), the Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05).

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

 

 

UBS Group AG

 

 

 

By: _/s/   Ralph Hamers _______________ 

Name:  Ralph Hamers

Title:    Group Chief Executive Officer

 

 

By: _/s/ Kirt Gardner__________________ 

Name:  Kirt Gardner

Title:    Group Chief Financial Officer

 

 

By: _/s/ Christopher Castello  ___________ 

      Name: Christopher Castello

      Title: Group Controller and

            Chief Accounting Officer

 

 

 

UBS AG

 

 

 

By:     /s/ Ralph Hamers ________________ 

Name:  Ralph Hamers

Title:    President of the Executive Board

 

 

By:     /s/ Kirt Gardner  _________________ 

Name:  Kirt Gardner

Title:    Chief Financial Officer

 

 

By:     /s/ Christopher Castello              _____ 

      Name: Christopher Castello

      Title:    Controller and Chief Accounting Officer

 

 

 

 

Date:  October 26, 2021